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ABSTRACT 
 
RECENT ADVANCES IN IMINIUM SALT  
CATALYSED ASYMMETRIC EPOXIDATION 
 
DAVID DAY 
 
Key Terms: Epoxidation, Olefin, Iminium-salt, Kinetic resolution, Chromene, 
Dihydroquinoline, Tetrahydroquinoline  
 
The research in this thesis depicts some of the most current developments in the area of 
asymmetric epoxidation of alkenes using chiral iminium salt catalysts. The first chapter 
reviews past and present developments in; catalytic asymmetric epoxidation, and covers the 
application of this reaction towards the kinetic resolution of racemic olefins. 
Chapter two is separated into two key areas; (i) asymmetric epoxidation as a tool in the kinetic 
resolution of racemic chromene substrates, and (ii) investigations into the asymmetric 
epoxidation of new N-protected dihydroquinoline substrates.  In the first part of chapter two, 
the first examples of kinetic resolution in epoxidation reactions using iminium salt catalysts 
are reported, providing up to 98% ee in the epoxidation of racemic cis-chromenes.  
The second part of chapter two details the first known examples of asymmetric epoxidation 
upon nitrogen-protected dihydroquinoline substrates, affording enantioselectivities as high as 
73% ee. 
In both parts of chapter two, non-aqueous epoxidation conditions were employed using Page’s 
dihydroisoquinolinium iminium salt catalyst. The later part of chapter two introduces a 
biphenylazepinium iminium salt catalyst used under aqueous epoxidation conditions. 
Chapter three includes experimental data for all the compounds mentioned in chapter two, 
with chapter four containing HPLC traces to show determination of enantiomeric excess of 
epoxides, and enantioenriched alkene traces. 
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1.0 Introduction: Epoxides 
Epoxides, or oxiranes, are 3-membered ring systems containing an oxygen atom and two 
atoms of carbon (Figure 1). 
 
 Figure 1. The epoxide moiety  
Epoxides have been utilised as key synthetic tools in the synthesis of some complex organic 
compounds and natural products.
1
 Hardcastle’s total synthesis of Durgamone 1 is one of many 
interesting examples in the literature that utilises an epoxide moiety as the key synthetic 
intermediate (Scheme 1). Hardcastle employed Shi’s epoxidation methodology to generate the 
epoxide intermediate, which was then able to undergo an intramolecular polyepoxide 
cyclisation process, affording the target molecule in good yield.
2
  
 
Scheme 1. Hardcastle’s synthesis of Durgamone 1 
Epoxides are more stable than some other three-membered ring systems, such as bromonium 
ions, but they have three internal bond angles of ~60°, creating a large amount of ring strain. 
Nucleophilic attack on the epoxide releases this ring strain, allowing the preferential 
tetrahedral angle of 109.5° to be restored. The example below illustrates how nucleophilic 
addition to an epoxide can occur under acid- and base-catalysed reactions (Scheme 2). 
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Scheme 2. Nucleophilic addition to an epoxide 
Under acid-catalysed conditions, nucleophilic attack occurs at the most substituted carbon 
atom of the unsymmetrical epoxide. When R
1
 and R
2
 are alkyl substituents, they stabilize the 
positive charge on the carbon at the tertiary end of the protonated epoxide. Under base-
catalysed conditions, the epoxide oxygen is a poor leaving group and attack occurs at the least 
substituted carbon atom of the unsymmetrical epoxide by a strong nucleophile. The epoxide 
ring opening reactions are stereospecific; a cis-epoxide undergoes nucleophilic attack with 
inversion giving the trans-product (Scheme 3). 
 
Scheme 3. Nucleophilic attack from underneath the upward facing cis-epoxide 
Epoxide ring-opening methodology has been applied to the synthesis of many natural products 
and drug molecules, in order to generate the correct stereochemistry in the desired target 
molecule. This approach was utilised by Page in the total synthesis of anti-hypertensive agent 
levcromakalim (3) in 2005,
3
 natural products trans-khellactone (6) and lomatin (7) in 2009,
4
 
and most recently (+)-scuteflorin A (10) in 2012.
5
 The enantioenriched epoxide intermediates 
generated from chiral iminium-salt mediated catalytic epoxidation processes were subjected to 
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ring-opening procedures, affording the desired compounds in high enantiomeric excesses in 
each case (Scheme 4). 
 
Scheme 4. Reagents and conditions: (i) pyrrolidin-2-one, NaH, DMSO, r.t., 4 h, 52%; (ii) 
TPPP (2 eq.), iminium salt 11 (10 mol%), CHCl3, -30°C, 24 h, 65%; (iii) 1M 
H2SO4/CH3COCH3 (1:2 ratio), r.t., 1 h, 95%; (iv) NaBH3CN (1 eq.), BF3.OEt2, THF, 0 °C, 30 
min, 92%; (v) TPPP, iminium salt 12 (5 mol%), CHCl3, -30°C, 30 h, 97%. 
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1.1 Natural Product Epoxides 
The epoxide functional group can be found within numerous natural products, many of which 
exert specific biological activities. The pressure on pharmaceutical companies to supply an 
ever growing demand for more potent pharmaceuticals to be used in curing or treatment of 
illnesses has never been greater, with many drug molecules still being based upon natural 
product structures. This can be illustrated with the anti-cancer drug Ixempra® 13, a semi-
synthetic lactam derivative, which is based upon the bacterial natural product epothilone B 14 
(Figure 2).
6 
 
Figure 2. Advanced breast cancer drug Ixempra® and natural product Epothilone B 
New natural products containing this core epoxide motif are being discovered frequently from 
sources including bacteria, plants (15-19), and marine fungi (20-21) (Figure 3).
 Figure 3. Nigellamines 15-19,7 Ecklonialatone B 20,8 and 12-Epoxyobtusallene 21.9 
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1.2 Epoxidation Reactions 
1.2.1 Prileschajew Reaction 
The first non-selective epoxidation reactions using peroxycarboxylic acids were first 
discovered in 1909 by Prileschajew. Isolated double bonds within simple and complex 
molecules can be oxidized, forming oxiranes, as racemic mixtures (Scheme 5).
10
  
 
Scheme 5. Reagents and conditions: peroxycarboxylic acid (1 eq.), 
CHCl3/CH2Cl2/C6H6/(CH3)2CO, 0 – 30 °C 
The mechanism for the stereospecific Prileschajew epoxidation involves syn addition of 
electrophilic oxygen to the nucleophilic alkene double bond in a concerted process (Scheme 
6).  In 1950, Bartlett proposed the epoxidation of alkenes with peracids proceeded via a 
concerted butterfly mechanism,
11
 in which synchronous formation of the two C-O bonds is 
observed. Bach
12
 and Yamabe
13
 reported their individual theoretical studies on the epoxidation 
of ethylene with performic acid, and they showed the reaction proceeds via a spiro transition 
state (however, their individual models vary only by how synchronous the two C-O bond 
formations occur). The peroxycarboxylic acid is consumed within the reaction, and the 
carboxylic acid by-product is usually quenched by the addition of a weak base 
(NaHCO3/KHCO3/Na2HPO4).
14
 
 
Scheme 6. Mechanistic view of the Prileschajew reaction 
The application of the Prileschajew reaction has been essential to many natural product 
syntheses. In 2003, Overman applied the Prileschajew reaction as a key step in the synthesis of 
Briarellin F 23. The epoxidation of alkene 22 proceeded in good yield and diastereoselectivity, 
in which oxygen transfer is favoured from the underside of alkene 22 (Scheme 7).
15 
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Scheme 7. Overman’s synthesis of Briarellin F 23 
 
1.2.2  Sharpless Asymmetric Epoxidation 
The first advancements in highly enantioselective asymmetric epoxidation involved the use of 
metal-based catalysts. The epoxidation of allylic alcohols by Sharpless and Katsuki reported 
the first high enantioselectivities with metal based catalysts.
16
 The proposed mechanism for 
the Sharpless asymmetric epoxidation can be broken down into key steps (Scheme 8). Firstly, 
titanium(IV) tetraisopropoxide undergoes ligand exchange with a chiral diethyl tartrate, 
forming an active dimeric structure. The allylic alcohol substrate and the nucleophilic oxidant 
tert-butylhydroperoxide (TBHP) undergo ligand exchange with isopropoxide ligands. Both the 
allylic alcohol and TBHP are now coordinated axially on the titanium metal centre, allowing 
enantioselective epoxidation of the alkene.
16,17
 Sharpless was later awarded the Nobel prize for 
chemistry in 2001 for his groundbreaking discoveries in asymmetric catalysis. 
 
Scheme 8. Sharpless chemoselective asymmetric epoxidation  
Chapter 1 - Introduction 
 
 
7 
 
Depending on whether the natural L-(+)- or unnatural D-(–)-tartrate is used, it is possible to 
obtain either enantiomer of the epoxide product. All Sharpless epoxidation reactions follow a 
mnemonic model (Scheme 9). 
 
Scheme 9. Sharpless’s epoxidation of allylic alcohols. 
Sharpless reported a range of different allylic alcohol substrates which could be epoxidized 
using this metal-based asymmetric epoxidation methodology (using the natural L-(+)-diethyl 
tartrate), affording yields of 70 – 87%, and enantiomeric excesses greater than 90% (Table 1).  
 
Allylic Alcohol 
Substrate 
Epoxyalcohol 
Product 
% Yield 
(% ee) 
 
 
 
 
77 (95) 
 
 
 
 
79 (94) 
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70 (>95) 
 
 
 
 
87 (>95) 
  
Table 1. Asymmetric epoxidation of various allylic alcohols 
However, the Sharpless asymmetric epoxidation has its drawbacks; the use of potentially toxic 
transition metals is undesirable in organic reactions, and, more importantly, the methodology 
is limited to substrates that contain an allylic alcohol moiety. Furthermore, Sharpless noticed 
that trace amounts of water in the system poisoned the titanium-based catalyst, resulting in 
incomplete conversions (60% max.), longer reaction times and reduced enantioselectivities (39 
– 80% ee).18 This problem could, however, be overcome by the addition of 3Å or 4Å 
molecular sieves to the reaction, which in turn allowed the reduction of the titanium(IV) 
isopropoxide catalyst loading to a more economic 5 – 10 mol%. 
The key step in a total synthesis of (+)-parviflorin 26 was achieved using the Sharpless 
asymmetric epoxidation of the bis-allylic alcohol 24, using the natural L-(+)-diethyl tartrate, to 
give the enantiopure bis-epoxide in 87% yield (99% ee). The epoxide in turn undergoes a 
Sharpless asymmetric dihydroxylation to afford the bis-tetrahydrofuran backbone of the 
natural product (Scheme 10).
19
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Scheme 10. Hoye’s total synthesis of (+)-Parviflorin 26 utilising the Sharpless epoxidation 
 
1.2.3  Jacobsen-Katsuki Epoxidation 
The Jacobsen-Katsuki epoxidation of alkenes involves a manganese-salen based catalyst 
(Figure 4). Depending on the temperature required for the reaction, a range of oxidants 
(iodosylbenzene, sodium hypochlorite, Oxone™, hydrogen peroxide) can be used to oxidize 
the manganese(III) metal centre to manganese(V). The synthesis of salen-based catalysts is 
generally simple, and can be fine-tuned by choosing the appropriate diamine and 
salicylaldehyde precursors.  
 
Figure 4. Examples of Jacobsen’s 27 and Katsuki’s 28 manganese-salen catalysts 
Jacobsen initially showed that his manganese-salen catalysts could oxidize a range of alkyl 
and aryl substituted olefins in good to high enantioselectivities (Table 2).
20
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Olefin Catalyst % Yield % ee Configuration 
 
30-(R,R) 50 59 (–)-1R,2S 
 
30-(R,R) 52 93 (–)a 
 
29-(S,S) 63 33 (–)-S,S 
 
30-(R,R) 72 78 (+)-1R,2S 
a
 Absolute configuration not ascertained. Solvents used vary depending upon which catalyst 
used; (R,R) = CH2Cl2, (S,S) = CH3CN. 
Table 2. The first examples of high enantioselectivities observed using a manganese-salen 
catalyst 
Further probing of the ligands surrounding the manganese metal centre yielded catalyst (27) 
(Figure 4), showing further increases in enantioselectivity. Jacobsen tested other oxidants, 
including commercial bleach, and found that epoxidation reactions at 4 °C yielded 
enantioselectivities above 90% ee for selected olefins (Table 3).
21
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Olefin 
Epoxide yield 
/ % 
% ee 
 
84 92 
 
96 97 
 
65 89 
Table 3. Asymmetric epoxidation of representative olefins using catalyst (27) 
 
Katsuki reported some excellent enantioselectivities for the catalytic asymmetric epoxidation 
of cis-olefins with his salen-manganese(III) complex (Figure 4, catalyst 28). Their best 
conditions involved the use of iodosylbenzene as the terminal oxidant in the presence of an 
additive, such as pyridine N-oxide, with enantiomeric excesses as high as 91% (Table 4).
22
 
 
Cis-olefin substrate 
Time, 
(h) 
% Yield % ee 
 
 
 
24 77 86 
 
 
 
24 99 89 
 
 
 
24 52 91 
Table 4. Katsuki’s asymmetric epoxidation of various cis-olefins 
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Both Jacobsen and Katsuki have proposed their own mechanisms to explain how the oxygen 
transfer to the olefin occurs, but both mechanisms are consistent in assuming the intermediate 
is the manganese(V) species.
23
 The different mechanisms proposed by Jacobsen and Katsuki 
account for the enantioselectivity observed. Lineker has also discussed the mechanistic aspects 
of the manganese-salen catalysed epoxidation.
24
 
 
For the manganese salen catalyst drawn below (Scheme 11), Jacobsen’s theory involves the 
approach of the olefin from a ‘top-on’ approach, where the olefin approaches from the 
direction of the diimine bridge, with the smallest substituent on the olefin aligned with the 
axial hydrogen of the chiral center. Jacobsen reported the high enantioselectivity observed in 
the epoxidation of cis-β-methylstyrene was due to the less hindered diimine bridge (in 
comparison to diimine bridge in catalyst 28-(R,R), table 2), favouring attack from above, and 
any side-on olefin approaches were nullified by the introduction of large 
t
Bu groups.
17
 
Jacobsen’s theory was supported by testing upon further cis-olefins, affording ee’s above 90% 
(Table 3).  
In contrast, Katsuki has suggested a ‘side-on’ approach of the olefin to the manganese-oxo 
bond due to favourable π-π interactions.25  
The lack of stereospecificity observed in the manganese-catalysed epoxidations has led to 
controversy in the mechanism of oxygen transfer to the double bond. A radical mechanism 
suggests that the trans-epoxide can be formed by a single electron transfer mechanism, due to 
C-C bond rotation around the intermediate species (Scheme 11).
26
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Scheme 11. The proposed mechanisms of enantioselective epoxidation utilising manganese-
salen based catalysts. 
Jacobsen found that epoxidation reactions using his manganese-salen based catalysts can be 
affected by chiral quaternary ammonium salts, which cause a dramatic reversal in epoxidation 
diastereoselectivity, favouring the trans-epoxide products in high d.r. (>96:4) and high 
enantioselectivity (>80 %)  (Scheme 11).
27
 The Jacobsen-Katsuki epoxidation has recently 
been utilized in the synthesis of the tetrasubstituted dihydroquinoline portion of Siomycin D1 
33 (related to peptide antibiotics) by Hashimoto. Epoxidation of the double bond at the C7-C8 
position gave epoxide 32 in 43% yield and 91% ee (Scheme 12).
28
 
Scheme 12. Reagents and conditions: (i) 4-phenylpyridine-N-oxide (50 mol%), NaOCl, 
CH2Cl2, 28 (5 mol%), r.t., 2.5 h, 43%, 91% ee. 
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1.3  Organocatalysis 
Entering the 21
st
 century, the demand for organic chemists to develop new methodologies and 
strategies to make syntheses of drug molecules and natural products more cost-efficient and 
most importantly, environmentally-friendly, has never been greater. With rapid progress being 
made in ‘green chemistry’, a reduction in the use of toxic metals becomes ever more desirable. 
The discovery of metal-free catalysts that are easily synthesized, that give high levels of 
conversion at low catalyst loadings, and provides high enantioselectivities would be an ideal 
alternative. Such catalysts have been coined ‘organocatalysts’, with many being derived from 
simple, cheap, low molecular weight starting materials, obtained from the pool of chiral 
compounds. There are many examples of these organocatalysts in the literature, but a few of 
the most successful are highlighted below, all affording enantiomeric excesses of >90% (Table 
5). The organocatalysts themselves could be taken from the chiral pool directly, for example 
proline and quinine, and others are formed after short syntheses from chiral building blocks. 
 
Precursor to organocatalyst / 
Organocatalyst 
Discovered 
By/Year... 
Reaction / Function 
 
 
 
L-proline 
 
Hajos and 
Parrish,
29
 Eder, 
Sauer and 
Wiechert.
30
 
Catalyses Aldol type 
reactions, via iminium 
ion or enamine 
pathways  
 
 
 
Quinine 
 
 
Wynberg et al. 
31
 / Bolm et al.
32
 
Chiral base catalysed 
Michael additions, 2 + 
2 cycloadditions/ 
Alkaloid-mediated 
opening of prochiral 
cyclic anhydrides 
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Oligo-L-Leu amino acid 
Juliá, Colonna et 
al.
33
 
Epoxidation of 
chalcones 
 
 
 
Oxazolidinone 
MacMillan et 
al.
34
 
Secondary amine 
catalysed Diels-Alder 
reaction 
 
 
 
Chiral pyrrolidine 
Jørgensen et 
al.
35
 
Asymmetric 
Organocatalytic 
Epoxidation of α,β-
Unsaturated 
Aldehydes  
   
Table 5. Organocatalysts used to affect asymmetry in different organic reactions 
The popularity of organocatalysts is evident; a recent search in the literature showed that in 
2011 alone, over 584 reviews, journals and publications contained the terminology 
‘organocatalyst’.36 Over the past few decades, there has been a significant increase in 
publications in this ever developing area of organic chemistry, as represented in the chart 
below (Figure 5). 
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Figure 5. Publications containing the term ‘organocatalyst’ from 2000 onwards 36   
 
1.4  Non-Metal Catalysed Epoxidations 
Most recently, a new generation of metal-free epoxidation catalysts have been developed and 
offer some key advantages. Organocatalysts used in epoxidation reactions show a lack of 
sensitivity to moisture and oxygen allowing the use of water as a solvent in reactions, and 
have low toxicity due to the absence of transition metals (e.g Ti, Mn, Co). 
Chiral dioxiranes,
 
oxaziridines, amines and oxaziridinium salts
 
are all examples of 
organocatalysts that have been recently reported to effect the asymmetric epoxidation of both 
electron rich and deficient olefins, and their corresponding successes are discussed in depth 
below. 
 
1.4.1  Ketone Catalysed Epoxidations 
When suitable ketones are used in the presence of an oxidant (e.g. Oxone™), dioxirane 
species are formed in situ, which are potent oxygen transfer agents.
37
 Some of the most 
powerful dioxirane reagents can be prepared from cheap ketones, such as acetone. The most 
common dioxiranes used in epoxidation reactions are dimethyldioxirane 34 and 
methyl(trifluoromethyl)dioxirane 35 (Figure 6). 
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Figure 6. dimethyldioxirane 34 and methyl(trifluoromethyl)dioxirane 35 
Isolation of the dioxiranes shown above is generally achieved by distillation of the crude 
reaction mixture between the ketone and Oxone™. Dioxirane formation starts by nucleophilic 
attack of a peroxomonosulfate anion on the carbon atom of ketone 36 affording Criegee 
intermediate 37. This intermediate breaks down to form dioxirane 38 driven by the loss of 
potassium hydrogen sulfate (Scheme 13).  
 
Scheme 13. Formation of dioxirane from ketone 
The catalytic cycle shown below indicates the transfer of electrophilic oxygen to an alkene, 
resulting in the formation of an epoxide product, and the recycling process involving the 
ketone catalyst (Scheme 14).  
 
Scheme 14. Catalytic cycle for ketone-catalysed epoxidation with Oxone™ 
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In the instance of the ketone being chiral, oxygen transfer to a prochiral alkene will occur with 
chirality induced into the epoxide product, thus making the catalytic cycle asymmetric. 
Dioxiranes are useful synthetic tools. They are usually employed under mild conditions, and 
they can be used for the epoxidation of electron-rich and electron-deficient alkenes. Another 
key advantage of dioxiranes is their stereoselectivity. 
 
1.4.2 Curci’s Ketones: The First Examples of Ketone Based Asymmetric Epoxidation  
Comprehensive studies by Curci,
38
 Adam
39
 and Baumstark
40
 attempted to elucidate the oxygen 
transfer mechanism from dioxirane species to alkene substrates. Epoxidation of acyclic 
alkenes with dimethyldioxirane was found to yield the cis-epoxides from cis-alkenes at a 
much faster rate than the trans-epoxide from trans-alkenes.
39,40
 Baumstark originally proposed 
a spiro arrangement in the transition state to be favoured;
40
 however, calculations by Bach, 
and more recently calculations by Houk, have shown that the energy difference between the 
two extreme geometries turned out to be quite small (Figure 7).
41
 
 
Figure 7. ‘Spiro’ transition state 
Curci showed that ketone-mediated epoxidations could be applied asymmetrically. His 
reported initial enantioselectivities were low (10 – 12% ee), when chiral ketones (S)-(+)-3-
phenylbutan-2-one 39 and (+)-isopinocamphone 40 were used in the epoxidation of 1-
methylcyclohexene (Scheme 15).
42
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Scheme 15. Reagents and conditions: (i) Ketone (0.2 – 0.5 eq.), Oxone (2.5 eq.), CH2Cl2-H2O, 
pH 7-8 (Bu4N
+
 HSO4
-
), 5°C, 8 – 24 h. 
The chiral ketones used by Curci have only one stereogenic centre adjacent to the carbonyl 
group. With good yields being generated using the ketone-based epoxidation, an explanation 
for the low enantioselectivites observed was proposed. It is thought that the olefin has access 
to both faces of the non-C2-symmetric dioxirane, which would result in differing 
stereoselectivities, and potentially opposing stereoselectivity, during the transfer of oxygen to 
the olefin (Figure 8).
43
 
 
Figure 8. Curci’s asymmetric epoxidation utilising non-C2-symmetric dioxiranes 
The pioneering work reported by Curci, however, set the foundations for further advancements 
in asymmetric epoxidation reactions using chiral ketones. 
 
1.4.3  Yang’s Ketone-Based Epoxidations 
Yang’s first development in the field of ketone-catalysed epoxidations was the introduction of 
a new biphasic solvent system: acetonitrile-water (Scheme 16). These new biphasic 
epoxidation conditions improved upon the previous dichloromethane-water biphasic 
conditions employed by Curci, which were known to induce much lower reaction rates. 
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Methyl(trifluoromethyl)dioxirane 35 was already known to be 1000 times more reactive than 
DMDO, so in choosing dioxirane 35 coupled with the new solvent system, both electron-
deficient olefins and electron-rich olefins were successfully oxidized in excellent yields (Table 
6).
44
 
 
Scheme 16. Reagents and conditions: (i) Methyl(trifluoromethyl)dioxirane 35, Oxone, 
NaHCO3, CH3CN-H2O, 0 °C, pH 7 – 7.5, <2 h.  
Olefin Time Epoxide % Yield 
 
15 min 
 
96 
 
30 min 
 
99 
 
1.3 h 
 
99 
 
1.25 h 
 
99 
 
30 min 
 
97 
 
15 min 
 
84 
Table 6. Epoxidation of olefins using methyl(trifluoromethyl)dioxirane 35 generated in situ 
 
Yang identified two key approaches to improve upon the poor enantioselectivities observed in 
the case of Curci’s non-C2-symmetric dioxiranes. By blocking one face of the dioxirane, it 
would allow oxygen transfer to take place at the other face exclusively. Alternatively, Yang 
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proposed designing a ketone-based catalyst that has C2-symmetry, which would give rise to 
the same enantioselectivity irrespective of which face the olefin approaches. Both faces of the 
dioxirane in this instance have the same chiral environment for oxygen transfer (Figure 9). 
 
Figure 9. Asymmetric epoxidation by C2 symmetric dioxiranes. 
In 1998, Yang and co-workers investigated the catalytic activities of various cyclic ketones in 
the epoxidation of trans-stilbene. Their best result came from a biphenyl-derived 11-
membered-ring ketone catalyst 41. Trans-stilbene oxide was obtained in 99% yield in 7 
minutes, with 93% catalyst recovery (Scheme 17).
45
 
 
Scheme 17. Reagents and conditions: (i) Ketone 41 (1 mol%), Oxone, NaHCO3, CH3CN-
H2O, pH 7 – 7.5, r.t., 5 min. 
Epoxides that are acid labile could be easily isolated when sodium bicarbonate was used to 
regulate the pH of the reaction at around 7 – 7.5. A range of olefins were then tested using this 
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biphenyl-derived 11-membered-ring ketone catalyst under these conditions, resulting in high 
yields ranging from 75 – 96% (Table 7).45  
Alkene 
Time 
(min) 
Product % Yield 
 
160 
 
91 
 
60 
 
75 
 
330 
 
96 
Table 7. Reagents and conditions: Ketone 41 (5 mol%), Alkene (0.2 mmol), Oxone™ (0.4 
mmol), NaHCO3 (1.24 mmol), MeCN/H2O (1.5:1) 
 
Encouraged by these results, Yang replaced the biphenyl segment on their 11-membered ring 
ketone catalyst 41 with a chiral binaphthalene unit, to generate a chiral ketone catalyst that has 
C2-symmetry. Chiral ketone 42 catalysed the asymmetric epoxidation of trans-4,4’-
diphenylstilbene in 87% ee (Figure 10).
46
 
 
Figure 10. Asymmetric epoxidation of trans-4,4’-diphenylstilbene using Yang’s C2-
symmetric chiral (R)-binaphthalene catalyst 42 
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Yang expected the H-3 and H-3’ atoms of the binaphthyl group to act as steric recognition 
elements. The distance between the catalytic keto group and the H-3 and H-3’ atoms of the 
binaphthyl group is around 5 Å apart. By replacing the protons with other larger atoms or 
groups (ketones 43-49, Table 8) Yang hoped that increased enantioselectivities would be 
obtained. The reported enantioselectivities are shown below (Table 8).
46  
 
 Catalyst X ee (%) 
Epoxide 
Config. 
 
(R)-42 H 47 (−)-(S,S) 
(R)-43 Cl 76 (−)-(S,S) 
(R)-44 Br 75 (−)-(S,S) 
(R)-45 I 32 (−)-(S,S) 
(S)-46 Me 56 (+)-(R,R) 
(R)-47 CH2OCH3 66 (−)-(S,S) 
(R)-48 
 
71 (−)-(S,S) 
(S)-49 SiMe3 44 (+)-(R,R) 
 
Table 8. Asymmetric epoxidation of trans-stilbene catalysed by ketones 42-49 
Interestingly, the enantioselectivities increase with increasing size of group X, to a point, then 
decrease when the group is too large, i.e. when X = I, SiMe3. 
Yang’s ketone catalyst (R)-42 was used by the Japanese company Tanabe Seikayu to effect the 
epoxidation of methyl p-methoxycinnamate 50 (MPC), which yields an important chiral 
epoxide intermediate 51 (64% yield, 99% ee after recryst.) in the synthesis of the chiral drug 
Diltiazem hydrochloride 52 (Scheme 18).
47
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Scheme 18. Asymmetric epoxidation of MPC catalysed by (R)-42 
 
1.4.4  Shi’s Fructose Ketone Epoxidations 
In 1996, Shi reported fructose-derived ketone 54 as an enantioselective epoxidation catalyst.
48
 
This chiral ketone catalyst can be easily synthesized from D-fructose 53 in two steps (Scheme 
19).
49
 
 
Scheme 19. Reagents and conditions: (i) Acetone, HClO4, 0 °C, 53%; (ii) PCC, CH2Cl2, r.t., 
93% 
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In 1997, Shi reported extremely high enantioselectivities for catalyst 54 when used 
catalytically (30 mol%) for the asymmetric epoxidation of various trans- and trisubstituted 
olefins (Table 9).
48 
Substrate % Yield 
% ee / 
(config.)  
 85 98 (R,R) 
 94 96 (R,R) 
 
92 92 (R,R) 
 
89 96 (R,R) 
 
94 98 (R,R) 
 
41 97 (R,R) 
 
Table 9. Shi’s epoxidation examples of trans and trisubstituted olefins with chiral ketone 54 
Shi also showed that catalyst 54 was highly effective for the epoxidation of various 2,2-
disubstituted vinylsilanes, affording ee’s up to 94%.50 Shi further showed that 
hydroxyalkenes,
51
 conjugated dienes,
52
 conjugated enynes,
53
 and silyl enol ethers and esters
54
 
all underwent asymmetric epoxidation reactions using ketone 54 in very high 
enantioselectivity (>90% ee) (Table 10).  
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Substrate % Yield 
% ee / 
(config.) 
 
74 94 (R,R) 
 85 94 (R,R) 
 
93 94 (R,R) 
 
78 93 (R,R) 
 
87 91 (R,R) 
 
82 95 (R,R) 
 
Table 10. Shi’s epoxidation of a broad range of olefin substrates utilizing versatile catalyst 54 
After the initial successes achieved with chiral ketone 54, Shi observed that it would be 
desirable to reduce the high catalyst loadings associated with the methodology (usually 30 
mol%). He studied the effect of pH on the epoxidation reaction, and found at pH 7-8 that 
enantiomeric excesses >90% could be achieved for trans- and trisubstituted olefins.
48
 He 
believed that the high catalyst loadings were required at this pH as intermediate 55 could 
undergo a decomposition side reaction through a Baeyer-Villiger oxidation, to yield the 
corresponding lactones 58 and 59 (Scheme 20). 
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Scheme 20. Mechanism of oxygen transfer in Shi’s asymmetric epoxidation utilising chiral 
ketone 54 
Shi reported the epoxidation of trans-β-methylstyrene with ketone 54 at pH >10, and found 
that the higher pH enhanced catalyst efficiency, without any loss of enantioselectivity 
observed during the epoxidation reaction (ee’s remained high, >90%). The optimum pH for 
the reaction was 10.5, at which ketone 54 reacts with Oxone at a greater rate than that of the 
autodecomposition of Oxone at a higher pH.
55
 
Hydrogen peroxide is a suitable alternative to Oxone; hydrogen peroxide possesses a high 
active oxygen content and its reduction product is water. Shi found that replacing Oxone, the 
traditional oxidant used in dioxirane formation, with a system that generates peroxyimidic acid 
in situ was capable of yielding the corresponding dioxirane from ketone 54. Shi reported good 
yields and enantioselectivities for a range of olefins under these acetonitrile-hydrogen 
peroxide conditions (Table 11).
56
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Substrate % Yield  % ee  
 
77 92 
 90 98 
 
93 95 
 71 89 
 
Table 11. Asymmetric epoxidation with ketone 54 and H2O2 as oxidant 
As stated briefly above, Curci,
38
 Adam
39
 and Baumstark
40
 have shown that dioxirane-mediated 
epoxidations of olefins occur via a spiro transition state, as opposed to a planar one. The spiro 
transition state is favoured for the epoxidation of ethylene with DMDO due to oxygen lone 
pair interactions with the π* orbital of the alkene (Figure 11).40 
 
Figure 11. ‘Favoured’ spiro and ‘Disfavoured’ planar transition states 
Shi reported that chiral ketone catalyst 54 can form two key sterically favoured transition 
states in the asymmetric epoxidation of various trans and trisubstituted olefins; these are the 
favoured spiro transition state and a competing planar transition state (Figure 12).
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Figure 12. Possible spiro and planar transition states with catalyst 54 
As shown (Figure 12) the spiro transition state and planar transition state yield opposite 
configurations of the epoxide product. However, the planar transition state may become more 
prominent depending on the electronic and steric substituents on the olefin substrate. Spiro 
transition states are favoured when the olefin contains a conjugated group, such as 
phenyl/alkyne, or for example when R1 is small in size, encouraging a spiro transition state, or 
when R3 is large, disfavouring a planar transition state (Figure 13).  
Shi furthered these studies with the kinetic resolution of racemic olefins with ketone 54.
57
 Shi 
later reported a number of analogues of chiral ketone catalyst 54 prepared in order to 
investigate the key moieties of the catalyst structure (Figure 13). Initially, he replaced the 5-
membered spiro ketal in ketone 54 with a 6-membered cyclic ketal 60,
58
 varied the size of the 
groups attached to the ketal 61, and replacing the oxygen of the pyranose ring 62.
59
 In each 
structural comparison, ketone 54 was still the superior catalyst, indicating that all moieties in 
catalyst 54 are beneficial to catalyst functionality. 
 
Figure 13. Shi’s analogues of ketone catalyst 54 
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Shi initially reported two possible lactones, 58 and 59, could be generated in the competing 
Baeyer-Villiger decomposition reaction (Scheme 20). When ketone catalyst 54 was reacted 
with mCPBA, he observed lactone 59 was the major product, indicating that C4 on ketone 
catalyst 54 is more prone to migrate than C2 in the Baeyer-Villiger reaction.
60
 Shi synthesized 
oxazolidinone catalyst 63 in order to investigate the electronic effect at C4 in these ketone 
catalysts. The electron withdrawing nature of the oxazolidinone moiety in catalyst 63 allowed 
lower catalyst loadings (1 – 5 mol%, in comparison to catalyst 54; 20 – 30 mol%), yet still 
affording good yields and high enantioselectivities for a range of olefins.
60
  
Enhanced ketone stability and reactivity was shown in ketone catalyst 64, where the fused 
ketal moiety in catalyst 54 was replaced with electron withdrawing acetate groups. Catalyst 64 
was found to be effective for the epoxidation of challenging substrates such as α,β-unsaturated 
esters, affording ee’s up to 98%.61  
Ketone 65 was found to be highly effective for the epoxidation of a variety of cis-olefins and 
terminal olefins.
62
 Mechanistic studies have shown that electronic interactions between the 
oxazolidinone moiety of ketone 65 and the approaching substituents on the cis-olefin 
substrates play a key role in the transition state of oxygen transfer. 
Most recently, the Shi group has reported that ee’s of up to 92% have been achieved using 
catalyst 65 in the epoxidation of various cis-olefins as substrates (Table 12).
63
   
Substrate 
R subst. on ketone 
40 
Temp. 
/ ˚C 
Time / 
h 
% Yield % ee 
 
p-n-BuPh 0 8 52 64 
 
p-n-BuPh -10 4 89 82 
 
BOC -10 12 76 92 
Table 12. Shi’s epoxidation of various cis-based olefins 
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1.4.5  Armstrong’s Tropinone-Catalysed Epoxidations 
Armstrong has shown that a range of -substituted-N-ethoxycarbonyltropinone catalysts (66-
67,
64
 68 – 76)65 is capable of epoxidizing alkenes using Oxone as the terminal oxidant, 
affording excellent conversions and good enantioselectivities (Figure 14).
64,65 
 
Figure 14. Armstrong’s -substituted-N-ethoxycarbonyltropinone ketone catalysts 
Initial studies by Armstrong looked into the commercially available racemic N-
ethoxycarbonyltropinone 66 (Figure 14). Promising initial results showed that the epoxidation 
of trans-stilbene was complete after 3 hours. Armstrong proposed that the introduction of an 
electron-withdrawing substituent adjacent to the carbonyl group would increase the reactivity 
of the catalyst, for example racemic -fluoro-derivative 67, which at 25 mol% afforded trans-
stilbene oxide in 100% conversion after 30 minutes (Table 13). 
Entry 
(+)-67  
(mol%) 
Conv.  
(%) 
Time 
(h) 
1 100 100 <0.25 
2 50 100 <0.25 
3 25 100 <0.5 
4 10 100 2 
5 5 100 ≤20 
6 1 62 24 
 
Table 13. Oxone derived epoxidation of trans-stilbene catalysed by racemic ketone 67 
Armstrong further showed that chiral ketone 67 could be employed for the asymmetric 
epoxidation of a range of olefins, affording ee’s up to 83% (Table 14). 
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Alkene 
(+)-67 
(mol%) 
% 
Conv.   
Time 
/ h 
% 
Yield 
% ee 
Config. 
 
10 100 < 3 88 76; R,R 
 
10 100 < 4 100 73; R,R 
 
10 100 < 4 100 83; R 
 
10 100 <6 97 69; R 
 
10 100 < 2 33 29; R 
 
25 64 24 33 64 
 
Table 14. Asymmetric epoxidation of alkenes catalysed by ketone (+)-67 
 
Armstrong subsequently showed that non-racemic esters of hydroxy-8-
oxabicyclo[3.2.1]octan-3-one (catalysts 70 – 76) afforded promising asymmetric epoxidation 
(98% ee for phenylstilbene with 70), after initial screening experiments of the corresponding 
racemic catalysts yielded moderate to good conversions (Table 15).
65
 
 
 
Chapter 1 - Introduction 
 
 
33 
 
Ketone 
(E)-Stilbene Styrene α-Methylstyrene 
Conv. ee Conv. ee Conv. ee 
70 85 93 100 48 100 10 
72 39 75 100 36 100 11 
73 41 78 100 35 100 15 
74 46 81 100 40 100 10 
75 53 67 100 31 75 19 
76 24 46 100 25 65 26 
Table 15. Epoxidation results for Armstrong’s ester-derived non-racemic ketones 70 – 76 
(Figure 14) 
 
1.4.6  Denmark’s Ketone-Catalysed Epoxidations 
Denmark’s first adventures into ketone-derived epoxidations began in 1995, when he 
investigated a phase-transfer ketone catalyst operating under a new biphasic epoxidation 
system, utilising Oxone as the oxidant.
66
 Optimization of the catalytic system led to a range of 
olefins oxidized in excellent yields (> 83%) (Table 16). Denmark identified that using the 
correct pH (7.5 - 8) with an N-dodecyl chain present on the catalyst were essential for 
effective epoxidation reaction. 
 
 
Table 16. Denmark’s N-alkyl, N-methyl piperidinium triflate phase-transfer catalyst 77 
 
 
 
Alkene % Conv. % Yield 
1-octene 100 91 
cyclohexene 100 92 
2-cyclohexen-1-ol 96 83 
(E)-2-methylstyrene 100 96 
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Denmark later reported that a seven-membered ring carbocyclic chiral ketone 78 containing a 
fluorine substituent at the α-carbon had a dramatic effect on the epoxidation of olefins. 
Catalyst 78 was found to afford ee’s up to 94% (Table 17).67 
 
Substrate % Yield % ee 
 
79 59 
 
67 12 
 80 88 
 
55 43 
 46 94 
 
Table 17. Denmark’s α-fluorinated ketone mediated epoxidations 
 
1.4.7  Oxaziridine Mediated Epoxidations 
During the eighties, Davis reported the synthesis of optically active 2-sulfonyl- and 2-
sulfamyloxaziridines (Figure 15), formed by oxidation of their corresponding sulfonylimine or 
sulfamylimine using either mCPBA or Oxone.
68
 
 
 
Figure 15. Davis’s 2-Sulfonyloxaziridine and 2-Sulfamyloxaziridine 
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These chiral oxaziridines were reported to oxidize non-functionalized sulfides (enantiomeric 
excesses up to 91% observed),
69
 and to epoxidize olefins (up to 65% ee, Table 18) utilising 
oxidants 79 – 82.70 
 
Oxaziridine  Solvent Temp (˚C) Alkene ee (%) Config. 
79 CHCl3 60  34.9 (R,R) 
80 CHCl3 60  30.3 (S,S) 
81 CHCl3 25  53 (R,R) 
82 CHCl3 25 
 
61.1 (S) 
 
Table 18. Davis epoxidation using chiral 2-sulfonyl- and 2-sulfamyloxaziridines 79 – 82 
In 1995, Page reported that enantioselectivities as high as 98% ee could be achieved for the 
enantioselective oxidation of sulfides utilizing [(3,3-dimethoxycamphoryl)sulfonyl]oxaziridine 
83 (Figure 16).
71
  
 
Figure 16. Page’s highly effective oxaziridine catalyst 83    
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1.4.8  Aggarwal’s Amine-Catalysed Epoxidations 
Chiral amine-catalysed epoxidations of simple olefins were first reported by Aggarwal in 
2000.
72
 Aggarwal reported that a chiral derivative of pyrrolidine, (S)-2-
(diphenylmethyl)pyrrolidine 84, allowed the conversion of 1-phenylcyclohexene into its 
corresponding epoxide in 57% ee (Scheme 21).  
 
Scheme 21. Aggarwal’s epoxidation mechanism utilizing amine 84 
 
However, the reproducibility of key reactions proposed has led to ongoing research into the 
exact mechanism for the chiral-amine catalysed reactions.
73 
Aggarwal later proposed a new 
catalytic cycle for the asymmetric epoxidation of various olefins utilizing the hydrochloride 
salt of amine 84, affording ee’s up to 52%.74 
 
1.4.9  Yang’s Amine-Catalysed Epoxidations 
Yang showed that her fluorinated chiral secondary amine catalysts were effective in the 
epoxidation of 1-phenylcyclohexene, affording ee’s as high as 61% when utilizing chiral 
proline-derived catalyst 85 (Scheme 22).
75
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Scheme 22. Reagents and conditions: (i) Amine 85 (5 mol%), Oxone (2 eq.), NaHCO3 (5 eq.), 
CH3CN-H2O (10:1), r.t., 2 h, 92%, 61% ee. 
 
1.4.10  Page & Lacour’s Amine-Catalysed Epoxidations 
 
Page & Lacour have recently reported novel binaphthalene–amine catalysts for the 
asymmetric epoxidation of a range of alkenes. The epoxidation of 1-phenylcyclohexene was 
achieved in 81% ee under aqueous conditions using chiral binaphthalene amine 86 (Scheme 
23).
76
 
 
 
Scheme 23. Reagents and conditions: (i) Amine 86 (10 mol%), Oxone (2 eq.), NaHCO3 (5 
eq.), CH3CN-H2O (10:1), 0 °C, 2 h, 81% ee. 
 
 
1.4.11  Oxaziridinium Salt-Catalysed Epoxidations 
Lusinchi first reported steroid-based oxaziridinium salts in 1976. Lusinchi initially described 
the formation of an oxaziridine 88 from a reaction between enamine 87 and p-nitroperbenzoic 
acid in dichloromethane, whilst observing two side products, a hydroxylactam 89 and lactam 
90 (Scheme 24).
77
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Scheme 24. Lusinchi’s primary investigations into oxaziridine formation 
 
They suggested that the hydroxylactam side product 89 is a direct result of elimination 
reactions occurring in the intermediate oxaziridinium salt (Scheme 25). 
 
Scheme 25. Mechanism of formation of the oxaziridinium salt and hydroxylactam side 
products 
 
Lusinchi showed it was possible to methylate imine 95 utilizing ‘magic methyl’ (methyl 
fluorosulfonate), yielding iminum salt 97, which in the presence of p-nitroperbenzoic acid, 
yields steroid-based oxaziridinium salt 98 (Scheme 26).  
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Scheme 26. Lusinchi’s oxaziridinium salt 98 
 
Dihydroisoquinolinium-derived oxaziridinium salt 99 was later reported to be effective for the 
epoxidation of various olefins (Table 19).
78
 
 
 
 
 
 
 
 
 
 
 
 
Table 19. Lusinchi’s epoxidation utilizing oxaziridinium salt 99 
 
 In 1993, Lusinchi reported the first synthesis of a chiral enantiomerically pure oxaziridinium 
salt 100 (Scheme 27), which was shown to effect the epoxidation of trans-stilbene in 33% 
ee.
79
 
 
Substrate 
Time / 
mins 
Epoxide % 
Yield  
 30 96 
 
60 89 
 
10 84 
 
10 75 
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Scheme 27. Lusinchi’s synthesis of enantiomerically pure oxaziridinium salt 100 from 
(1S,2R)-(+)-norephedrine 
 
Bohé later showed that oxaziridinium salt 99 can be deactivated by in-situ base-catalysed 
dehydration, accounting for the poor catalyst efficiency observed (Scheme 28).
80
 
 
 
 
Scheme 28. In-situ base catalysed dehydration of oxaziridinium salt 99 
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Bohé developed an achiral 3,3-disubstituted-dihydroisoquinolinium catalyst 101 (Figure 17) 
that, in the presence of Oxone, can generate an oxaziridinium salt with an improved catalyst 
turnover in comparison to iminium salt 99, due to the exclusion of the aromatization pathway 
(Scheme 28). Iminium-salt 101 is capable of epoxidizing trans-stilbene in 87% yield in 7 h (in 
comparison, catalyst 99 completes the same reaction in 16 h).
81
 
 
 
Figure 17. Bohé’s improved 3,3-disubstituted-dihydroisoquinolinium catalyst 101 
 
Several research groups have since also reported their individual chiral oxaziridinium-salt 
catalysts capable of catalyzing epoxidations of various olefins, and are discussed herein. 
 
1.4.12  Aggarwal’s Chiral Binaphthalene Azepinium Salt Catalyst  
 
Aggarwal reported an effective chiral binaphthalene azepinium salt catalyst 102, containing an 
achiral methyl group as the nitrogen substituent (Table 20), which produced promising results 
and 71% ee for the epoxidation of 1-phenylcyclohexene.
82 
 
 
 
Table 20. Reagents and conditions: Conditions: 102 (5 mol%), Oxone (1 eq.), NaHCO3  
(4 eq.), MeCN-H2O  
Alkene 
Reaction 
Time / h 
% 
Yield 
% ee 
 3 71 31 (R,R) 
 
2 60 45 (R,R) 
 
2 80 71 (R,R) 
 
1 80 
39 
(1S,2R) 
 
12 66 8 
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1.4.13  Armstrong’s Exocyclic Iminium Salts 
 
In 1997, Armstrong reported a range of exocyclic iminium triflate salts, generated from the 
condensation of N-TMS-pyrrolidine and aromatic aldehydes (Scheme 29). Catalysts 106 and 
107, containing ortho electron-withdrawing substituents were found to be most effective, with 
catalyst 107 affording yields up to 93% for the epoxidation of various olefins with Oxone.
83
 
 
 
Scheme 29. Reagents and conditions: (i) ArCHO (1 eq.), TMSOTf (1 eq.), Et2O. 
 
Armstrong later reported chiral variants of exocyclic iminium salt catalysts 103 – 108. These 
chiral catalysts were difficult to synthesize, and in the best cases, were isolated and used as 
crude samples. One equivalent of chiral iminium salt 109 was shown to effect the epoxidation 
of 1-phenylcyclohexene in 22% ee (Figure 18).
84  
 
 
Figure 18. Armstrong’s chiral pyrrolidine derived iminium salt 109 
 
1.4.14  Yang’s Chiral Iminium Salts 
 
Yang showed that moderate to good enantioselectivities could be achieved for the epoxidation 
of various olefins, when iminium salts were generated in situ from a range of aldehydes and 
amines.
85
 The epoxidation of trans-stilbene occurred in 65% ee utilising C2-symmetric amine 
110 and β-branching aldehyde 111 (Scheme 30). 
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Scheme 30. Yang’s asymmetric epoxidation of trans-stilbene 
 
1.4.15  Lacour’s TRISPHAT Counter Ions 
 
In 2002, Lacour reported a novel biphasic asymmetric epoxidation system for a range of 
simple olefins, utilizing a biphenyl-derived iminium salt 112 containing a TRISPHAT 
counterion 113 (Figure 19).
86
 
 
 
Figure 19. Lacour’s biphenyl-derived iminium 112 and TRISPHAT anion 113 
 
Chapter 1 - Introduction 
 
 
44 
 
Initial reactions carried out under standard aqueous epoxidation conditions (MeCN:H2O, 1:1) 
with the new iminium salt yielded similar results as reported by Page,
87
 who utilised a 
biphenyl azepinium salt with tetraphenylborate as the counterion (both systems affording ee’s 
~60%). 
Lacour then proposed a biphasic solvent system (CH2Cl2:H2O) that was tested in the 
epoxidation of a range of olefins, but, no sign of epoxidation was observed. They realised the 
addition of a catalytic amount of 18-C-6 would allow the transportation of KHSO5 (Oxone) 
between the aqueous and organic layers (Scheme 31).  
 
Scheme 31. Lacour’s proposed mechanism for the epoxidation of olefins in the presence of 
catalytic amounts of 18-C-6 
This new methodology allowed the epoxidation of olefins in up to 89% yield, and showed 
good enantioselectivities; the combination of iminium 112 and TRISPHAT 113 was shown to 
effect the epoxidation of 1-phenyl-3,4-dihydronaphthalene in 76% ee. 
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Lacour later reported a range of their biphenyl and binaphthyl tertiary azepines and quaternary 
iminium salts, and showed both to be effective for the asymmetric epoxidation of 
unfunctionalized olefins, affording ee’s up to 83%.88  
 
1.4.16  Page’s Iminium Salt-catalyzed Epoxidations 
Page was the first to report iminium salt catalysts containing a chiral substituent on the 
iminium nitrogen atom, exocyclic to the ring containing the iminium unit: by bringing the 
enantiocontrolling asymmetric centre close to the site of oxygen transfer, the belief was that 
higher enantioselectivities would be obtained.  In 1998, Page reported his new catalytic 
procedure for the asymmetric epoxidation of olefins, utilizing easily prepared 
dihydroisoquinolinium iminium salts 114 – 116 (5 – 10 mol%) and Oxone as the oxidant, 
achieving ee’s of up to 73% (Table 21).89 
 
Catalyst Alkene 
Catalyst 
Loading/ 
mol% 
% Yield % ee 
114 
 
1 39 25 
115   
 
0.5 47 14 
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Table 21. Page’s dihydroisoquinoline iminium salts used in the catalytic asymmetric 
epoxidation of alkenes by Oxone 
The novel catalytic procedure reported by Page had some advantages over previously reported 
chiral iminium salt-catalyzed epoxidations, including; 
 The iminium salts can be synthesized with ease; they require no purification via 
chromatography, and most of the starting materials can be purchased or made using 
simple synthetic steps (catalyst synthesis can be easily scaled up to 70 g) 
 Epoxidations require a reduced catalyst loading (<10 mol%); a direct comparison to 
Shi’s general chiral dioxirane-catalyzed epoxidation procedure which requires up to 30 
mol% in cases 
For these reasons alone, further investigations were undertaken including extending the 
substrate scope and modifying the existing iminium salt structure. To understand the 
mechanism of oxygen transfer in these asymmetric epoxidation reactions, Page later proposed 
a catalytic cycle similar to that previously reported by Hanquet and Lusinchi,
90
 in which the 
oxidative intermediate is an oxaziridinium salt (Scheme 32).
91
 
 
116 
 
5 68 40 
116  10 78 73 
Chapter 1 - Introduction 
 
 
47 
 
 
Scheme 32. Page’s proposed catalytic cycle for oxaziridinium-mediated asymmetric 
epoxidation 
 
Analysis of the mechanism shows the likely first step to be nucleophilic attack of the 
persulfate anion on the carbon of the iminium bond. The generation of two possible 
diastereoisomers arises from persulfate attack occurring from both the si and re faces of the 
iminium bond, and, after irreversible expulsion of sulfate, two diastereomeric oxaziridinium 
species can be formed. In theory, these diastereomers would afford differing levels of 
enantioselective oxygen transfer occurring to pro-chiral olefin substrates. Page proposed that 
the rate determining step in the mechanism is the irreversible expulsion of sulfate. 
 
1.4.17.1  Analysis of the Reaction Parameters 
Page further studied the reaction parameters in attempts to optimize the reaction conditions; 
these included counter ion effect, effect of the solvent system, temperature variation and 
catalyst loading.
91
 Since the N-isopinocampheyl-derived iminium salt 116 showed an optimum 
between reactivity and enantioselectivity, this catalyst was chosen as a model for testing these 
parameters.
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1.4.17.1 Effect of Counter-Ion 
Iminium salt 116 was found to be successful in forming precipitates with a variety of counter-
ions, which allowed the generation of not only the tetraphenylborate salt, but also the 
tetrafluoroborate, hexafluorophosphate, perchlorate and periodate salts. Under aqueous 
conditions (Oxone (2 eq.), Na2CO3 (4 eq.), MeCN:H2O (1:1), 0 °C), the asymmetric 
epoxidation of 1-phenylcyclohexene was observed with 5 mol% of catalyst 116 with various 
counter-ions.
91
 The periodate salt produced an enantioselectivity (35% ee) comparable to the 
tetraphenylborate species (40% ee), but the perchlorate species produced the poorest 
enantioselectivity of all the species tested (20% ee). However, all of the salts afforded the 
same enantiomer of epoxide product (R,R) and all reactions were completed after 45 minutes. 
 
1.4.17.2 Effect of Solvent System 
Page observed that increasing the ratio of water:acetonitrile from 1:1 to 2:1 had the general 
effect of increasing the reaction rate, presumably due to increased Oxone solubility and thus 
increased availability for consumption in the desired oxygen transfer process. Page reasoned 
that increasing the amount of water would allow quicker nucleophilic attack of the persulfate 
ion on the iminium bond, and better solvation of the departing sulfate anion.  
The effect was noticed to be more pronounced at lower catalyst loadings; for example, the 
asymmetric epoxidation of 1-phenylcyclohexene utilizing 0.5 mol% of iminium salt 116 with 
a tetraphenylborate anion under aqueous conditions (H2O:MeCN, 1:1) afforded only 30% 
yield of 1-phenylcyclohexene oxide after 1 hour. However, at a 2:1 ratio (H2O:MeCN) 1-
phenylcyclohexene oxide was attained in quantitative yield under similar conditions.
91
  
Reducing the amount of Oxone (1 eq.) and sodium carbonate (2 eq.) used in the asymmetric 
epoxidation reactions by half resulted in incomplete conversion after one hour in the improved 
(2:1) conditions.  
Page later disclosed results linking the effects of co-solvent polarity with any asymmetric 
induction observed, hoping to clarify the mechanism of the epoxidation reactions (Scheme 
32).
91 
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The co-solvents were selected so that they differed significantly in dielectric constant (ε, 
indicated by the values in brackets), including dichloromethane (8.9), trifluoroethanol (26.7), 
acetonitrile (37.5), water (78.4) and formamide (111). The epoxidation of 1-
phenylcyclohexene was studied this time using iminium salt 116 (10 mol%) as both its 
tetraphenylborate and perchlorate salts using the co-solvents stated above in a 1:1 ratio with 
water. The perchlorate salt exhibited an interesting trend; when the co-solvent was 
trifluoroethanol, the reaction was complete in 30 minutes with quantitative conversion and 
26% ee. But, in dichloromethane the reaction took three hours to reach 50% conversion, 
affording the epoxide in an increased 33% ee. In formamide there was no reaction, and this 
result was the same for the tetraphenylborate salt. Page reasoned that the lack of reactivity in 
formamide could be linked to the iminium species becoming highly solvated, and potentially 
leads to the irreversible attack of formamide on the iminium species. When the 
tetraphenylborate salt was tested under chlorinated co-solvent conditions, no conversion was 
observed after three hours, which is probably the result of poor miscibility between the two 
solvents, thus limiting the availability of inorganic oxidant in the organic phase.
91 
 
1.4.17.3 Effect of Temperature 
Oxone is known to be unstable at elevated temperatures under alkaline conditions, and the 
freezing point of aqueous solvent systems limits the temperature of asymmetric epoxidations 
to close to 0 °C. Epoxidation experiments conducted at –10 °C under the standard 1:1 
conditions were found to be slow due to the insolubility of inorganic Oxone and sodium 
carbonate. Upon increasing the ratio of water:acetonitrile to 3:1, the epoxidation of 1-
phenylcyclohexene using catalyst 116 at –10 °C went to full conversion after 45 minutes, 
affording 1-phenylcyclohexene oxide in good yield and similar enantioselectivity (35% ee) in 
comparison to the reaction carried out at 0 °C (40% ee).
91
 When the reactions were repeated 
between 27 – 32 °C, negligible epoxidation was observed after 1 hour, and this is linked to the 
instability of either Oxone or the oxaziridinium species at elevated temperatures. 
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1.4.17.4 Effect of Catalyst Loading 
The epoxidation of 1-phenylcyclohexene at 0 °C utilizing iminium salt 116 at various catalyst 
loadings was investigated. Analysis of the data found the optimum loading was 2 mol% for 
this model (Figure 20). Page further observed in this model that at very low catalyst loadings, 
lower enantioselectivities were achieved. In this instance, Page didn’t report how the 
conversion was affected by varying the catalyst loading. Through all the evidence accrued, 
Page proposed that the alkene is not involved in the rate determining step in the mechanism.
91
 
 
Figure 20. Effect of catalyst loading on the asymmetric epoxidation of 1-phenylcyclohexene 
utilising iminium salt 116 
 
1.4.18  Page’s Alcohol, Ether and Acetal Derived Dihydroisoquinolinium Salts 
In 2001, Page reported a range of iminium salts functionalized at the nitrogen atom, which 
could be easily prepared from amino alcohols, amino ethers and amino acetals, affording 
enantiomeric excesses up to 60%. Page reasoned that the extra polar units within the chiral 
exocyclic substituent might help to control the diastereofacial selectivity of attack of the 
iminium unit by persulfate and/or the diastereofacial selectivity of approach of the alkene 
substrate to the reactive oxidizing intermediate.
87
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1.4.18.1 Page’s Iminium Salts Derived from Chiral 1,2-Amino Alcohol Precursors 
Containing a Primary Hydroxyl Group 
Readily available -amino acids can be easily reduced to afford the corresponding chiral 1,2-
amino alcohols, which in turn undergo condensation reactions with 2-(2-
bromoethyl)benzaldehyde to afford the desired dihydroisoquinolinium salts 117 – 120 (Figure 
21).
87
  
 
Figure 21. Page’s iminium salts derived from chiral 1,2-amino alcohol precursors containing a 
primary hydroxyl group 
Similar dihydroisoquinolinium salts containing a pendent hydroxyl group such as 121 have 
been reported to undergo base-induced ring closure yielding oxazolidines 122 (Scheme 33),
92  
but Page did not observe such problems in the synthesis of his iminium salts. 
 
Scheme 33. Yamamoto’s base induced ring closure 
When salts 117 – 120 were employed in the epoxidation of 1-phenylcyclohexene, some 
interesting observations were made. Firstly, they react slower than catalysts that lack the 
pendent hydroxyl group, such as iminium salt 116. Secondly, they all produce racemic 1-
phenylcyclohexene oxide. Catalyst 116 (0.5 mol%) afforded the full conversion of 1-
phenylcyclohexene to its corresponding epoxide in one hour, yet more than 2 mol% of catalyst 
117 – 120  is required to achieve the same effect. Page reasoned the high catalyst loadings 
were required for 117 – 120 due to equilibrium between the ring-opened active iminium salt 
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and ring-closed inactive oxazolidine forms of the catalyst occurring under alkaline reaction 
conditions.
87 
 
1.4.18.2 Page’s Iminium Salts from Chiral 1,2-Amino Alcohol Precursors 
Containing a Secondary Hydroxyl Group 
Iminium salts 123 – 125 (Figure 22) were prepared from chiral 1,2-amino alcohols containing 
a secondary hydroxyl group, and these salts afforded improved enantioselectivities compared 
to catalysts 117 – 120 that contain primary hydroxyl group (up to 33% ee for the epoxidation 
of 1-phenyl-3,4-dihydronaphthalene utilizing iminium salt 125).
87 
 
Figure 22. Page’s iminium salts derived from chiral 1,2-amino alcohol precursors containing a 
secondary hydroxyl group 
These catalysts containing a secondary hydroxyl group require a higher catalyst loading (5 
mol%) for a convenient reaction time, presumably due to the equilibrium favouring the ring-
closed inactive oxazolidine iminium form.
 
 
1.4.18.3 Page’s Iminium Salts from Amino Ether Precursors 
Iminium salts 126 – 128 (Figure 23) were prepared from simple amino ethers, and iminium 
salt 126 afforded poor enantioselectivity in the epoxidation of 1-phenylcyclohexene (7% ee), 
but was a more reactive salt than its corresponding parent alcohol 118. This is presumably due 
to the absence of the ring closing effect observed with the amino alcohol derivative 118.
87 
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Figure 23. Page’s iminium salts derived from amino ether precursors 
 
1.4.18.4 Page’s Iminium Salts from Amino Acetal Precursors 
Page prepared an acetonide-derived dihydroisoquinolinium tetraphenylborate salt 129 
(Scheme 34) which showed similar enantioselectivities for the epoxidation of various olefins 
to the isopinocampheyl-derived catalyst 116. Dihydroisoquinolinium salt 129 containing the 
dioxane functionality was shown to effect the epoxidation of triphenylethylene in 59% ee 
(Scheme 34).
87 
 
Scheme 34. Reagents and conditions: iminium-salt 129 (5 mol%), Oxone (2 eq.), Na2CO3 (4 
eq.), CH3CN-H2O (1:1), 0 °C 
A key feature of compound 129 is the syn relationship between the nitrogen heterocycle and 
the phenyl group. The dioxane unit can adopt two conformations 130 and 131, in which either 
the phenyl or dihydroisoquinolinium group must be axial (Scheme 35). 
 
Scheme 35. Two potential chair conformations of the dioxane ring 
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Proof of the 1,3-dioxane ring occupying a chair conformation in the solid state was shown 
through single crystal X-ray analysis; 131 is expected to be the thermodynamically favoured 
conformer due to reduced 1,3-diaxial interactions and a double gauche effect. 
Page reported that the asymmetric induction in the epoxidation process may arise from 
conformer 131 hindering attack of the oxidant on the iminium bond from the direction of the 
phenyl substituent, rendering the opposite side more accessible. This would lead to major 132 
and minor 133 diastereoisomeric oxaziridinium species (Scheme 36). 
 
Scheme 36. Hindered attack of the oxidant affords two possible diastereoisomeric species 
Oxygen transfer is believed to occur via a spiro transition state, in which oxaziridinium 
intermediate 134 (Scheme 37) oxidizes triphenylethylene 135 to its corresponding (S)-
enantiomer epoxide product 136.
40,41 
 
Scheme 37. Olefin approach to oxaziridinium intermediate 134 via a spiro transition state 
As shown above, it is thought that the alkene approaches the oxaziridinium moiety so that the 
carbon-carbon double bond is perpendicular to the iminium bond axis.  
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The dihydroisoquinolinium backbone was later replaced with a biphenyl 12/binaphthyl 137 
fused to a seven-membered azepinium salt, leading to a new generation of iminium salts 
(Figure 24).
93,94
 Under aqueous derived reaction conditions, biphenyl-azepinium salt 12 
catalysed the conversion of 1-phenylcyclohexene to its corresponding epoxide in 60% ee in 
just 3 minutes.
93 
 
Figure 24. Page’s biphenyl/binaphthyl azepinium salt catalysts 
 
1.4.19  Variation of the Oxidant 
Page initially reported the use of Oxone as the main stoichiometric oxidant during the iminium 
salt catalysed asymmetric epoxidation reactions,
87,89
 but Oxone has its drawbacks. Oxone is 
insoluble in most organic solvents, is atom-inefficient, and can be unstable at room 
temperature. Page has recently reported new organocatalytic epoxidation systems through 
variation of the oxidant used to oxidize the iminium salts, and these are discussed in detail 
below. 
 
1.4.19.1 Tetraphenylphosphonium Monoperoxysulfate 
Page investigated an alternative to the oxidant Oxone, which was limited to aqueous-based 
conditions due to low solubility issues of Oxone in many organic solvents, with the terminal 
oxidant tetraphenylphosphonium monoperoxysulfate (TPPP).
95
 This new discovery led to the 
development of the first ever non-aqueous epoxidation system mediated by iminium salt-
catalysts.  
The biphenyl-azepinium salt 12 was used in the optimized epoxidation of 1-
phenylcyclohexene, affording full conversion within 3 minutes, yielding the epoxide in 67% 
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ee.
94
 In 2012, Page further illustrated this system with the enantioselective total synthesis of 
(+)-scuteflorin A 10 (Scheme 4, Section 1.0).
5
 The key step was the biphenyl-azepinium salt 
12-mediated asymmetric epoxidation of xanthyletin 8 under non-aqueous conditions, yielding 
the chiral oxirane product 9 in >99% ee.
 
Page reported a new sulfone-containing analogue of the amino-acetal catalyst 11, which, under 
the non-aqueous conditions, afforded high yields (up to 89%). Epoxidation of 6-cyano-2,2-
dimethyl chromene 2 with iminium salt 11 afforded the corresponding epoxide in 97% ee, 
which was subsequently ring-opened to afford the antihypertensive agent levcromakalim 3.
3
 
Natural products (−)-(3’S)-lomatin 7 and (+)-(3’S,4’R)-trans-khellactone 6 were obtained in 
57 and 58% overall yields; a non-aqueous enantioselective epoxidation of seselin afforded the 
enantioenriched epoxide product in 97% ee using iminium salt 11 as the key step (Figure 25, 
Scheme 4).
4 
 
Figure 25. Levcromakalim 3, (+)-(3’S,4’R)-trans-khellactone 6, (−)-(3’S)-lomatin 7 and Page’s 
sulfone-derived dihydroisoquinoline iminium salt 11 
 
1.4.19.2 Electrochemical Generation of Persulfate 
In 2008, Page showed that a monoperoxysulfate oxidant could be generated through 
electrochemistry. The results reported using this new system yielded comparable ee’s to those 
observed when using commercially available persulfate; for example, the epoxidation of 1-
phenylcyclohexene afforded ee’s up to 64%.96  
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1.4.19.3 Utilization of Hydrogen Peroxide as an Oxidant 
Page identified that hydrogen peroxide could be used as an alternative stoichiometric oxidant 
in the presence of carbonate.  Optimization of this new system resulted in enantiomeric 
excesses of up to 56% being achieved for the asymmetric epoxidation of 1-
phenylcyclohexene. A double catalytic cycle was proposed; percarbonate is generated by 
reaction of hydrogen peroxide and hydrogen carbonate anion. This percarbonate species is 
then thought to oxidize the iminium salt (Scheme 38).
97 
 
Scheme 38. Page’s proposed double catalytic cycle 
 
1.4.19.4 Utilization of Sodium Hypochlorite as an Oxidant 
Page reported the first examples of iminium salt-mediated asymmetric epoxidation of olefins 
utilizing sodium hypochlorite as the stoichiometric oxidant: enantiomeric excesses of up to 
68% were obtained for the epoxidation of 1-phenylcyclohexene.
98 
As indicated above, Page observed that carbonate salts co-catalyse the epoxidation process. 
Two possible mechanisms have been proposed for the asymmetric epoxidation when sodium 
hypochlorite is used. The first is a double catalytic cycle as shown previously in Scheme 38, 
where hypochlorite may generate percarbonate, which then acts as the oxygen transfer agent to 
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oxidize the iminium salt. Alternatively, hypochlorite itself could add directly to the iminium 
salt (Scheme 39). 
 
Scheme 39. Alternative formation of the oxaziridinium salt 
 
1.5    Kinetic Resolution 
Enantioenriched compounds are highly sought after building blocks for asymmetric synthesis 
and there are a number of methods available to generate them. These include; 
 Utilising the chiral pool: This involves the use of relatively simple, potentially cheap 
enantiopure starting materials (e.g. amino acids, monosaccharides) provided by nature 
itself to create more complex compounds. The advantage here is that the chirality is 
‘built-in’, which can then be maintained throughout the synthesis. 
 The chemical resolution of enantiomers from a racemate. 
 Use of a chiral auxiliary. 
 Utilisation of a chiral catalyst or reagent that is able to react with achiral starting 
materials, generating chirality into the product. 
In the late twentieth century, Professor Henri Kagan studied kinetic resolution, becoming one 
of the most published in the field. Kagan defined kinetic resolution as: 
99
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“a process in which one of the enantiomers of a racemic mixture is more readily transformed 
into a product than is the other” 
 
Figure 26. Kagan’s explanation of the kinetic resolution of two starting material enantiomers 
Kagan stated that kinetic resolution occurs when kR≠kS, and the reaction is stopped between 
zero and 100% conversion. Ideally only one enantiomer reacts,  e.g. enantiomer R,  so that at 
50% conversion, a mixture of 50% S enantiomer is recovered, and 50% of product P is 
obtained (Figure 26). 
One of the major drawbacks associated with kinetic resolutions is that the maximum yield of 
the desired product is limited to 50%. One of the major advantages of a kinetic resolution is 
that racemic starting materials are considerably cheaper than their chiral counterparts, and this 
reason alone makes an effective kinetic resolution attractive.  
Jacobsen has most recently reviewed the advances in kinetic resolution reactions for a range of 
metal-based and organocatalytic epoxidation reactions.
100
 He reported a number of conditions 
that should be met to make kinetic resolutions more attractive for utilizing this methodology 
on a large scale in asymmetric syntheses of complex molecules; 
 The racemic starting material should be cheap, and the product cannot be made using 
other resolution methodologies. 
 The catalyst employed should: (1) be cheap to synthesize, (2) consume only one 
enantiomer from the racemate, (3) be used at the lowest possible catalyst loading. 
 The starting material recovered should be easily separable from the product obtained. 
 Both the chiral product obtained from the resolution and the recovered starting material 
are valuable and are obtained in high enantioselectivities. 
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 1.5.1     Alternative Resolution Methods 
Classic resolutions typically utilize a stoichiometric amount of chiral resolving agent that can 
generate a separable pair of diastereoisomers by formation of complexes, and after removal of 
the chiral resolving agent, the chiral substrate is produced. The first manual resolution was 
demonstrated by Louis Pasteur in 1848 without the use of a chiral resolving agent on racemic 
ammonium sodium tartrate,
101
 and later in 1858 he discovered the enantioselective destruction 
of a racemic mixture (ammonium tartrate) with a chiral reagent (Penicillium glaucum).
102
  
Chiral chromatography can be applied on a preparative scale, and allows a mobile phase 
containing the racemate to pass over a chiral stationary phase, thus allowing the separation of 
enantiomers on a large scale. This method is however limited by costs, including long 
separation times and high volumes of solvent required. 
Dynamic kinetic resolutions utilize a starting material racemization step which occurs at a 
faster rate than that of the starting material to product transformation (Figure 27). The main 
advantage this method has over kinetic resolutions is that the product can be isolated in 100% 
yield, with the enantiomeric excess determined by the magnitude of difference in energy 
between the diastereomeric transition states in the selectivity determining step. 
 
Figure 27. Dynamic kinetic resolution 
 
1.5.2   Kinetic Resolution of Racemic Alkenes Using Catalytic Asymmetric Epoxidation 
Kinetic resolution of racemic alkenes using asymmetric epoxidation is an attractive topic for 
asymmetric catalysis, as racemic alkenes are generally cheap and readily available, but is 
potentially more challenging than the asymmetric epoxidation of prochiral alkenes. Catalytic 
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kinetic resolutions are attractive because only small amounts of chiral agent are required. 
Kinetic resolution in asymmetric epoxidation has been observed previously by Sharpless,
103
 
Jacobsen,
104
 Katsuki,
105
 Shi
57
 and Yang,
107 
and is discussed below. 
 
1.5.3  Sharpless’s Kinetic Resolution 
Some of the first reports of kinetic resolution in asymmetric epoxidation were published by 
Sharpless in 1981.
103
 Sharpless applied his titanium alkoxide tartrate catalysts in the 
epoxidation of racemic secondary allylic alcohols. Sharpless initially found three variables that 
defined the kinetic resolution results observed. These include the enantiomeric excess of the 
recovered starting material, the percentage conversion of racemic substrate, and the relative 
rate of the reaction. The relative rate can be calculated if the first two factors are already 
known (e.g. at 50% conversion, and 75% ee starting material retained, relative rates of krel = 5 
– 10 are observed). Sharpless showed that the epoxidation of racemic trans-
cyclohexylpropenylcarbinol under his epoxidation conditions using L-(+)-diisopropyltartrate 
afforded some interesting results (Scheme 40). 
 
Scheme 40. Differences observed in erythro-threo selectivity for the enantiomers of trans-
cyclohexylpropenylcarbinol 
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The epoxidation of the (S)-enantiomer of trans-cyclohexylpropenylcarbinol proceeded at a 
faster rate than its opposite (R)-enantiomer, affording the major product as the erythro product 
(98:2). Scheme 9 shows that L-(+)-tartrates deliver oxygen from the underside of the molecule 
when posed as in the standard Sharpless mnemonic. The experimental data collected by 
Sharpless confirm this theory (the (S)-enantiomer reacts 104 times faster than the (R)-
enantiomer). As shown in Scheme 40, the allylic alcohol is drawn so that the alkene carbons 
and hydroxyl lie in the plane of the paper, with the carbinol carbon positioned at the lower 
right. Nearly all of the secondary allylic alcohols Sharpless tested adhere to a recurring trend; 
when L-(+)-tartrates are used the fastest reacting enantiomer is the one in which the 
substituent on the carbinol carbon is up when the allylic alcohol moiety is drawn ((S)-
enantiomer, Scheme 40).  
These high erythro:threo ratios obtained when using Sharpless conditions can be compared to 
those of the achiral vanadium metal-based epoxidation catalyst (VO(acac)2/TBHP/CH2Cl2), 
which is the next best alternative. The ratios are slightly lower for the vanadium-based catalyst 
(ratios of erythro/threo of 75-80/25-20).
106
 
Sharpless also performed epoxidation experiments where the reaction was stopped at 50% and 
100% conversion respectively. Followed by GC, at 50% conversion, 49% yield of erythro 
epoxide product was obtained in 96% ee. Meanwhile, at 100% conversion, after 
chromatography, the threo product was also isolated in 20% yield and 92% ee.  
Interestingly, Sharpless observed that increasing the size of the tartrate ligand (DMT  DET 
 DIPT) greatly affects the rate difference in epoxidation of the enantiomers from the 
racemic starting material. He also concluded that an excess of tartrate ligand (1.5:1.0 of 
tartrate:titanium isopropoxide) was essential in order to detect resolution in complex 
secondary allylic alcohol substrates, and that, under normal conditions of 1:1 (tartrate:titanium 
isopropoxide), no kinetic resolution would be observed, presumably due to unwanted 
epoxidation by non-ligated titanium-alkoxide species. 
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1.5.4  Jacobsen’s Kinetic Resolution 
In 1995, Jacobsen reported that using his manganese salen catalyst 27, in the presence of an 
oxidant (mCPBA), under non-aqueous conditions, he was able to oxidize racemic conjugated 
olefins, more specifically cis-chromenes in up to 97% ee. Jacobsen interestingly found that at 
partial conversions of alkene to epoxide, the major epoxide product 139 (in which the iso-
butyl group is trans to the epoxide, confirmed by circular dichroism and NOE measurements) 
is generated in preference, and could be separated from the minor product by flash 
chromatography. This would indicate a difference in reactivity of each of the two alkene 
enantiomers (Scheme 41). Jacobsen did not report any yields for either the major or minor 
products of the kinetic resolution reaction.
104
 
 
Scheme 41. Reagents and conditions: (i) Catalyst 27, mCPBA, CH2Cl2, NMO, -78 °C. 
Jacobsen found that these kinetic resolution results could be enhanced further by reducing the 
temperature to –78 °C and by changing the manganese-salen catalyst’s steric and electronic 
properties. The most pronounced changes occurred when the sterically hindered, electron rich 
catalyst 141 was used, leading to greater enantioselectivity in the epoxidation and the highest 
relative rate of 6.9.  
Chapter 1 - Introduction 
 
 
64 
 
 
Jacobsen also observed that the nature of the alkyl substituents on the starting materials was 
important to obtain high selectivity. He observed a highest rate of selectivity of 9.3, when the 
alkyl substituent was an isopropyl group, in comparison to a rate of 4.5 for the unbranched n-
pentyl alkyl group (Table 22). 
Compound 
Reference 
Substrate krel 
142 
 
6.9 
143 
 
9.3 
144 
 
6.1 
145 
 
4.5 
146 
 
2.7 
  
Table 22. krel = relative rate, calculated by; ln[(1 - C)(1 - ee)]/ln[(1 - C)(1 + ee)], C is the 
fraction of remaining olefin, ee is the % enantiomeric excess 
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Jacobsen also applied his methodology to the epoxidation of tricyclic substrates (144, Table 
22), but found that the substrates reacted much more slowly, yielding 60% conversion over 
long reaction times (in comparison bicyclic >80% conversion in 10 minutes). 
Interestingly, the lowest selectivity was achieved using 2-pentylchromene, which only 
providing a rate of 2.7. Jacobsen accounted for this selectivity by proposing that the 
epoxidation proceeded through a competitive, non-asymmetric aromatization pathway, which 
in turn yielded multiple complex products. Jacobsen’s kinetic resolution was applied to the 
synthesis of teretifolione B 147. The key epoxide was isolated at 80% conversion, and only 
15% yield (30% theoretical), but more importantly in high enantiomeric excess (91% ee). The 
observed relative rate was 3.4, which was lower than the one observed for tricyclic chromene 
144 (Table 22, krel = 6.1).
104
  
 
Overall, Jacobsen’s kinetic resolution data involves high selectivity, but with moderate 
substrate-induced selectivity. 
 
1.5.5  Katsuki’s Kinetic Resolution 
Katsuki reported results of kinetic resolution observed with their manganese-salen based 
catalysts 28.
105
 Katsuki’s substrates for kinetic resolution were all racemic conjugated olefins. 
Their theory involved the metal centre of the manganese-salen catalyst being capable of 
differentiating between enantiomers in racemic substrates. As described earlier, they believed 
that a radical-based mechanism accounts for the formation of the major epoxide product in 
high enantioselectivity. Their main substrates for epoxidations were 3-alkylindenes 148 
(Scheme 42). 
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Scheme 42. Reagents and conditions: (i) Catalyst 28, NaOCl, CH2Cl2, -20 °C 
When these substrates were reacted with mCPBA, no cis/trans selectivity was observed. The 
ratio of trans:cis was 2:1 when a bulky optically active manganese-salen catalyst 28 was 
employed as the catalyst. Katsuki’s relative rates of epoxidation were similar to those obtained 
by Jacobsen (2.6-7.5), depending on the substrate tested.
105 
 
1.5.6  Shi’s Kinetic Resolution 
In 1999, Shi reported results of kinetic resolution with his epoxidation procedure using chiral 
ketone catalyst 54. Shi used cyclic olefins 149 with the chiral centre at the allylic position for 
his kinetic resolution test substrates, reasoning that the rigid conformation of the cyclic olefins 
and proximity of the chiral centre make them key targets for kinetic resolution.
57 
 
Shi proposed that two possible spiro transition states could be formed (Figure 28). He 
proposed a favoured transition state (1), in which steric interaction between R2 group of the 
alkene and one of the dioxirane oxygens was minimized, thus allowing one enantiomer of the 
racemic starting material to be oxidized faster. 
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Figure 28. Favoured and disfavoured transition states 
This theory was supported by experimental results, when testing kinetic resolution on a range 
of cyclohexene substrates at 50% conversion. Shi isolated major epoxide 151 as the trans-
epoxide (>20:1) in 95% ee, and also managed to recover the starting material 150 in similar 
enantiomeric excesses (96% ee) (Scheme 43). The relative rate values calculated for Shi’s 
kinetic resolution data range from krel = 4 to >100 for the epoxidation of 1,3 and 1,6 
disubstituted cyclohexene substrates.
50 
 
Scheme 43. Reagents and conditions: (i) Catalyst 54 (35 mol%), Oxone (2.3 eq.), K2CO3 (9.5 
eq.), CH3CN-DMM-0.05M Na2B4O7
.
10 H2O in aqueous EDTA solution. 
 
1.5.7  Yang’s Kinetic Resolution of Acyclic Secondary Allylic Silyl Ethers  
In 2001, Yang reported that chiral chloro ketone epoxidation catalyst (R)-43 was suitable for 
the kinetic resolution of α-trichloromethyl allylic alcohols 152. Yang observed that (R)-
substrates were consumed at a faster rate than the (S)-substrates 153, affording selectivities up 
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to s = 100 (s = krel).
107
 Yang also showed that diastereoselectivities were excellent, with ratios 
of erythro:threo consistently around 49:1 (Table 23). 
 
Substrate 
Time 
/ h 
Conv. 
(%) 
Recovered 
SM 
Epoxide 
% 
Yield 
% ee  
erythro: 
threo 
% 
Yield 
% 
ee 
s
i 
 
10 55 84 
96 
(S) 
>49:1 85 77 30 
 
4 50 87 
94 
(S) 
>49:1 82 93 100 
 
1.5 38 80 
58 
(S) 
>49:1 76 - 55 
 
6 46 94 
78 
(S) 
>49:1 85 - 54 
Table 23. Yang’s kinetic resolution of various α-trichloromethyl allylic alcohols utilising 
chiral catalyst (R)-43 
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1.6  Conclusions  
This introduction has covered the most recent advancements in the field of asymmetric 
epoxidation. The most successful methodologies for asymmetric epoxidation reactions utilize 
either a metal-based catalyst (Sharpless’s titanium-derived catalyst or Jacobsen’s manganese-
derived catalysts), or a non-metal based catalyst (for example various chiral ketones developed 
by Shi, Yang, Denmark and Armstrong). Since the earliest advancements by Sharpless in 
asymmetric epoxidations on allylic alcohol substrates, there have been a number of 
methodologies developed (using either metal or non-metal based catalysts), that work for a 
broad range of olefins and maintain excellent enantioselectivity in the oxygen transfer step.  
Following on from previous studies in asymmetric catalytic oxygen transfer reactions in the 
Page group, herein is described two new projects that further extend our understanding of 
oxaziridinium salts as catalysts. 
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2.0 Chapter Preview 
This chapter builds upon the achievements made within the Page group in the field of 
iminium-salt catalysed asymmetric epoxidation over the last 15 years. The first examples 
of kinetic resolution of various racemic benzopyrans utilizing Page’s iminium salt-
mediated non-aqueous asymmetric epoxidation conditions are described. The aims of this 
particular study are to: 
 Prepare a number of racemic chromenes 
 Obtain enantioenriched products from the epoxidation reactions 
 Recover enantioenriched starting material if the kinetic resolution is successful 
 Identify the major epoxide diastereoisomer generated from the reaction 
All the information derived from the kinetic resolution experiments should help elucidate 
the selectivity of the oxygen transfer process.  
The second part of this chapter details the first examples of asymmetric epoxidation of 
dihydroquinoline substrates catalysed by chiral iminium salts. This methodology will allow 
access to various quinoline-derived natural products and pharmaceuticals, such as 
helquinoline
1
 1 and virantmycin
2
 2 (Figure 1). 
 
Figure 1. Tetrahydroquinoline-derived natural products  
 
2.1  Reactions Utilized in the Synthesis of 2H-Benzopyrans 
The resolution of racemic 2H-benzopyrans is an attractive research topic that has already 
received attention from many synthetic groups worldwide. The literature is well 
documented with many syntheses of 2H-benzopyrans, and a number of key reactions are 
discussed herein. 
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2.1.1    Claisen Rearrangement 
Harfenist first investigated the rearrangement of aryl propargyl ethers 3 to chromenes 4, 
investigating the effect of the gem-dimethyl moiety on the rate of cyclization. Harfenist 
reported excellent yields for various 2-methyl- or 2,2-dimethyl-chromenes when o-
dichlorobenzene was used as the solvent, applying heat if necessary to form a 
homogeneous solution (Scheme 1).
3
  
 
Scheme 1. Reagents and conditions: propargyl ether 3 (1 eq.), o-dichlorobenzene,  
 
Subramanian reported the synthesis of various flav-3-enes 6 in excellent yields (up to 
95%), utilizing the Claisen rearrangement as the key step under similar conditions to those 
used by Harfenist (Scheme 2).
4
  
 
 
Scheme 2. Reagents and conditions: propargyl ether 5 (1 eq.), solvent; N,N-diethylaniline 
or o-dichlorobenezene, 
 
The main advantage of this cyclization reaction in both examples shown above is the 
consistently high levels of yields observed in all cases tested, irrespective of the number of 
substituents at the C2-position or the size of the substituent. The downside to this method 
is the need for using elevated temperatures (in excess of >180 °C for Subramanian’s 
examples). 
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2.1.2    Oxidation of Allylphenols 
Cardillo reported the synthesis of various 2,2-substituted chromenes by two 
methodologies, both proceeding through oxidation of the phenol starting material. The first 
method involved adding a benzene solution of methyl-trialkyl-ammonium dichromate to a 
refluxing solution of the required allylphenol 7 in benzene. Reaction completion was 
observed after one hour, affording chromenes 8 - 10 in moderate to good yields (Scheme 
3).
5
 
 
 
Scheme 3. Reagents and conditions: benzene solution of methyl-trialkyl-ammonium 
dichromate (1 eq.), allylphenol 7 (1 eq.), benzene, 1 h 
 
The second method reported by Cardillo involved the oxidation of allylphenols 7 utilizing 
an etheral DDQ solution. The reaction proceeds at ambient temperature, affording various 
chromenes in yields up to 90% (Scheme 4).
5
 
 
Scheme 4. Reagents and conditions: DDQ (1.1 eq.) in ether, allylphenol (1 eq.) in ether, 
r.t., 2 h 
The yields for this reaction remain high in both methods reported; yet the main 
disadvantage observed with both is the use of potentially toxic materials. DDQ can react 
with water to yield hydrogen cyanide gas, whilst potassium dichromate and benzene are 
known carcinogens. 
 
2.1.3    Iodination of Allylphenols 
Bongini reported that N-iodosuccinimide can be used in the cyclization of various 
substituted 2-allylphenols 14, yielding 3-iodochromanes 15, which in turn may be 
dehydrohalogenated to give various chromenes 16 in excellent yields (up to 95%) (Scheme  
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5).
6
 The reaction however has to be conducted in the dark due to the instability of NIS in 
the presence of light. 
 
Scheme 5. Reagents and conditions: (i) NIS (1.1 eq.), 2-allylphenol 14 (1 eq.), CH2Cl2, r.t., 
1 h. (ii) 3-iodochromane 15 (1 eq.), KOH/MeOH (10%), 50 °C, 2 h 
 
Jurd later reported a similar protocol for the synthesis of various 2H-flavenes, except this 
time cyclization of 2-cinnamylphenols was achieved using hydrogen peroxide and iodine.
7
 
 
2.1.4    Combination of Metal Phenoxides and Carbonyl Compounds 
Casiraghi reported the synthesis of various 2H-benzopyrans by reacting various metal 
phenoxides (titanium(IV) or magnesium phenolates in toluene), with an assortment of α,β-
unsaturated carbonyl compounds. The isolated yields for various chromene substrates are 
good to excellent (50–81%), and the methodology could be extended to the synthesis of 
naturally occurring chromenes, for example, 6-demethoxyageratochromene 18, which was 
achieved in 81% yield (Scheme 6).
8
  
 
Scheme 6. Reagents and conditions: (i) Ti(OEt)4 (1 eq.), 17 (4 eq.), toluene, reflux, ½ h 
then, removal of excess ethanol (ii) 3-methylbut-2-enal (6 eq.), toluene, reflux, 8 h 
 
2.1.5   Formation of Chromenes by Metathesis: Utilization of a Ruthenium-carbene 
Catalyst 
The facile synthesis of chromenes reported by Hoveyda is one of the best examples of 
chromene synthesis in the literature due to the consistently high percentage yields obtained 
for various chromene products, in which Grubbs 1
st
 generation catalyst is employed in the 
ruthenium-catalysed rearrangement of styrenyl ethers.
9,10 
Hoveyda showed that under an 
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ethylene atmosphere, the reaction can be driven to yield only the formation of chromene 
substrates, and reduce the formation of unwanted dimerization products.
9
 When the 
styrenyl ether is enantioenriched, e.g. 19 (>99% ee), no loss in enantioselectivity is 
observed during the ruthenium-catalysed rearrangement, affording enantioenriched 20 in 
81% yield (Scheme 7). 
 
Scheme 7. Reagents and conditions: (i) (PCy3)2Cl2Ru=CHCH=CPh2 (5 mol%), r.t., 24 h, 
ethylene atm. 
Grubbs later reported the use of his ruthenium-carbene catalyst in the ring-closing 
metathesis of 2-styrenyl allyl ethers (such as 21), affording an assortment of chromenes in 
up to 99% yield, as shown below for the formation of 6-bromo-2H-1-benzopyran 22 (99%) 
(Scheme 8).
11
  
 
Scheme 8. Reagents and conditions: (i) [Cl2(PCy3)2Ru=CHPh] (2 mol%), CH2Cl2, r.t., 2 h. 
However, one of the limiting factors of this reaction is the cost of the catalyst employed. 
Weighing up the advantages and disadvantages of ruthenium-carbene catalysts, one has to 
compare the price of the catalyst against the high reaction yields this catalyst affords, in 
comparison to other methods in the literature that utilize much cheaper reagents but 
ultimately provide lower reaction yields. For this reason, we chose not to consider using 
this approach to synthesize our racemic chromene substrates. 
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2.1.6   The Petasis Reaction: Formation of Chromenes 
Finn reported the first examples of catalytic 2H-benzopyran formation using the Petasis 
reaction with the inclusion of a resin-bound amine, and generated substituted chromenes in 
excellent yields. For example, 23 was formed in 99% yield from the corresponding 
alkenylboronic acid and o-hydroxyaromatic aldehyde (Scheme 9).
12
 Finn observed the 
reaction proceeded well when the aromatic aldehyde has the hydroxy group at the ortho-
position; no reaction was observed when the hydroxy group was situated meta or para to 
the aldehyde functionality. 
 
Scheme 9. Reagents and conditions: (i) alkenylboronic acid (1 eq.), o-hydroxyaromatic 
aldehyde (1 eq.), resin-bound amine (40 mol%), dioxane, 90 °C, 24 h 
 
Das,
13
 Petasis,
14
 and Gois
15
 later reported their own individual adjustments to the reaction 
by either modifying the boron component (potassium vinylic borates),
13,14
 or by changing 
the reaction solvent (water),
15
 yet they all report good to excellent yields for various 2H-
benzopyran substrates. 
 
2.2   Base-catalysed Synthesis of Racemic 2H-Benzopyran Substrates 
To the best of our knowledge, the kinetic resolution of racemic chromenes utilizing 
iminium salt-catalysed epoxidation processes has not yet been reported. Given the high 
levels of enantioselectivities observed in the epoxidation of various 2,2-substituted 
benzopyrans utilizing chiral iminium salts reported by Page in recent years,
 16,17,18
 we 
decided to evaluate chromene substrates as possible candidates for kinetic resolution.
 
Results and Discussion 
 
 
82 
 
The reactions described above afford 2,2-substituted benzopyrans or alternatively provide 
racemic 2-substituted benzopyrans in good yields. The most enantioselective synthesis of 
2-substituted chromenes was reported by Hoveyda as described above (Scheme 7).
9,10
  
Our approach to the synthesis of chromenes required us to allow variation of the chromene 
structure at the 2- and 6- position, but we wished to avoid the use of expensive transition 
metal complexes such as Grubbs ruthenium-carbene derived catalyst. At the same time, we 
desired high yields of racemic benzopyrans as observed in the most successful metal-
catalysed reactions.  
We first looked into the procedures reported by Crombie
19
 and Camps
20
, both of whom 
reported similar cyclization procedures in which a substituted phenol 24, a conjugated 
aldehyde or its corresponding dimethyl acetal 25, and a base (such as pyridine) were 
combined in one flask and heated under reflux, affording various -C5, -C6, -C7 & -C8 
substituted benzopyrans 26 in moderate to good yields. Scheme 10 below highlights the 
conditions reported by Camps and co-workers in their synthesis of various 2H-
benzopyrans.  
 
 
Scheme 10. Reagents and conditions: (i) 24 (1 eq.), 25 (2 eq.), pyridine (1 eq.), 140 °C. 
 
North later modified and optimized the conditions initially proposed by Crombie and 
Camps.
21
 He investigated the various factors that affect the yield of chromene formed; 
these included adjustments to the ratio of reagents used in the reaction, changing the base-
catalysts employed and introducing various acid additives to activate the acetal towards 
nucleophilic attack. The optimized conditions for the formation of 6-cyano-2,2-dimethyl 
chromene 29 are shown below (Scheme 11).
21
 
North’s methodology appealed to us for a number of reasons: 
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 All starting materials for the two step procedure are cheap and commercially 
available  
 The acetals are formed under mild conditions and can be easily purified by vacuum 
distillation 
 The chromenes are formed using Dean-Stark conditions in good yields (>60%), and 
can be purified by crystallization or chromatography 
 North shows that the procedure works remarkably well for 4-substituted phenols 
(>60% yield), allowing us to modify the chromene’s electronic properties at the C6 
position 
Based upon these advantages, we decided to employ the optimized conditions described by 
North for the synthesis of our own library of -C2, -C6 substituted racemic chromenes.
21 
 
2.2.1  North’s Synthesis of Substituted 2,2-Dimethyl-2H-1-Benzopyrans 
In 1995, North reported a procedure for the formation of the benzopyran core structure in a 
quick two-step synthesis. The first step involves the acetalization of 3-methyl-2-butenal 27 
in the presence of triethylorthoformate, yielding diethyl acetal 28, which can be purified by 
vacuum distillation or used directly as a crude mixture in the next step without a significant 
loss of yield.
22
 The second step of North’s reported synthesis of 6-cyano-2,2-dimethyl 
chromene 29 is a base-catalysed condensation reaction between diethyl acetal 28 with 4-
cyanophenol in xylene at an elevated temperature (Scheme 11).
19 
 
Scheme 11. Reagents and conditions: (i) 27 (1 eq.), triethylorthoformate (1 eq.), potassium 
hydrogen sulfate (0.05 eq.), r.t., 1 h. (ii) 4-cyanophenol (1 eq.), 28 (1.4 eq.), 3-picoline 
(0.25 eq.), p-xylene, 115 ˚C, 24 h 
 
North reported the following mechanism for the base-catalysed synthesis of 2,2-Dimethyl-
2H-1-Benzopyrans (Scheme 12). 
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Scheme 12. North’s proposed mechanism for the base-catalysed synthesis of benzopyrans  
North postulated that the starting phenol has a dual role; initially it is a reactant with the 
catalytic amount of base, but also acts as an acid catalyst in the activation of the acetal 
(presumably to an oxonium species). The base-catalysed alkylation of 30 by the activated 
acetal (oxonium ion) affords dienone 31. Following this, tautomerization gives 32, 
followed by elimination of ethanol forming 33. Electrocyclic ring closure of 33 affords 
chromene 34. 
North’s route allows easy variation of the substituents at both the C2 and C6 positions of 
the chromenes using the corresponding dialkylacetals and 4-substituted phenols. This 
methodology has been most recently employed within the Page group for the synthesis of 
various chromene structures, including the precursor to the anti-hypertensive agent 
levcromakalim 35.
16
  
 
Page utilized North’s methodology to synthesize the natural product seselin 37 from 7-
hydroxycoumarin 36 and 1,1-diethoxy-3-methyl-but-2-ene, which in turn was the olefin 
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intermediate used in the non-aqueous asymmetric epoxidation reaction utilizing iminium-
salt catalyst 41 to access natural products trans-khellactone 39 and lomatin 40 (Scheme 
13).
17 
 
 
Scheme 13. Reagents and condition: (i) 1,1-diethoxy-3-methyl-but-2-ene (1.2 eq.), 3-
picoline (0.25 eq.), p-xylene, reflux, 24 h, 73%; (ii) Catalyst 41 (10 mol%), TPPP (2 eq.), 
CHCl3, -30 °C, 24 h, 65%, 97% ee; (iii) NaBH3CN (1 eq.), BF3.OEt2, THF, 0 °C, 0.5 h, 
92%; (iv) 1M aq. H2SO4 (5.5 eq.), acetone (1:2 ratio), r.t., 1 h, 95%. 
 
Page showed that North’s procedure could alternatively be carried out neat under 
microwave conditions, and encouragingly seselin 37 was formed in an increased yield 
(94%) in comparison to 73% yield utilizing the conventional heating method.
17 
 
 
2.3 Kinetic Resolution in Asymmetric Epoxidation: The First Examples Using an 
Iminium Salt-catalyst 
The results reported herein show the first examples of the kinetic resolution of racemic 
chromene substrates utilizing iminium-salt catalysed asymmetric epoxidations as the key 
step. The synthesis of various –C2,–C6 substituted chromenes utilizing North’s procedure 
are discussed initially, leading onto the epoxidation of a library of chromene substrates.  
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The outcomes of the epoxidation reactions are influenced by two key variables; these are 
the steric effects of alkyl or aryl substituents at the C2 position and the electron-
withdrawing/donating substituents at the C6 position.  
The discussion begins with the synthesis of various acetal substrates. 
 
2.3.1  Formation of Dialkyl Acetals 
Four diethyl acetals 42-45 were synthesized according to the procedure proposed by 
Trost,
22
 starting from the corresponding commercially available aldehydes (Scheme 14, 
Table 1). The diethyl acetals were formed in good to excellent yields after purification by 
vacuum distillation, and could be stored at 0 °C for long periods of time without signs of 
decomposition. The corresponding dimethyl acetal 46, as used by Crombie
19
 and Camps
20
, 
was also synthesized under similar conditions, but was formed in much lower yield. 
Dimethyl acetal 46 decomposed over the period of a week when stored at 0 °C.  
 
Scheme 14. Reagents and Conditions: (i) (RO)3CH (1.2 eq.), NH4NO3 (0.25 eq.), ROH, 24 
h, r.t.   
Starting Material 
Compound 
No. 
Product Structure 
Yield 
(%) 
Crotonaldehyde 42 
 
52 
Cinnamaldehyde 43 
 
83 
(2E)-2-Hexenal 44 
 
47 
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4-Methylpent-2-enal 45 
 
78 
Crotonaldehyde 46 
 
31 
 
Table 1. Formation of various dialkyl acetals   
 
With a range of dialkyl acetals to hand, the synthesis of various chromene based substrates 
could be approached using North’s methodology. 
 
2.3.2  Formation of -C2,-C6 Substituted Racemic 2H-Benzopyran Substrates 
Acetals 42-46 were then subjected to the base-catalysed conditions reported by North,
21
 
with an interesting trend being observed. When the dimethyl acetal 46 was utilized, the 
benzopyran products were obtained in low yields (entries 3 and 5, Table 2), possibly due to 
decomposition of the dimethyl acetal. Pleasingly, the diethyl acetal derivatives 42-45  were 
found to be more stable under the base-catalysed conditions, and reacted well with 4-
chloro-, 4-cyano-, 4-methyl- and 4-nitro-phenols to afford chromenes 47-62 in good to 
excellent yields after purification using silica gel flash column chromatography of the 
crude reaction mixture (Scheme 15). 
 
Scheme 15. Reagents and Conditions: (i) phenol (2 eq.), alkyl acetal (1 eq., diethyl acetal 
unless stated otherwise), 3-picoline (0.25 eq.), p-xylene, reflux, 24 h. 
Entry 
Compound 
No. 
Product Structure 
Yield 
(%) 
1 47 
 
46 
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2 
48 
 
76 
3 5 
a 
4 
49 
 
43 
5 0 
a 
6 50 
 
0 
7 51 
 
89 
8 52 
 
97 
9 53 
 
74 
10 54 
 
5 
11 55 
 
55 
12 56 
 
44 
13 57 
 
13 
14 58 
 
11 
Results and Discussion 
 
 
89 
 
15 59 
 
33 
16 60 
 
31 
17 61 
 
16 
18 62 
 
43 
a 
Yields when the dimethyl acetal was utilized 
Table 2. Formation of various -C2, -C6 substituted chromenes utilizing North’s 
methodology 
The stability of the chromenes varies dramatically depending on the substituents at the C6 
position. When the group at C6 contains an electron withdrawing substituent, such as 
cyano or nitro, these were found to be the most stable chromenes when stored at room 
temperature. The chromenes containing methyl or chloro substituents at C6 formed viscous 
oils in all cases and had to be stored at 0 °C and used within a week to avoid 
decomposition. 
For each of the chromenes 47-62, full characterization of each of the compounds was 
required since nearly all of them are new compounds. The kinetic resolution experiments 
require resolved HPLC traces for the two enantiomers of the racemic chromene substrates, 
and these HPLC traces were used in direct comparison with HPLC traces from asymmetric 
epoxidation experiments. Examples of racemic substrate traces can be found in Appendix 
B. 
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2.3.3  Epoxidation of Racemic Chromenes Utilizing mCPBA 
Each of the chromenes synthesized was then submitted to standard epoxidation conditions 
using mCPBA (Scheme 16, Table 3). The diastereoisomeric ratios for the epoxide products 
were calculated from 
1
H NMR analysis of the inseparable mixture of diastereoisomers. The 
configuration of the major diastereoisomer was assigned as trans based on the epoxidation 
of more rapid addition of the electrophile to the less hindered face of the alkene and in 
accordance with related cyclohexene systems. The results show that increasing the bulk 
size of the substituent at the C2-position, e.g. methyl to phenyl, leads to a dramatic 
increase in the d.r., from 1:1 to trans only.  
 
Scheme 16. Reagents and Conditions: (i) mCPBA, CH2Cl2, 1-8 h, 0 °C  
Starting 
material 
Product 
Reference 
Product Structure 
Conv. 
(%) 
Epoxide 
d.r.
a 
47 63 
 
100 1.8:1 
48 64 
 
100 1:1 
51 65 
 
100 2:1 
52 66 
 
100 3.5:1 
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55 67 
 
100 trans only 
56 68 
 
100 trans only 
59 69 
 
81 4:1 
60 70 
 
80 4:1 
a
 epoxide diastereoisomeric ratios were determined from the 
1
H NMR spectra of the 
reaction mixture after work-up. 
Table 3. Racemic chromene epoxides generated from mCPBA epoxidations 
Unfortunately, all chromenes containing a chlorine or methyl substituent at the C6 position 
were highly unstable under the standard epoxidation conditions using mCPBA, 
decomposing readily, and yielding neither epoxide nor diol from their respective reaction 
mixtures as analysed by 
1
H NMR spectroscopy. Addition of one equivalent or two 
equivalents of sodium hydrogen carbonate with respect to mCPBA to the reaction mixture 
to neutralize excess acid failed to yield any further success for the epoxidation of these 
substrates.  
This unusual behaviour we have observed for electron-rich chromenes has been observed 
before in the work reported by Ohki, in which cis-chromene substrates readily decomposed 
when in the presence of an oxidant.
23
 The conditions are different from ours, but Ohki has 
postulated a possible mechanism for the decomposition of these electron-rich chromene 
substrates (Scheme 17).  
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Scheme 17. Potential decomposition of cis-chromenes by lead acetate as the oxidant 
 
2.4  Asymmetric Epoxidation Utilizing Iminium-Salt Catalysts 
Page has recently shown that catalyst 41 can be employed in the asymmetric epoxidation 
of various cis-alkenes, affording high enantioselectivities (up to 97% ee).
16,17 
Iminium salt 
41 has been highly effective under non-aqueous epoxidation conditions, where the terminal 
oxidant employed is TPPP 71 (tetraphenylphosphonium monoperoxysulfate) (Figure 
2).
16,17 
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Figure 2. Iminium-salt catalyst 41 and oxidant Tetraphenylphosphonium 
monoperoxysulfate (TPPP) 71 
 
2.4.1  Synthesis of Iminium salt Catalyst 41 
The synthesis of iminium salt 41 was divided into two parts; formation of chiral amine 76 
(4S,5S)-2,2-dimethyl-4-[4-(methylsulfonyl)-phenyl]-1,3-dioxan-5-amine from 
thiomicamine 72, and the formation of 2-(2-bromoethyl)benzaldehyde 78. To prepare 
(4S,5S)-2,2-dimethyl-4-[4-(methylsulfonyl)-phenyl]-1,3-dioxan-5-amine 76, thiomicamine 
72 was protected using methyl formate to give diol 73 and then treated with 2,2-
dimethoxypropane in the presence of p-TSA to give sulfide 74. Sulfide 74 was oxidized to 
sulfone 75 with mCPBA followed by removal of the formyl protecting group using 
hydrazine monohydrate to yield aminodioxane sulfone 76 in four steps (Scheme 18).
16 
 
Scheme 18. Reagents and conditions: (i) NaOMe (25% in MeOH), CH3OCHO (1.5 eq.), 
CH3OH, r.t., 12 h. (ii) DMP (5 eq.), pTSA (0.2 eq.), PhCH3, reflux, 12 h. (iii) mCPBA (3 
eq.), CH2Cl2, 0 °C – r.t., 2 h. (iv) H2N-NH2.H2O (85%, 20 mL/g), reflux, 2.5 h, 88% 
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The second part of the catalyst synthesis involved the formation of 2-(2-
bromoethyl)benzaldehyde 78, which was easily prepared from isochroman 77 in two steps 
followed by distillation of the crude mixture to afford bromo-aldehyde 78 as a colourless 
liquid (Scheme 19).
24
  
 
Scheme 19. Reagents and conditions: (i): Bromine (1.1 eq.), cyclohexene, reflux, 15 mins; 
(ii): HBr, reflux, 10 mins, 50% 
 
With both 2-(2-bromoethyl)benzaldehyde 78 and (4S,5S)-2,2-dimethyl-4-[4-
(methylsulfonyl)-phenyl]-1,3-dioxan-5-amine 76 in hand, a condensation reaction followed 
by an anion exchange yielded catalyst 41 in good yield (Scheme 20).
16 
 
Scheme 20. Reagents and conditions: (i) 78 (1.1 eq.), EtOH, 0 °C → r.t., 12 h; (ii) NaBPh4 
(1.1 eq.), MeCN, r.t., 5 min, 89% 
 
2.4.2  Synthesis of Tetraphenylphosphonium Monoperoxysulfate (TPPP) 71 
Page has shown that a range of oxidants can be implemented in the catalytic iminium-salt 
mediated asymmetric epoxidation of olefins, including Oxone™,25 sodium hypochlorite,26 
hydrogen peroxide,
27 
and, most recently, tetraphenylphosphonium monoperoxysulfate 
(TPPP) under non-aqueous conditions.
16,17,18,28 
Di Furia first reported the synthesis of TPPP in 1994. He showed that TPPP could be 
utilized in the oxidation of manganese-based porphyrins in the presence of imidazole. The 
oxidized metallo-porphyrins were then shown to epoxidize olefins. We prepared 
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Tetraphenylphosphonium monoperoxysulfate 72 in 83% yield by an anion exchange 
reaction between tetraphenylphosphonium chloride 79 and Oxone™ (Scheme 21).29 
 
Scheme 21. Reagents and conditions: (i): Oxone (1 eq.), CHCl3:H2O, 10 °C, 0.5 h 
 
With both the oxidant and catalyst prepared, the kinetic resolution experiments could be 
conducted. However, it was important to identify sources of background oxidation, if any, 
from the oxidant alone. 
 
2.4.3  Control Experiments: The Absence of Iminium Salt 41 
Di Furia reported that tetraphenylphosphonium monoperoxysulfate alone is not capable of 
epoxidizing cyclooctene or styrene in the absence of manganese porphyrins.
29 
To confirm 
that there would be no background oxidation from TPPP in our catalytic procedure, a small 
number of control experiments were run in the absence of iminium salt 41 (Table 4). 
Pleasingly, we observed in most cases no background epoxidation to occur (trace 
epoxidation observed for compounds 48 and 51), as shown by the 
1
H NMR spectra of the 
crude reaction mixtures (Figure 3).  
Chromene substrate Substrate number Epoxide present 
 
47 No 
 
48 
epoxide region 
obscured by 
unidentified 
impurity 
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51 
epoxide region 
obscured by 
unidentified 
impurity 
 
55 No 
 
56 No 
 
Table 4. Control experiments conducted under standard non-aqueous conditions: TPPP (2 
eq.), CHCl3, -30 °C, 24 h 
 
Figure 3. 
1
H NMR spectra plots to test if epoxide was produced by the racemic non-
catalysed reaction conditions (see table 4) 
 
 
 
47 
48 
51 
55 
56 
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2.4.4 Trial Run: Asymmetric Epoxidation of (±)-6-cyano-2-methyl-chromene 48 
A preliminary experiment was conducted on (±)-6-cyano-2-methyl-chromene 48 under 
non-aqueous reaction conditions utilizing iminium salt 41, and provided a promising initial 
result (Scheme 22). 
 
Scheme 22. Reagents and conditions: (i) iminium salt 41 (10 mol%), TPPP (4 eq.), CHCl3,   
–30 °C, 24 h. (The upper structures of each pair are the major isomers in each case). 
Epoxide d.r.’s were determined from the 1H NMR spectra of the reaction mixture after 
work-up. 
The reaction showed a number of encouraging signs; most notably, a higher selectivity 
towards the product where the methyl group at C2 is trans to the epoxide moiety was 
observed than when mCPBA is used. At 52% conversion, 
1
H NMR spectroscopic data of 
the mixture of inseparable diastereoisomers indicated a 3:1 d.r. (Scheme 22). Chiral HPLC 
analysis showed the enantiomeric excess of the major epoxide diastereoisomer (trans) was 
86% ee, and 97% ee for the minor epoxide diastereoisomer (cis) (Figure 4). The recovered 
starting material 48 was measured as 37% ee. 
       
Figure 4. HPLC traces for racemic epoxide 64 (above left, table 3) and enantioenriched 
epoxide 64 (above right, scheme 22) 
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2.4.5  Kinetic Resolution of Racemic Benzopyrans 47 - 60 Utilizing Iminium Salt 41 
Encouraged by the preliminary result gained for compound 48, we tested the full library of 
benzopyran substrates 47 – 60 under the original conditions (iminium salt 41 (10 mol %), 
TPPP (4 eq.), CHCl3, −30 °C), allowing us to analyse the electronic effects by variation of 
groups at the C6 position on the chromene, and steric influences by varying the alkyl/aryl 
substituent at the C2 position (Table 5). 
Starting 
material 
Product 
No. 
Conv. 
(%)
b 
Epox 
d.r. 
(trans:
cis)
d
 
Major 
epoxide 
Diastereo
-isomer ee 
(%)
c 
Minor 
epoxide 
Diastereo-
isomer ee 
(%)
c
 
Recovered 
chromene 
ee (%)
c 
Rotation 
of 
recovered 
chromene 
krel
e 
47 63 48 2.5:1 87 97 26 (+) 2.3 
48 64 52 3:1 86 97 37 (+) 2.9 
51 65 50 4:1 87 98 40 (+) 3.4 
52 66 56 3.5:1 73 92 41 (+) 2.8 
55 67 26 
trans 
only 
76 / 17 (+) 3.4 
56 68 37 
trans 
only 
78 / 14 (+) 1.9 
59 69 38 10:1
 
76 82 42 (+) 8.0 
60 70 36 16:1
 
64 95 50 (+) 27.9 
a
 All reactions were carried out with substrate (1 eq.), catalyst (10 mol%) and 
tetraphenylphosphonium monoperoxysulfate (TPPP) (4 eq.) in CHCl3 at −30 °C.  
b
 Conversion was determined from the 
1
H NMR spectra of the crude reaction 
mixture.  
c
 Enantioselectivity was determined using chiral stationary phase HPLC with a 
Chiralcel OD-H column.  
d
 Diastereoisomeric ratios were determined from the 
1
H NMR spectra of the 
reaction mixture after work-up.  
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e
 krel = ln[(l - C)(1 - ee)]/ln[(l -C)(1 + ee)] where C is the fraction of 47, 48, 51, 52, 55, 
56, 59, 60 consumed (or conversion) and ee is the percentage enantiomeric excess of 
the recovered starting material/100. The krel indicates the difference in reactivity 
between the two competing starting material enantiomers in the form of a rate constant. 
Table 5. Kinetic resolution of olefins using asymmetric epoxidation mediated using 
catalyst 41 
Looking at the electronic effects of various substituents on the benzopyrans core, in all 
cases, we again found that the compounds 49, 50, 53, 54, 57, 58, 61, 62 containing the 
chloro or methyl substituent at C6 on the benzopyran were unstable under the epoxidation 
reaction conditions, and yielded neither epoxide nor diol. The best results were obtained 
with those compounds containing nitro and cyano substituents on the aromatic ring; 
presumably their presence stabilizes the epoxide product, preventing decomposition. 
As we expected, increasing the bulk size of the alkyl/aryl substituent at C2, from methyl → 
propyl → phenyl, leads to an increase in the diastereoselectivity and enantioselectivity 
observed. When C2 is phenyl, we observe only the epoxide product that has the epoxide 
moiety trans with respect to the C2 substituent. The enantioselectivities were good in all 
cases for the major epoxide diastereoisomer, and were generally higher still for the minor 
diastereoisomer, with moderate enantioselectivity observed in the recovered starting 
material (15-50% ee).  
Taking the reaction past 50% conversion and near to completion was also investigated. For 
example, chromene 47 was submitted to the general asymmetric epoxidation conditions, 
but allowed to reach 84% conversion over one week. Analysis of the reaction mixture 
showed that the diastereoisomeric ratio remained at 2.5:1 for the major:minor epoxide, 
with the major epoxide attaining 70% ee, and the minor epoxide with 80% ee. The 
recovered starting material was <5 mg, but still provided a (+)-rotation and 64% ee. 
 
2.4.6  Determination of the Absolute Configuration of the Major Epoxide 
Product 
With a number of asymmetric epoxidation experiments now complete, we wished to 
isolate the major epoxide products from our reactions in order to fully determine the 
absolute configuration of the epoxide products observed.  
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In order to assign the absolute configuration of the major epoxide product, we first 
investigated the recovered starting material. In the literature, there are a number of chiral 
chromenes that have been previously synthesized as single enantiomers.
30
 Based upon 
these reports and the optical rotations of our recovered chromene starting materials (Table 
5), we were able to assign the absolute configuration of the products obtained.  
Further confirmation of our assignments of the absolute stereochemistry is based on 
previous outcomes observed within our group for the epoxidation of prochiral olefins with 
catalyst 41. We observe the same diastereofacial selectivity in our kinetic resolution 
experiments as previously observed in the epoxidation of prochiral chromenes.
16,17,18
 A 
simple reaction mnemonic (Figure 5) shows the favoured approach of oxygen transfer 
between catalyst 41 and racemic chromene substrates. 
 
Figure 5. Reaction mnemonic indicating the preferred trajectory of oxidation with catalyst 
41 
 
In order to confirm unequivocally the absolute configuration of the major enantiomer 
obtained in these reactions, we tried to isolate the major epoxide. We initially attempted 
separating the epoxide diastereoisomers of 6-cyano-2-methylchromene by column 
chromatography, but this proved to be unsuccessful. Separation of the diastereoisomers by 
chiral HPLC was trialled in the laboratory previously, but only small quantities of each 
isomer were attained (< 1 mg), and so proved unfruitful for the determination of accurate 
optical rotations.  
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We next looked at isolation of the major epoxide from the asymmetric epoxidation of 6-
cyano-2-phenylbenzopyran 56. Epoxide 68 was reductively ring-opened by hydrogenation 
over a palladium on carbon catalyst to give alcohol 80 in quantitative yield.
31
 Alcohol 80 
was then converted to the corresponding 10S-camphorsulfonyl ester 81 in 43% yield 
(Scheme 23).
32
  
 
Scheme 23. Reagents and conditions: (i) Pd/C, H2 (1 atm), MeOH, r.t., 20 min, 99%; (ii) 
(10S)-(+)-camphorsulfonyl chloride (1 eq.), Et3N (2 eq.), PhMe, r.t., 24 h, 43%. 
Excitingly, recrystallization of 6-cyano-(2R)-phenyl-(3S)-camphor(16S,19R)-sulfonylester 
chromene from a petroleum ether-dichloromethane two layered solvent system yielded 
long colourless crystals, that were suitable for X-ray analysis. Single crystal X-ray analysis 
of 81 confirmed our assignment of absolute and relative configuration (Figure 6, Appendix 
A).  
 
Figure 6. Single crystal X-Ray structure of sulfonyl ester 81 
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Analysis of the crystal structure data gives some key information: the mean bond length of 
the C2-C9 (phenyl substituent) is 1.540(13) Å, whilst the mean bond length of the C3-O3 bond 
is 1.477(9) Å. The bond angle between C3-C2-C9 is 113.0(7)°, whilst that of C3-O3-S3 is 
much larger at 123.2(5)°.  
In order to assign the absolute stereochemistry, we must look at the chromene core 
structure as lying flat in the plane of the page. From here, we can see that the phenyl 
substituent at C2 is coming out towards the reader, with the proton H2 going away from 
the reader. Looking at the oxygen atom O3, we observe it heading away from the reader, 
with the hydrogen H3 coming out of the plane of the paper towards the reader. The 
addition of (+)-camphorsulfonyl ester moiety to the oxygen O3, which has known 
stereochemistry at C16 and C19 respectively, enabled us to make the assignment 
unequivocally. 
With this information in hand, firstly, we can see that the major epoxide product is the one 
that has the epoxide moiety trans to the R substituent at the C2 position. Secondly, the 
stereochemistry observed would indicate that the oxygen transfer process is more selective 
for the alkene enantiomer where the phenyl or R substituent at C2 is coming out of the 
plane of the paper towards the reader, allowing the catalytic oxygen transfer step to occur 
from the opposite side/underneath.  
Analysis of this oxygen transfer step from the crystallographic data collected agrees 
directly with the same diastereofacial selectivity previously observed when our group has 
conducted the epoxidation of various prochiral chromenes. 
 
2.5  Conclusions and Future Applications 
The results accumulated within this research project have shown that the resolution of 
racemic benzopyrans by iminium-salt mediated asymmetric epoxidation with catalyst 41 
can be achieved with excellent enantioselectivities for the minor epoxide and good 
enantioselectivites for the major epoxide product. The recovered starting material can also 
be isolated in moderate enantioselectivities (15-50% ee). The methodology works well for 
those chromenes containing electron-withdrawing substituents at the C6 position on the 
chromene, but fails when electron-rich chromenes are subjected to the same reaction 
conditions. 
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Future aims should look towards developing a new catalytic system, maybe utilizing 
another iminium-salt catalyst developed within the group that is more favoured towards 
sensitive olefin substrates, or adapting the methodology to work under Page’s aqueous 
epoxidation conditions.  
Catalyst 82 and 83 (Figure 7) have recently shown great promise within the Page group for 
the epoxidation of various cis-olefins under aqueous and non-aqueous conditions.
33
 In 
another project I have been involved in the Page group, we reported the epoxidation of 
various 2,2-substituted benzopyrans under non-aqueous conditions affording ee’s up to 
98% ee (Table 6, Appendix C). 
Epoxide Catalyst 
Conv
/% 
Reaction  
time (h) 
ee/
% 
Major 
enantiomer 
 
82 90 20 97 (−)-1S,2S 
83 100 48 98 (−)-1S,2S 
 
83 74 120 94 (−)-1S,2S 
 
83 100 45 86 (+)-(3’S,4’S) 
 
Table 6. Epoxidation conditions: iminium salt catalyst 82/83 (10 mol%), TPPP (2 eq.),  
CHCl3, 0 °C 
Applications of this methodology to natural product syntheses can be envisaged for those 
target molecules containing a chromen-3-ol core, such as catechin 84, containing a proton 
and phenyl substituent at C2.  
Some key examples found in the literature include green tea catechins such as EGCG 85 
(Figure 7), which are known to exert excellent bio-activities,
34
 but many syntheses of 
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various green tea catechins are achieved in low overall yield,
35 
either following tedious and 
in some cases expensive asymmetric synthesis. 
 
Figure 7. Iminium-salt catalysts 82 and 83, Green tea compounds Catechin 84 and EGCG 
85 
Current projects within the Page research group are investigating implementing this kinetic 
resolution methodology to gain access to generate these chromen-3-ol green tea catechins.  
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2.6  The First Examples of Asymmetric Epoxidation on Dihydroquinoline 
Substrates catalysed by Chiral Iminium-salts 
The tetrahydroquinoline motif is a key moiety found in a number of natural products and 
pharmaceuticals, for example, benzastatins C & D 86-87, and virantmycin 2, all of which 
exhibit potent biological activity (Figure 8).
2
  
 
Figure 8. Tetrahydroquinoline-derived natural products  
This particular area of heterocyclic chemistry has been reviewed by Menéndez in 2011,
36
 
and has allowed us to identify some natural products and drug molecules that could be 
synthesized within the Page group, such as helquinoline 1 and tetrahydroquinoline drug 
molecule 88 (Figure 9).
1,37
 
 
Figure 9. Potential synthetic target molecules helquinoline 1 and drug molecule 88 
 
2.6.1  Reactions Utilized in the Synthesis of Dihydroquinoline Substrates 
Our strategy to develop a methodology to access tetrahydroquinoline natural products such 
as helquinoline 1, would start with the synthesis of the dihydroquinoline motif followed by 
enantioselective epoxidation to obtain chiral non-racemic tetrahydroquinolines.  
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Some of the most successful reactions employed in the generation of dihydroquinolines are 
discussed herein. 
 
2.6.2  Nicolaou’s Polymer-Supported Selenium Cyclizations 
Nicolaou reported the cyclization of a limited number of para-substituted ortho-prenyl 
anilines in the presence of a polymer-bound selenenyl bromide resin. When Nicolaou 
utilized the unprotected aniline 89, he observed a 6-endo-trig cyclization to afford the 2,2-
dimethyldihydroquinoline nucleus 90 in just 30 minutes. The final product, 6-cyano-2,2-
dimethyldihydroquinoline 91, was formed in 85% yield after oxidative cleavage of the 
selenenyl resin.
38
 
 
Scheme 24. Reagents and conditions: (i) Polymer-bound selenenyl bromide resin, Aniline 
(2 eq.), Dichloromethane, 0 °C, 30 min. (ii) Hydrogen Peroxide, THF. 
However, the methodology has a few important drawbacks to note; Nicolaou’s attempts to 
derivatize the nitrogen of the dihydroquinoline scaffold failed due to severe steric 
encumbrance of the position by the adjacent gem-dimethyl group. Secondly, the 
methodology only afforded clean conversion to the quinoline motif when para-substituted 
electron-deficient substituents (such as cyano or nitro substituents) were present on the 
aniline. 
 
2.6.3  Hartwig’s Palladium-catalysed Hydroamination 
Hartwig has recently reported a palladium-catalysed hydroamination reaction of cyclic 
trienes, in which he proposes that the bridged bicyclic products of the reaction are 
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generated from a consecutive intermolecular hydroamination and transannular 
intramolecular hydroamination reaction.
39
 The major products in each example reported 
are the tropene products, such as 93 (Scheme 25), which are all formed in good to excellent 
yields. However, the main drawback of this methodology is that the dihydroquinoline side-
products, such as 94, are formed in much lower yields (9 – 38%). Interestingly, Hartwig 
showed that heating 93 with just the catalyst components of the system, and without the 
amine present, gave 87% unreacted starting material after 1.5 hours, showing that tropene 
93 is not a direct precursor to quinoline 94. 
 
Scheme 25. Reagents and conditions: (i) Cycloheptatriene 92 (2.0-4.0 mmol, 4 eq.), 
Aniline (0.5-1 mmol), Pd(TFA)2 (2%), Xantphos (4%), Benzoic Acid (10%), Toluene, 110 
°C 
 
2.6.4  Gold Catalysed Intramolecular Allylic Amination 
Chan has shown that various 1,2-dihydroquinolines (96) can be synthesized from 2-
tosylaminophenylprop-1-en-3-ols (95) in good to excellent yields when reacted specifically 
at room temperature, in toluene, catalysed by a specific gold-silver catalyst combination 
(Scheme 26).
40
 This intramolecular allylic amination reaction works best when the 2-
tosylaminophenylprop-1-en-3-ol starting materials contain electron-donating substituents. 
 
Scheme 26. Reagents and conditions: (i) AuCl3 (5 mol%), AgSbF6 (10 mol%), Toluene, 
r.t., 1 h 
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Chan’s methodology, however, has its drawbacks. Firstly, the reaction only proceeds 
efficiently in toluene (acetonitrile and 1,4-dioxane were tested as solvents, yet showed no 
sign of reaction). Secondly, the catalyst mixture employed in the reaction is limited to 
using a gold trichloride-silver antimony hexafluoride mixture (at relatively high catalyst 
loadings), with other precious metals such as ytterbium triflate and indium trichloride 
affording relatively low yields (up to 11%). 
 
2.6.5  Tandem Michael-aldol additions 
Hamada showed that a base-catalysed tandem Michael-aldol reaction was feasible starting 
from N-protected o-aminobenzaldehydes 97 and -unsaturated carbonyl compounds 98, 
affording various 3-substituted dihydroquinolines 99 in good yields (Scheme 27).
41
 They 
observed that under these reaction conditions a base-catalysed dehydration was taking 
place. In the absence of benzyltriethylammonium chloride, no reaction was observed at all. 
 
Scheme 27. Reagents and conditions: (i) BnEt3NCl (0.2 eq.), 4M K2CO3, CHCl3, r.t., 64 h 
(Mbs: 4-MeOPhSO2) 
The reaction is, however, limited to two specific examples in the report, and no further 
expansion of substrate scope was reported by the authors. The inclusion of a substituent at 
the 3-position on the dihydroquinoline core may hinder our efforts to conduct successful 
epoxidation reactions on the C3-C4 alkene moiety, and for this reason this methodology 
was not considered as a suitable method to access our dihydroquinoline substrates.  
  
The examples described above do not include the enantioselective syntheses of 2-
substituted dihydroquinolines, but it is worth noting that excellent enantioselectivities have 
been reported independently by Shibasaki (96 % ee)
42
, Takemoto (97% ee)
43
 and Alexakis 
(75% ee) respectively.
44
 The work reported in this chapter looks to employ an 
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enantioselective iminium-salt catalysed epoxidation step to form enantioenriched 
tetrahydroquinoline products from various prochiral dihydroquinoline substrates. 
 
2.6.6 Copper catalysed cyclization of N-(1,1-disubstitutedpropargyl)anilines 
In 1960, Hennion reported the first examples of alkylation of aromatic amines with tertiary 
acetylinic chlorides catalysed by cuprous chloride. The methodology reported by Hennion 
allowed various N-(1,1-disubstitutedpropargyl)anilines 100 to be synthesized in good 
yields (up to 56%). The addition of a catalytic amount of cuprous chloride was found to be 
essential for the reaction to proceed within a reasonable reaction time (≤ 3 hours), since the 
aromatic amines react very poorly in its absence.
45
 
Ward later showed that these N-(1,1-disubstitutedpropargyl)anilines 100 could be cyclised 
by refluxing them in toluene in the presence of cuprous chloride, affording various 2,2-
disubstituted-1,2-dihydroquinolines 101 in good yields (up to 82%). He showed that 
electron donating groups at the para-position of the ring (such as methyl or methoxy 
moieties) enhanced the rate of reaction, whilst electron withdrawing substituents slowed 
the reaction rate (Scheme 28).
46
 
 
 
Scheme 28. Reagents and conditions: (i) Aniline (1 eq.), Triethylamine (1.3 eq.), 3-
Chloro-3-methyl-1-butyne (1 eq.), Copper(I) chloride, Copper bronze powder, Diethyl 
ether, r.t., 3 h.
45
 (ii) Copper(I) chloride (10% by weight), reflux, toluene, 0.5 – 16 h.46 
 
Ward’s aim was to find a quick route to synthesizing 2,2-disubstituted-3-
chlorotetrahydroquinolines, compounds that are close in structure to the known natural 
product virantmycin 2.
2
 He showed that his 2,2-disubstituted-1,2-dihydroquinoline 
Results and Discussion 
 
 
110 
 
substrates could be cis-dichlorinated, followed by selective monodechlorination at the 
benzylic position to afford 3-chlorotetrahydroquinolines 102 (Figure 10).
46,47 
 
 
Figure 10. Tetrahydroquinoline-derived natural product Virantmycin 2 and Ward’s 3-
chlorotetrahydroquinoline 102 
 
We decided to implement Ward’s methodology as it would allow us to generate a library 
of 2,2-disubstituted-1,2-dihydroquinolines with various electron-withdrawing or electron-
donating substituents at the para-position on the aniline used to construct the quinoline 
core. The synthesis can be achieved in two simple steps from relatively inexpensive 
commercially available starting materials. Encouraged by the results reported by Ward for 
the cis-dichlorination of dihydroquinolines, we envisaged the possibility of applying our 
iminium-salt catalysts to effect an asymmetric epoxidation reaction on the alkene moiety of 
the dihydroquinoline substrate. 
Ward has already reported that mCPBA can be used to prepare non-chiral epoxides of 
various nitrogen-protected dihydroquinoline substrates.
47
 Smith has alternatively shown 
that the hydrobromination of dihydroquinolines using aqueous NBS followed by base 
catalysed elimination affords the subsequent non-chiral epoxides.
48
 
The asymmetric epoxidation of dihydroquinolines has only been very rarely reported. The 
only examples in the literature are shown by Wuts,
49
 in which intermediates towards the 
synthesis of sumanirole 103,
48
 include chiral 3,4-epoxy-tetrahydroquinoline substrates 
(Figure 11). The two methodologies utilized by Wuts for the epoxidation of 1-acetyl-8-
nitrodihydroquinoline 104 (Figure 11) include Shi’s epoxidation conditions,50 and 
Jacobsen’s epoxidation conditions,51 with the chiral epoxide ee determined as 13% and 
97% in each case, respectively.  
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Figure 11. Anti-parkinson’s drug molecule sumanirole 103 and 1-acetyl-8-
nitrodihydroquinoline 104 
The results discussed herein are the first examples of organocatalytic iminium-salt derived 
asymmetric epoxidation reactions of 1,2-dihydroquinoline substrates to afford chiral 3,4-
epoxytetrahydroquinoline products. 
 
2.7  Preparation of Dihydroquinoline Substrates 105-112 
Encouraged by Ward’s methodology, we found that dihydroquinoline substrates 105-112 
could be synthesized in moderate yields (Scheme 29, Table 7). During the reaction, the 
intermediate N-(1,1-disubstitutedpropargyl)anilines 100 were not observed as a product. 
Isolation of dihydroquinolines 105-112 was achieved by refluxing the anilines and 3-
chloro-3-methyl-1-butyne in toluene until complete consumption of starting material was 
observed by thin layer chromatography. 
 
Scheme 29. Reagents and conditions: 3-Chloro-3-methyl-1-butyne (1 eq.), Aniline (1 eq.), 
Copper Bronze powder (0.1 eq.), Copper (I) chloride (1 eq.), toluene, reflux, 24 h. 
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Product Dihydroquinoline Yield (%) 
105 
 
30 
106 
 
32 
107 
 
25 
108 
 
14 
109 
 
0 
110 
 
0 
111 
 
0 
112 
 
0 
 
Table 7. Various 6-substituted dihydroquinolines synthesised according to Scheme 29 
In an attempt to increase the yields of compounds 105-108, the methodology was repeated 
in a sealed glass vial and submitted to microwave irridation for 20 minutes, previously 
utilized in the group for increasing the yield of seselin 37 (Scheme 13) when changing 
from the conventional reflux conditions to microwave conditions.
17
 This methodology 
however proved to be unsuitable for this particular copper-catalysed cyclisation reaction, 
and in two cases tested, compounds 105 and 107 were not observed after 1 hour of 
irridation, either by thin layer chromatography of the reaction mixture, or by analysis of the 
1
H NMR spectra of the crude reaction mixture.  
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The yields of dihydroquinolines 105-108 are only moderate at best, and further attempts 
were made to increase the yields of this cyclization reaction. We first looked at protecting 
the aniline with a protecting group, such as a tosyl-protecting group as used in Chan’s 
gold-catalysed intramolecular allylic amination reactions.
40
 This would then be followed 
by alkylating with 3-chloro-3-methyl-1-butyne in the same fashion as Hennion’s 
procedure,
45
 and finally cyclization by refluxing in toluene in the presence of cuprous 
chloride (Scheme 30). We hoped that this would not only increase the yields of the 1,2-
dihydroquinoline products, but would also result in the protection of the secondary amine, 
which could prove to be necessary for a successful epoxidation of the alkene moiety. 
The results from this procedure are indicated below (Table 8). The tosylation of three 
aromatic amines occurred in nearly quantitative yield after stirring at room temperature for 
24 hours under base catalysed conditions. However, attempts to alkylate the protected 
aromatic amines with 3-chloro-3-methyl-1-butyne failed under numerous base-catalysed 
conditions tested (Table 8).  
 
Scheme 30. Reagents and conditions: (i) Aniline (1 eq.), Triethylamine (1.5 eq.), p-
Toluenesulfonyl chloride (1.2 eq.), r.t., 24 h; (ii) 3-Chloro-3-methyl-1-butyne (1 eq.), See 
Table 8. 
Aniline Starting 
Material 
Yield of 
Tosyl-
Protected 
Product (%) 
Conditions Utilized for Attempted 
Alkylation Step 
Yield of 
Alkylated 
Aniline (%) 
 
97 
Triethylamine (1.5 eq.), THF, r.t., 24 h 0 
n-BuLi (1.5 eq.), THF, -78 C – r.t., 3 h 0 
Pyridine (1.5 eq.), CH2Cl2, r.t., 24 h 0 
 
96 Triethylamine (1.5 eq.), THF, r.t., 24 h 0 
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n-BuLi (1.5 eq.), THF, -78 C – r.t., 3 h 0 
 
95 Triethylamine (1.5 eq.), THF, r.t., 24 h 0 
Table 8. Attempted synthesis of alkylated aromatic amines 
Since the results obtained from this modified method proved to be unfruitful, we decided 
to proceed to the next stage of our methodology using our original conditions to synthesize 
the 1,2-dihydroquinoline substrates. 
With the dihydroquinolines in hand, a number of trial epoxidations were conducted 
utilizing either mCPBA or various iminium salt catalysts under aqueous and non-aqueous 
conditions upon the dihydroquinolines 105-112 above (Table 9). We found that 
consumption of alkene starting material was observed in most cases, but, the desired 
epoxide product was not isolated. From 
1
H NMR spectra of the crude reaction mixtures 
conducted in CDCl3, only peaks in the aromatic region were seen, at approximately the 
same chemical shifts as the starting material aniline.  
Starting material 
Oxidation 
system 
Epoxide product 
detected 
105 
mCPBA, 
CH2Cl2, 0 °C 
No, complex 
mixture observed 
106 
mCPBA, 
CH2Cl2, 0 °C 
No, complex 
mixture observed 
107 
mCPBA, 
CH2Cl2, 0 °C 
Aniline SM 
observed 
TPPP (2 eq.), 
Iminium-salt 
82 (10 mol%), 
CHCl3, 0 °C 
Aniline SM 
observed 
108 
mCPBA, 
CH2Cl2, 0 °C 
Aniline SM 
observed 
Table 9. Epoxidation of dihydroquinoline substrates with various oxidizing agents 
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The instability of the dihydroquinolines towards oxidants such as meta-chloroperbenzoic 
acid made us re-think our strategy. Ward had reported that protecting the secondary amine 
of his 1,2-dihydroquinolines with a trifluoroacetyl protecting group allowed only the 
alkene moiety to be dichlorinated to give various 3,4-dichlorotetrahydroquinolines, with no 
sign of aromatic chlorination taking place. He also showed that N-trifluoroacetyl protected 
113 can react with mCPBA, affording the racemic epoxide 114 in good yield (70%) 
(Scheme 17).
47
  
 
 
Scheme 31. Reagents and conditions: (i) mCPBA (1 eq.), NaHCO3 (1.25 eq.), CH2Cl2, r.t., 
41 h 
 
Encouraged by Ward’s findings, we looked at potential protecting groups for the secondary 
amine of the dihydroquinolines we had generated in order to perform successful 
epoxidation reactions.  
 
 2.7.1  Preparation of Nitrogen-protected Dihydroquinoline Substrates  
Our first attempt at protecting the secondary amine of our dihydroquinolines with a 
trifluoroacetyl moiety was achieved by following the same procedure as reported by Ward 
(Scheme 32).
47  
 
Scheme 32. Reagents and conditions: (i) Pyridine (1 eq.), trifluoroacetic anhydride (2 eq.), 
CH2Cl2, 0 °C → r.t., 1 h
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The best methodology in our hands involved the use of trifluoroacetic anhydride under 
basic conditions (pyridine), which afforded yields up to 97% (Table 10).
47
 Other bases 
were tested, for example, triethylamine and n-butyl lithium, on compounds 105 and 107, 
but in both cases of these bases tested the yields of product obtained of 115 and 117 were 
lower than that observed when pyridine was used (Table 10). 
Starting Material Product Reference 
Conditions 
used 
Time (h) Yield (%) 
 
105 
 
115 
(a) 1 97 
(b) 12 65 
(c) 4 40 
 
106 
 
116 
(a) 1.5 0 
 
107 
 
117 
(a) 1 68 
(b) 12 43 
(c) 4.5 40 
Table 10. Reagents and conditions: (a) dihydroquinoline (1 eq.), trifluoroacetic anhydride 
(2 eq.), pyridine (1 eq.), CH2Cl2, 0 °C → r.t., 1 h; (b) dihydroquinoline (1 eq.),  
trifluoroacetic anhydride (2 eq.), triethylamine (1 eq.), CH2Cl2, r.t., overnight (12 h); (c) 
dihydroquinoline (1 eq.), n-BuLi (1.4 eq.), THF, -78 °C, 1 h, then, trifluoroacetic 
anhydride (2 eq.) dissolved in minimum amount of THF, -78 °C → r.t., 3 h. 
Following on from the success of the trifluoroacetyl protecting group, we decided to try a 
range of protecting groups under various conditions. Our best results were obtained when a 
strong base such as n-butyl lithium was used to deprotonate the dihydroquinoline nitrogen 
(Table 11). This time, however, bases such as triethylamine and pyridine resulted in the 
isolation of the products in much lower yields, if at all. Protection of dihydroquinolines 
105 and 107 with acetyl moieties using the same procedure as reported by Ward resulted in 
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isolation of only the starting material in both cases.
47
 An attempt to formylate the nitrogen 
atom of dihydroquinoline 105 under similar conditions used for the synthesis of our 
iminium salt catalysts 41 and 82 as reported by Thomas et al. failed.
52
 6-nitro-substituted 
1,2-dihydroquinoline 106 also failed to react with a benzoyl moiety when using n-butyl 
lithium as base. 
 
Starting Material Product Conditions Used 
Yield 
(%) 
 
105 
 
118 
(a) 0 
(b)
 
0 
 
119 
(c) 0 
 
120 
(d) 41 
 
121 
(e) 33 
 
122 
(f) 55 
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118 
 
 
106 
 
123 
(d) 0 
 
107 
 
124 
(a) 0 
 
125 
(d) 0 
 
126 
(e) 40 
 
127 
(f) 14 
 
Table 11. Reagents and conditions: Each starting with 1 equivalent of 1,2-
dihydroquinoline (a) Ac2O (1.5 eq.), pyridine (0.5 mL), CH2Cl2, 0 ˚C → r.t., 3 h.; (b) AcCl 
(1.5 eq.), triethylamine (1.3 eq.), CH2Cl2, 0 ˚C → r.t., 1 h.
47
; (c) NaOMe (1 eq.), CH3CHO 
(1.5 eq.), MeOH, r.t., 24 h.
52
; (d) n-BuLi (1.4 eq.), benzoyl chloride (1.5 eq.), THF, -78 °C 
→  r.t., 4 h.; (e) n-BuLi (1.4 eq.), di-tert-butyl dicarbonate (1.5 eq.), THF, -78 °C → r.t.; (f) 
n-BuLi (1.4 eq.), benzyl chloroformate (1.5 eq.), THF, -78 °C → r.t. 
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The dihydroquinolines that contained a -chloro or -cyano substituent at the C6 position 
were most stable during the nitrogen protection reactions, with nitro substituted 
dihydroquinolines being the least stable. The least favourable group to protect the 
dihydroquinolines was found to be the acetate protecting group, despite repeating Ward’s 
successful methodology of dihydroquinoline acetate protections.
47
 Protecting the 
dihydroquinolines 105 and 107 with tert-butoxycarbonyl or carbobenzoxy moieties 
proceeded in moderate yields (≤55%), but nevertheless it provided five new compounds 
that could be tested for reactivity in subsequent epoxidation reactions, alongside the two 
compounds generated from trifluoroacetyl protection. 
The results obtained for the non-chiral and chiral epoxidations of these new nitrogen-
protected 1,2-dihydroquinoline substrates are detailed below.  
 
2.7.2  Non-chiral Epoxidations of Dihydroquinoline Substrates 120-127 
utilizing meta-Chloroperbenzoic Acid 
The new nitrogen-protected dihydroquinoline substrates 120-127 were subjected to achiral 
epoxidation conditions using mCPBA as the oxidant, to determine their reactivity towards 
oxidative species, their stability, and to provide racemic standards (Table 12). 
 
R
1
 R
2 
Substrate 
Product 
no. 
Conversion 
(%) 
Yield 
(%) 
CN C(O)CF3 115 128 100 60 
Cl C(O)CF3 117 129 100 52 
CN C(O)Ph 120 130 100 53 
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120 
 
CN C(O)O
t
Bu 121 131 100 71 
CN C(O)OCH2Ph 122 132 100 78 
Cl C(O)O
t
Bu 126 133 100 53 
Cl C(O)OCH2Ph 127 134 - 0 
 
Table 12. Reagents and conditions: mCPBA (2 eq.), NaHCO3 (4 eq.), CH2Cl2, 0 °C, 24 h 
The epoxide products generated were surprisingly stable (no decomposition was observed 
after being left at room temperature for 2 months) and could be easily purified by flash 
column chromatography on silica gel. The epoxidation of various N-protected 
dihydroquinolines with mCPBA showed that the olefin double bond is reactive towards 
electrophilic oxygen sources, and the products appear to be stabilized by the electron-
withdrawing nature of the protecting groups. The conversion of olefin to epoxide in each 
reaction reported above (Table 12) was followed by 
1
H NMR spectroscopic analysis of the 
crude reaction mixture. 
The isolated yields of epoxide products 128-133 after chromatography were good. It 
should be noted that all the successful results were achieved when the dihydroquinolines 
contained a cyano or chloro moiety at C6 on the quinoline core structure. Since there were 
no successful protection reactions on the nitro-containing dihydroquinoline 106 
(previously shown in tables 10 and 11), the subsequent epoxidation reactions on these 
substrates could not be tested. Encouraged by these results, we felt that an asymmetric 
variant of the epoxidation reaction could be attempted. It is important to note that most of 
the racemic samples obtained could be analysed using chiral HPLC or using a chiral shift 
reagent in 
1
H NMR spectroscopy.  
2.7.3 Initial Attempt at the Asymmetric Epoxidation of Dihydroquinoline Substrate 
115 under non-aqueous conditions 
The asymmetric epoxidation of N-protected dihydroquinoline substrates 115-126 could be 
approached in two ways, both of which have been previously developed within the group: 
The first method attempted would be under non-aqueous conditions, where TPPP is 
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employed as the primary oxidant, and the second, uses aqueous conditions utilizing Oxone 
as the oxidant.  
Our first attempt at an asymmetric epoxidation of these substrates involved non-aqueous 
conditions with iminium salt 41, previously shown to be highly effective in the asymmetric 
epoxidation of the complementary chromene-derived substrates (Scheme 33). Our initial 
test substrate was dihydroquinoline 115, containing a cyano moiety at the C6 position of 
the core structure, and also a trifluoroacetyl protecting group on the nitrogen atom. 
Dihydroquinoline 115 was observed to be extremely unreactive under these oxidative 
conditions, and the reaction achieved 37% conversion after 5 days. Excitingly, the 
corresponding epoxide product 128 was isolated with excellent enantioselectivity (73% 
ee). 
Scheme 33. Reagents and conditions: iminium-salt 41 (10 mol%), TPPP (2 eq.), CH2Cl2, 0 
°C, 5 days 
To test whether the conversion of this reaction could be improved under these non-aqueous 
conditions, the reaction was repeated two more times in the same solvent 
(dichloromethane), initially leaving the reaction for a longer time period (1 week), and 
secondly by increasing the number of equivalents of oxidant added (5 equivalents of 
TPPP). In both cases attempted the reaction maintained a low conversion (each time 
achieving <40%), yet the enantioselectivity remained consistent (~73% ee).  
Attempting this reaction in another non-aqueous solvent, for example chloroform (the 
preferred solvent for the non-aqueous iminium salt-catalysed asymmetric epoxidation 
reactions of the corresponding racemic chromene substrates used in the kinetic resolution 
experiments), proved to be unfruitful, yielding only trace amounts of the epoxide product 
as detected by 
1
H NMR spectroscopic analysis of the crude reaction mixture. 
We turned our attention to improving the conversion of this reaction; in order to achieve 
this we would require a much more reactive catalyst, perhaps changing the reaction 
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conditions to aqueous conditions. Biphenylazepinium-derived iminium salt 82 was 
previously reported by Page to be much more reactive than various dihydroisoquinolinium 
salts in the epoxidation of simple olefins under both aqueous conditions
53
 and non-aqueous 
conditions.
33
  
 
2.7.4  Synthesis of Biphenyl Azepinium Iminium-salt 82  
The preparation of iminium salt 82 was achieved by a similar procedure to that shown 
above in this chapter for iminium salt 41 (Schemes 18-20), starting this time from known 
chiral (S)-(−)-2-amino-3-phenyl-1-propanediol 135 (Scheme 34). The procedure reported 
by Thomas could be employed to synthesize the aminodioxane part of the catalyst, which 
can be formed in a 3 step synthesis from chiral amine 135 (Scheme 34).
52
 
The synthesis started from the commercially available amine 135, and was first protected 
using methyl formate to give diol 136, and then treated with 2,2-dimethoxypropane in the 
presence of camphorsulfonic acid to afford N-((4S,5S)-2,2-dimethyl-4-phenyl-1,3-dioxan-
5-yl)formamide 137 in quantitative yield. Removal of the formyl protecting group was 
achieved using hydrazine monohydrate, and after extraction with ethyl acetate, 
aminodioxane 138 was isolated in good yield (88%). 
 
 
Scheme 34. Reagents and conditions: (i) NaOMe (25% in MeOH), methyl formate (1.5 
eq.), MeOH, r.t., 12 h; (ii) 2,2-Dimethoxypropane (10 eq.), CSA (0.1 eq.), acetone, reflux, 
4 h, quant.%; (iii) Hydrazine monohydrate (85%, 20 mL/g of 137), reflux, 2.5 h, 88% 
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With aminodioxane 138 to hand, the other half of the catalyst, the biphenyl backbone, was 
required. 2,2’-bis(Bromomethyl)biphenyl 140 was formed by refluxing 2,2’-biphenyl-
dimethanol 139 in hydrobromic acid according to the literature procedure reported by Lygo 
(Scheme 35).
54
  
 
Scheme 35. Reagents and conditions: (i) 2,2’-biphenyldimethanol (1 eq.), HBr (48% wt. in 
H2O), reflux, 2 h 
 
2,2’-Bis(bromomethyl)biphenyl 140 was then subsequently condensed with aminodioxane 
138 under basic conditions (potassium carbonate) in refluxing acetonitrile for 24 hours, 
with the reaction progress monitored by thin layer chromatography. Upon completion, the 
resulting amine 141 could be used directly in the next step without further need for 
purification. The addition of N-bromosuccinimide to a solution of amine 141 yielded 
iminium salt 142 with a bromide counter ion, which was then exchanged for a 
tetraphenylborate anion by the addition of sodium tetraphenylborate dissolved in a 
minimum amount of acetonitrile. Catalyst 82 could be isolated by filtration, and its purity 
could be further increased by recrystallization from hot ethanol (Scheme 36).
53 
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Scheme 36. Reagents and conditions: (i) 2,2’-Bis(bromomethyl)biphenyl (1 eq.), 
aminodioxane 138 (1 eq.), K2CO3 (2 eq.), CH3CN, reflux, 24 h (ii) 141 (1 eq.), NBS (1.1 
eq.), EtOH, r.t., 1 h; then (iii) NaBPh4 (1.2 eq.) in minimum CH3CN, r.t., 5 min 
 
With both iminium-salts 41 and 82 to hand, we could now test a range of nitrogen 
protected dihydroquinoline substrates 115-126 under both aqueous and non-aqueous 
conditions. 
 
2.7.5  Asymmetric Epoxidation of N-Protected Dihydroquinoline Substrates 115-
126: Comparing Aqueous and Non-aqueous conditions 
After the initial success of the non-aqueous epoxidation conditions, we next looked at 
employing catalyst 82 and utilizing aqueous conditions for the asymmetric epoxidation of 
dihydroquinoline 115. Page has previously shown that both catalysts 41 and 82 can be used 
under the aqueous conditions reported by Yang (acetonitrile:water in a 10:1 ratio).
55
 The 
combination of catalyst 82 with aqueous conditions allowed full conversion of alkene 115 
to its corresponding epoxide 128 in under 2 hours (in comparison to the non-aqueous 
conditions; 5 days for 37% conversion), yet the enantioselectivity was only moderate at 
37% ee (Scheme 37). 
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Scheme 37. Reagents and conditions: (i) Dihydroquinoline (1 eq.), Oxone (2 eq.), 
NaHCO3 (5 eq.), catalyst 82 (5 mol%), CH3CN:H2O (10:1), 0 °C, 2 h. 
Encouraged by this result, we submitted the protected dihydroquinolines 115-126 to non-
aqueous and aqueous conditions with catalysts 41 and 82; the results are reported below 
(Table 13). Enantioselectivities range from low to good, depending upon the epoxidation 
conditions, protecting group, and catalyst used. 
Substrate Product no. 
Epox. 
cond. 
Time 
(h) 
Conv. 
(%) 
Yield 
(%) 
ee 
(%) 
Rotation 
of 
epoxide 
 
115 
 
128 
(a) 24 97 76 37 (–) 
 
120 
 
130 
(a) 24 89 68 66 (–) 
 
121 
 
(a) 2 100 90 12 (–) 
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126 
 
131 
 
117 
 
129 
(a) 24 100 87 22  (–) 
 
122 
 
132 
(a) 48 - 0 - n/a 
 
126 
 
133 
(a) 0.5 100 0 <5% n/a 
 
127 
 
134 
(a) 24 - 0 - n/a 
 
120 
 
130 
(b) 120 <5 0 - n/a 
 
117 
 (b) 120 46 13 62 (–) 
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127 
 
 
129 
 
 
115 
 
128 
(b) 120 37 10 73 (–) 
 
122 
 
132 
(b) 120 - 0 - n/a 
 
120 
 
130 
(c) 120 - 0 - n/a 
 
126 
 
133 
(c) 18 - 0 - n/a 
 
Table 13. Reagents and conditions: System (a) = Catalyst 82; 5 mol%, Oxidant; Oxone (2 
eq.), NaHCO3 (5 eq.), Solvent system; Acetonitrile:Water (10:1), Temperature; 0 °C 
(Yang’s conditions).55 System (b) = Catalyst 41; 10 mol%, Oxidant; TPPP (2 eq.), Solvent 
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system; Dichloromethane, Temperature; 0 °C. System (c) = Catalyst 82; 10 mol%, 
Oxidant; TPPP (2 eq.), Solvent system; Dichloromethane, Temperature; 0 °C. 
 
The results presented in Table 13 show a range in enantioselectivity and conversion.  
Focusing on those reactions conducted under aqueous conditions, where each reaction 
proceeds to full completion, we observe the following effects.  
Utilizing biphenyl-derived iminium salt 82 in each of the aqueous reactions the 
enantioselectivity dramatically varied depending on the protecting group attached to the 
nitrogen atom. When the protecting group is BOC, the enantioselectivity obtained was low 
(12% ee). When this group was replaced with a benzoyl protecting group, we observed a 
dramatic increase in enantioselectivity; for example, the enantioenriched epoxide product 
130 of substrate 120 was achieved in 66% ee under the aqueous conditions. 
Investigating the effect of changing the solvent system to a non-aqueous system with a 
different complementary catalyst, in this case utilizing dichloromethane with 
dihydroisoquinolinium iminium salt 41, we observed some of the best enantioselectivities, 
at the cost of sacrificing conversion towards the product. The most successful substrates 
tested were those that contain a trifluoroacetyl protecting group; for example the non-
aqueous asymmetric epoxidation of 115 (cyano) and 117 (chloro) afforded higher 
enantioselectivities for the epoxide products (73 and 62% ee respectively), but both were 
obtained at a low conversion (<50%). When the protecting group was changed from a 
trifluoroacetyl group to a carbobenzoxy or a benzoyl protecting group, the conversion was 
extremely poor under the non-aqueous conditions, even after 5 days. In an attempt to 
increase the conversion in these non-aqueous epoxidation reactions, some reactions were 
trialled utilizing non-aqueous conditions and the more reactive iminium salt 82 (System C, 
Table 13). However, we were disappointed to see that in both cases tested, the system 
afforded either just starting material in the case of substrate 120 (after 5 days), and 
decomposition products from substrate 126 (
1
H NMR analysis of the crude reaction 
mixture showed no sign of epoxide nor alkene after 18 hours). 
As shown in table 13, the non-aqueous epoxidations only proceeded when 
dichloromethane was the chosen solvent. When testing this reaction with a number of 
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substrates using chloroform or acetonitrile, no sign of epoxidation was recorded, with only 
starting material recovered. 
We have shown that the organocatalytic asymmetric epoxidation reaction can be applied to 
these N-protected dihydroquinoline substrates under both aqueous and non-aqueous 
conditions. The use of two different iminium salt catalysts was trialled, and in both cases, 
the chiral epoxide products from these asymmetric epoxidation reactions were afforded in 
moderate to good enantioselectivities. There has only been one example in the literature to 
date, for this asymmetric epoxidation reaction of dihydroquinoline substrates,
49
 and the 
results we report here show that this unusual methodology may have future applications in 
inducing chirality at the C3 and C4 positions of the quinoline structure, and thus, a useful 
tool in the total synthesis of natural products.     
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2.8 Overall Conclusions and Future Work 
The results accumulated within this part of the project have shown the first successful 
examples of the asymmetric epoxidation reaction on nitrogen-protected dihydroquinoline 
substrates using iminium salt catalysis, providing moderate to good enantioselectivities 
(highest being 73% ee).  
These results are encouraging, and have shown the clear potential for this methodology to 
be utilized in the total synthesis of tetrahydroquinoline natural products such as 
helquinoline 1
1
 and virantmycin 2
2
. 
 
Figure 12. Future applications: tetrahydroquinoline-derived natural products 
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3.0 Experimental 
 
3.1  General experimental details 
 
Infrared spectra were acquired using a Perkin Elmer System 2000 FT-IR 
spectrophotometer. Solid samples were run as nujol mulls or as thin films of their solution 
in DCM on sodium chloride plates. Liquid samples were run neat.  
 
1
H and 
13
C NMR spectra were measured respectively at 400.13 and 100.62 MHz using 
Varian Unity Plus (400 MHz) spectrometers, at 300.05 and 75.45 MHz using a Varian 
Gemini 200 (300 MHz) instrument, at 400.13 and 100.03 MHz using a 400 MHz Bruker 
Avance III 2 channel nanobay NMR spectrometer, or at 500.21 and 125.05 MHz using a 
Bruker Avance III 500 MHz NMR spectrometer. The solvent used for NMR spectroscopy 
was deuteriated chloroform unless stated otherwise, using tetramethylsilane as the internal 
reference. Chemical shifts are given in parts per million (ppm) and J values are given in 
Hertz (Hz).  
 
High resolution mass spectra were obtained from the EPSRC Mass Spectrometry Service 
at the University of Swansea. Melting points were recorded using a Büchi B-545 melting 
point instrument and are reported uncorrected. Optical rotation values were measured with 
a Bellingham and Stanley ADP-440+ instrument, operating at =589 nm, corresponding to 
the sodium D line at room temperature. The solvents used for these measurements were of 
spectrophotometric grade. The solutions for these measurements were prepared in 
volumetric flasks for maximum accuracy of the volume of solvent used. 
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Enantiomeric excesses were determined by chiral high performance liquid 
chromatography, (chiral HPLC). HPLC samples were prepared by silica gel-based 
chromatography or using silica gel preparative TLC plates. Data was recorded using a 
Hitachi Elite LaChrom instrument fitted with a L2400 UV detector (256 nm unless stated 
otherwise), L2300 column oven, L2200 autosampler, L2130 pump, a chiracel OD-H 5µm 
particle size column. All HPLC samples were run under hexane – isopropanol conditions 
with varying methods.  
 
Except where noted, all chemicals were used as received from Sigma Aldrich. Organic 
solvents were dried prior to use: diethyl ether and tetrahydrofuran were dried over sodium 
benzophenone ketyl and distilled; toluene was dried over sodium wire and distilled; 
petroleum ether 40/60 was distilled over calcium hydride.  
 
Diethyl acetal reaction products were purified under vacuum distillation of the crude 
reaction mixture; chromenes, chromene epoxides, dihydroquinolines, N-protected 
dihydroquinolines and N-protected dihydroquinoline epoxides were eluted using flash 
column chromatography with various eluents. 
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3.2 Numbering systems 
 
The NMR spectroscopic measurements have been assigned in accordance with the 
numbering system shown in Figure 1. The systems use standard nomenclature. Aromatic 
systems are numbered according to standard protocol. Aromatic carbon atoms bearing a 
substituent are indicated C quat., arom.. All aromatic carbon atoms which are attached to a 
hydrogen atom are called C arom in 
13
C spectra, or CH arom. in 
1
H spectra. The 
dihydroisoquinolinium carbon atoms are termed isoq. except carbon atoms C3 and C4, 
which are termed CH2N isoq-3 and Ar-CH2 isoq-4 in the assignment. The biphenyl system 
is numbered (Figure 1) with carbon atoms termed as biphenyl. Chromene and 
dihydroquinoline compounds are labelled (Figure 1) in accordance with standard protocol. 
 
Figure 1. Numbering systems employed in the experimental procedures. 
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3.3 Individual experiments 
 
3.3.1 Kinetic resolution section 
 
General Procedure for Acetal Formation
1
 
 
The aldehyde was dissolved in anhydrous alcohol (20 mL/gram of aldehyde). Solid 
ammonium nitrate (0.25 equiv.) and the corresponding trialkylorthoformate (1.2 equiv.) 
were added directly to the solution. The solution was allowed to stir under a nitrogen 
atmosphere at room temperature for 24 h, and quenched with saturated aqueous sodium 
hydrogen carbonate (20 mL/gram of aldehyde). The acetal product was extracted three 
times using dichloromethane (10 mL/gram of aldehyde), the combined organic extracts 
were dried over magnesium sulfate, and the organic solvents removed under reduced 
pressure. The crude acetal products were purified using vacuum distillation (35 – 45 °C, 2 
mbar) to afford pure colourless products.  
 
1,1-Diethyoxybut-2-ene (42): 
1,2,3
  
 
1,1-Diethyoxybut-2-ene was prepared using the general procedure for acetal formation 
from crotonaldehyde (10 g, 143 mmol), yielding the desired compound as a colourless 
liquid (10.6 g, 51%) after purification using vacuum distillation (2 mbar, 35-38 °C). νmax 
(film) / cm
-1
: 2976, 2880, 1677, 1446, 1371, 1125. 
1
H NMR (300 MHz, CDCl3): δH 1.17 
(6H, t, J = 7 Hz, 2x OCH2CH3), 1.65 (3H, dd, J = 7, 2 Hz, CH3), 3.38 – 3.45 (2H, m, 
OCH2CH3), 3.50 – 3.61 (2H, m, OCH2CH3), 4.77 (1H, d, J = 6 Hz), 5.48 (1H, ddq, J = 16, 
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6, 2 Hz), 5.78 (1H, dqd, J = 16, 7, 1 Hz). 
13
C NMR (75 MHz, CDCl3): δC 14.9, 17.2, 60.7, 
101.7, 128.9, 129.5. 
 
(3,3-Diethoxyprop-1-enyl)benzene (43): 
4,5 
 
 (3,3-diethoxyprop-1-enyl)benzene was prepared using the general procedure for acetal 
formation from trans-cinnamaldehyde (12 g, 91.0 mmol), yielding the desired compound 
as a colourless liquid (15.6 g, 83%) after purification using vacuum distillation (2 mbar, 
37-40 °C). νmax (film) / cm
-1
: 2975, 2877, 1949, 1655, 1449. 
1
H NMR (300 MHz, CDCl3): 
δH 1.25 (6H, t, J = 7 Hz, 2x OCH2CH3), 3.40 – 3.83 (4H, m, 2x OCH2CH3), 5.06 (1H, dd, J 
= 5, 1 Hz), 6.21 (1H, dd, J =16, 5 Hz), 6.71 (1H, d, J = 16 Hz), 7.08 – 7.47 (5H, m, Ar-H). 
13
C NMR (75 MHz, CDCl3): δC 15.1, 60.9, 101.5, 126.8, 126.8, 128.0, 128.6, 132.9, 136.3. 
 
1,1-Diethoxyhex-2-ene (44): 
6 
 
1,1-Diethoxyhex-2-ene was prepared using the general procedure for acetal formation from 
hex-2-enal (3 g, 30.6 mmol), yielding the desired compound as a colourless liquid (2.1 g, 
40%) after purification using vacuum distillation (2 mbar, 35-37 °C). νmax (film) / cm
-1
: 
3105, 2799, 1587, 1491, 1301. 
1
H NMR (300 MHz, CDCl3): δH 0.79 (3H, t, J = 7 Hz, 
propyl-CH3), 1.09 (6H, t, J = 7 Hz, 2x ethyl-CH3), 1.24 – 1.37 (2H, m, propyl-CH2), 1.93 
(2H, dd, J = 8, 15 Hz, propyl-CH2), 3.31 – 3.51 (4H, m, 2x ethyl-CH2CH3), 4.71 (1H, d, J 
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= 6 Hz), 5.37 (1H, dd, J = 6, 16 Hz), 5.68 (1H, dt, J = 7, 16 Hz). 
13
C NMR (75 MHz, 
CDCl3): δC 13.3, 14.9, 21.7, 33.9, 60.6, 101.7, 127.5, 134.6 
 
1,1-Diethoxy-4-methylpent-2-ene (45): 
7 
 
1,1-Diethoxy-4-methylpent-2-ene was prepared from 4-methyl-2-pentenal (2.0 g, 20.4 
mmol), using the general procedure for acetal formation, yielding the desired compound as 
a pale yellow liquid (2.75 g, 78%) after purification using vacuum distillation (2 mbar, 42-
45 °C). νmax (film) / cm
-1
: 3092, 2887, 1560, 1505, 1275, 1150. 
1
H NMR (300 MHz, 
CDCl3): δH 0.88 (6H, d, J = 7 Hz, 2x iso-propyl-CH3), 1.08 (6H, t, J = 6 Hz, 2x ethyl-
CH2CH3), 2.10 – 2.28 (1H, m, iso-propyl-CH(CH3)2), 3.23 – 3.41 (2H, m, 2x ethyl-
CH2CH3), 3.40 – 3.55 (2H, m, 2x ethyl-CH2CH3), 4.69 (1H, d, J = 6 Hz), 5.30 (1H, dd, J = 
16, 6 Hz), 5.65 (1H, dd, J = 16, 6 Hz). 
13
C NMR (75 MHz, CDCl3): δC 14.5, 21.4, 30.0, 
60.0, 101.3, 124.3, 140.8. 
 
1,1-Dimethyoxybut-2-ene (46): 
1
  
 
1,1-Dimethyoxybut-2-ene was prepared using the general procedure for acetal formation 
from crotonaldehyde (2.54 g, 36.2 mmol), ammonium nitrate (0.72 g, 9.1 mmol) and 
trimethylorthoformate (4.61 g, 43.5 mmol), yielding the desired compound as a light 
yellow volatile liquid (1.3 g, 31%) after purification using vacuum distillation (2 mbar, 35-
38 °C). 
1
H NMR (300 MHz, CDCl3): δH 1.75 (3H, d, J = 6 Hz, CH3), 3.30 (6H, s, 2x 
OCH3), 4.72 (1H, d, J = 6 Hz), 5.44 (1H, dd, J = 16, 6 Hz), 5.83 (1H, dq, J = 16, 7 Hz). 
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General Procedure for the Formation of Chromenes 
 
The required phenol (2 equiv.) was dissolved in p-xylene (15 mL per gram of phenol), and 
3-picoline (0.25 equiv.) and the corresponding acetal (1 equiv.) were added. The reaction 
mixture was heated under reflux under nitrogen for 24 h. The solvent was removed under 
reduced pressure. The product was purified using column chromatography using a 
petroleum ether:toluene mixture as the eluent, yielding chromenes as pure crystals or oils. 
 
6-Nitro-2-methyl-chromene (47): 
8 
 
The compound was prepared using the general procedure for chromene formation from 4-
nitrophenol (3.19 g, 23.0 mmol) and 1,1-Diethoxybut-2-ene (1.65 g, 11.49 mmol), yielding 
the compound as a yellow crystalline solid (1.01 g, 46%; mp 67-69 °C, lit.
8
 66-66.5 °C) 
after purification using column chromatography (Eluent: 1:1, petroleum ether: toluene). 
νmax (film) / cm
-1
: 1575, 1506, 1480, 1373, 911. 
1
H NMR (300 MHz, CDCl3): δH 1.49 (3H, 
d, J = 7 Hz, CH3), 5.14 – 5.22 (1H, m, C2-H), 5.80 (1H, dd, J = 10, 3 Hz, C3-H), 6.41 (1H, 
dd, J = 10 Hz, 2 Hz, C4-H), 6.81 (1H, d, J = 9 Hz, C8-H), 7.87 (1H, d, J = 3 Hz, C5-H), 
8.02 (1H, dd, J = 9, 3 Hz, C7-H). 
13
C NMR (75 MHz, CDCl3): δC 22.0, 73.2, 116.4, 121.4, 
122.3, 125.5, 128.7, 159.2. HRMS m/z: 191.0578 [M
+
]; C10H9NO3 requires 191.0577. 
HPLC trace (90:10, 30 min, 1 mL/min); 5.7 min (48.76%), 5.97 (51.24%). 
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6-Cyano-2-methyl-chromene (48): 
8
 
 
The compound was prepared using the general procedure for chromene formation from 4-
cyanophenol (1.65 g, 13.9 mmol) and 1,1-Diethoxybut-2-ene (1.0 g, 6.93 mmol), yielding 
the compound as a cream solid (0.90 g, 76%; mp 53-55 °C, lit.
8
 55.5-56 °C) after 
purification using column chromatography (Eluent: 1:1, petroleum ether: toluene). νmax 
(film) / cm
-1
: 2360, 2342, 2225, 1605, 1488, 1373, 1253, 765. 
1
H NMR (400 MHz, 
CDCl3): δH 1.46 (3H, d, J = 7 Hz, CH3), 5.08 – 5.14 (1H, m, C2-H), 5.75 (1H, dd, J = 10, 3 
Hz, C3-H), 6.33 (1H, dd, J = 10, 2 Hz, C4-H), 6.79 (1H, d, J = 8 Hz, C8-H), 7.22 (1H, d, J 
= 2 Hz, C5-H), 7.38 (1H, dd, J = 8, 2 Hz, C7-H). 
13
C NMR (100 MHz, CDCl3): δC 21.9, 
72.7, 104.2, 117.1, 119.4, 122.1, 122.3, 128.6, 130.4, 133.6, 157.3. HRMS m/z: 171.0678 
[M
+
]; C11H9NO requires 171.0679. HPLC trace (90:10, 30 min, 1 mL/min); 5.93 min 
(49.45%), 6.41 (50.55%). 
 
6-Chloro-2-methyl-chromene (49): 
8 
 
The compound  was prepared using the general procedure for chromene formation from 4-
chlorophenol (2.95 g, 23.04 mmol) and 1,1-diethoxybut-2-ene (1.66 g, 11.52 mmol), 
yielding the compound as a yellow oil (0.89 g, 43 %) after purification using column 
chromatography (Eluent: 1:1, petroleum ether: toluene). νmax (film) / cm
-1
: 3050, 2977, 
2932, 1767, 1645, 1481, 1368, 1208. 
1
H NMR (300 MHz, CDCl3): δH 1.44 (3H, d, J = 7 
Hz, CH3), 4.95-5.03 (1H, m, C2-H), 5.70 (1H, dd, J = 10, 3 Hz, C3-H), 6.31 (1H, dd, J = 
10, 2 Hz, C4-H), 6.71 (1H, d, J = 9 Hz, C8-H), 6.94 (1H, d, J = 3 Hz, C5-H), 7.05 (1H, dd, 
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J = 9, 3 Hz, C7-H). 
13
C NMR (75 MHz, CDCl3): δC 21.4, 71.8, 117.5, 123.0, 123.3, 125.8, 
126.2, 128.4, 128.8, 152.2. HRMS m/z: 180.0338 [M
+
]; C10H9ClO requires 180.0342. 
HPLC trace (98:2 hexane:iso-propanol, 0.5 mL/min); inseperable: 10.20 min (100 %). 
 
6-Nitro-2-propyl-chromene (51): 
8 
 
The compound was prepared using the general procedure for chromene formation from 4-
nitrophenol (1.0 g, 7.18 mmol) and 1,1-diethoxyhex-2-ene (0.62 g, 3.59 mmol), yielding 
the compound as a viscous orange oil (0.7 g, 89%) after purification using column 
chromatography (Eluent: 1:1, petroleum ether: toluene). νmax (film) / cm
-1
: 2961, 1614, 
1580, 1515, 1483, 1342, 1242, 1091, 1002, 747. 
1
H NMR (400 MHz, CDCl3): δH 0.96 (3H, 
t, J = 7 Hz, propyl-CH3), 1.40-1.85 (4H, m, propyl-CH2-CH2), 4.99-5.11 (1H, m, C2-H), 
5.79 (1H, dd, J = 10, 3 Hz, C3-H), 6.40 (1H, dd, J = 10, 3 Hz, C4-H), 6.79 (1H, d, J = 9 
Hz, C8-H), 7.84 (1H, d, J = 3 Hz, C5-H), 8.00 (1H, dd, J = 9, 3 Hz, C7-H). 
13
C NMR (100 
MHz, CDCl3): 13.7, 17.7, 37.9, 76.5, 116.1, 121.5, 122.1, 123.3, 125.3, 127.6, 141.6, 
159.3. HRMS m/z: 220.0962 [M + H]+; [C12H13NO3+H]+ requires 220.0968. HPLC trace 
(90:10, 30 min, 1 mL/min); 4.89 min (49.49%), 5.18 min (50.51%). 
 
6-Cyano-2-propyl-chromene (52): 
 
The compound was prepared using the general procedure for chromene formation from 4-
cyanophenol (1.73 g, 14.5 mmol) and 1,1-Diethoxyhex-2-ene (1.25 g, 7.25 mmol), 
yielding the compound as a yellow oil (1.40 g, 97%) after purification using column 
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chromatography (Eluent: 1:1, petroleum ether: toluene). νmax (film) / cm
-1
: 2960, 2874, 
2225, 1605, 1489, 1381, 1253, 1130, 1005. 
1
H NMR (300 MHz, CDCl3): δH 0.94 (3H, t, J 
= 7 Hz, propyl-CH3), 1.40-1.84 (4H, m, propyl-CH2CH2), 4.91-5.04 (1H, m, C2-H), 5.74 
(1H, dd, J = 10, 3 Hz, C3-H), 6.33 (1H, dd, J = 10, 2 Hz, C4-H), 6.77 (1H, d, J = 8 Hz, C8-
H), 7.19 (1H, d, J = 2 Hz, C5-H), 7.35 (1H, dd, J = 8, 2 Hz, C7-H). 
13
C NMR (75 MHz, 
CDCl3): δC 13.7, 17.7, 37.8, 76.0, 103.9, 116.8, 119.2, 122.2, 122.4, 127.5, 130.1, 133.4, 
157.4. HRMS m/z: 200.1065 [M + H]+; [C13H13NO + H]+ requires 200.1070. HPLC trace 
(90:10, 30 min, 1 mL/min); 5.11 min (50.47%), 5.47 min (49.53%). 
 
6-Chloro-2-propyl-chromene (53): 
 
The compound was prepared using the general procedure for chromene formation from 4-
chlorophenol (1.50 g, 11.7 mmol) and 1,1-Diethoxyhex-2-ene (1.0 g, 5.85 mmol), yielding 
the compound as a yellow oil (0.9 g, 74%) after purification using column chromatography 
(Eluent: 1:1, petroleum ether: toluene). νmax (film) / cm
-1
: 2960, 2873, 1481, 1378, 1235, 
1010, 878. 
1
H NMR (300 MHz, CDCl3): δH 0.95 (3H, t, J = 7 Hz, propyl-CH3), 1.42-1.82 
(4H, m, propyl-CH2CH2), 4.80-4.89 (1H, m, C2-H), 5.72 (1H, dd, J = 10, 3 Hz, C3-H), 
6.32 (1H, dd, J = 10, 2 Hz, C4-H), 6.70 (1H, d, J = 9 Hz, C8-H), 6.93 (1H, d, J = 3 Hz, C5-
H), 7.03 (1H, dd, J = 9, 3 Hz, C7-H). 
13
C NMR (75 MHz, CDCl3): δC 13.8, 17.9, 37.3, 
75.1, 117.2, 123.0, 123.3, 125.5, 126.0, 127.3, 128.6, 152.1. HRMS m/z: 209.0722 [M + 
H]+; [C12H13ClO + H]+  requires 209.0728. HPLC trace (99:1 hexane:iso-propanol, 30 
min, 0.5 mL/min); 7.61 min (56.49%), 7.90 min (43.51%). 
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6-Methyl-2-propyl-chromene (54): 
 
The compound was prepared via the general procedure for chromene formation from para-
cresol (4.6 g, 42.6 mmol) and 1,1-Diethoxyhex-2-ene (3.66 g, 21.3 mmol), yielding the 
compound as a yellow viscous oil (0.2 g, 5%) after purification via column 
chromatography (Eluent: 3:2, petroleum ether:toluene). νmax (film) / cm
-1
: 3018, 2959, 
2932, 2872, 1636, 1493, 1225, 1151, 1016, 813. 
1
H NMR (300 MHz, CDCl3): δH 0.86 (3H, 
t, J = 7 Hz, propyl-CH3), 1.34-1.76 (4H, m, propyl-CH2-CH2), 2.15 (3H, s, Ar-CH3), 4.69-
4.75 (1H, m, C2-H), 5.57 (1H, dd, J = 3, 10 Hz, C3-H), 6.26 (1H, dd, J = 1, 10 Hz, C4-H), 
6.59 (1H, d, J = 8 Hz, C8-H), 6.68 (1H, d, J = 2 Hz, C5-H), 6.81 (1H, dd, J = 2, 8 Hz, C7-
H). 
13
C NMR (75 MHz, CDCl3): δC 13.9, 18.1, 20.4, 37.3, 74.8, 115.7, 121.9, 124.0, 126.2, 
127.0, 129.5, 130.1, 151.4. HPLC trace (99.9:0.1, 120 min, 0.25 mL/min); 64.00 min 
(50.43%), 73.47 min (49.57%).  
 
6-Nitro-2-phenyl-chromene (55): 
 
The compound was prepared using the general procedure for chromene formation from 4-
nitrophenol (1.0 g, 7.2 mmol) and (3,3-diethoxyprop-1-enyl)benzene (0.73 g, 3.56 mmol), 
yielding the compound as a cream solid (0.496 g, 55%; mp 104-106 °C) after purification 
using column chromatography (Eluent: 3:2, petroleum ether:toluene). νmax (film) /  cm
-1
: 
3063, 3034, 1647, 1612, 1576, 1480, 1343, 1261, 913. 
1
H NMR (300 MHz, CDCl3): δH 
5.94 (1H, dd, J = 10, 3 Hz, C3-H), 6.07 (1H, dd, J = 3, 2 Hz, C2-H), 6.59 (1H, dd, J = 10, 
2 Hz, C4-H), 6.81 (1H, d, J = 9 Hz, C8-H), 7.35-7.46 (5H, m, Ph-H), 7.93 (1H, d, J = 3 Hz, 
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C5-H), 8.01 (1H, dd, J = 9, 3 Hz, C7-H). 
13
C NMR (75 MHz, CDCl3): δC 78.5, 116.3, 
120.9, 122.3, 122.4, 125.6, 127.2, 129.0, 129.1, 139.5, 141.8, 158.6. HRMS m/z: 254.0799 
[M + H]+; [C15H11NO3 + H]+ requires 254.0812. HPLC trace (95:5, 80 min, 0.5 mL/min); 
23.55 min (49.20%), 24.66 (50.80%). 
 
6-Cyano-2-phenyl-chromene (56): 
9 
 
The compound was prepared using the general procedure for chromene formation from 4-
cyanophenol (1.0 g, 8.4 mmol) and (3,3-diethoxyprop-1-enyl)benzene (0.86 g, 4.16 mmol), 
yielding the compound as a white crystalline powder (0.43 g, 44%, mp 123-125 °C) after 
purification using column chromatography (Eluent: 1:1, petroleum ether:toluene). νmax 
(film) / cm
-1
: 3033, 2222, 1677, 1602, 1570, 1489, 1374, 1251, 1229, 1128, 893, 825. 
1
H 
NMR (300 MHz, CDCl3): δH 5.90 (1H, dd, J = 10, 3 Hz, C3-H), 6.02 (1H, dd, J = 3, 2 Hz, 
C2-H), 6.52 (1H, dd, J = 10, 2 Hz, C4-H), 6.80 (1H, d, J = 8 Hz, C8-H), 7.29 (1H, d, J = 2 
Hz, C5-H), 7.35-7.45 (6H, m, C7-H & Ph-H). 
13
C NMR (75 MHz, CDCl3): δC 78.0, 104.4, 
117.0, 119.1, 121.7, 122.2, 126.3, 127.1, 128.9, 129.0, 130.4, 133.8, 139.7, 156.8. HRMS 
m/z: 251.1180 [M + NH4]+; C16H11NO + NH4]+  requires 251.1179. HPLC trace (99.5:0.5, 
180 min, 0.5 mL/min, 230 nm); 41.34 min (47.94%), 43.47 (52.06%). 
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6-Chloro-2-phenyl-chromene (57): 
8 
 
The compound was prepared using the general procedure for chromene formation from 4-
chlorophenol (1.0 g, 7.62 mmol) and (3,3-diethoxyprop-1-enyl)benzene (0.78 g, 3.81 
mmol) yielding the compound as a viscous colourless oil (0.12 g, 13%) after purification 
using column chromatography (Eluent: 1:1, petroleum ether: toluene). νmax (film) / cm
-1
: 
3032, 1639, 1477, 1424, 1368, 1261, 1231, 1200, 1121, 1034, 814, 755, 697. 
1
H NMR 
(300 MHz, CDCl3): δH 5.88 (1H, dd, J = 10, 3 Hz, C3-H), 5.94 (1H, dd, J = 3, 2 Hz, C2-H), 
6.47 (1H, dd, J = 10, 2 Hz, C4-H), 6.72 (1H, d, J = 9 Hz, C8-H), 7.02 (1H, d, J = 3 Hz, C5-
H), 7.08 (1H, dd, J = 9, 3 Hz, C7-H), 7.37-7.49 (5H, m, Ph-H). 
13
C NMR (75 MHz, 
CDCl3): δC 77.4, 117.5, 122.8, 123.3, 126.0, 126.2, 126.3, 127.2, 128.8, 128.9, 129.2, 
140.4, 151.8. HRMS m/z: 243.0561 [M + H]+; [C15H11ClO + H]+ requires 243.0571. 
HPLC trace (99.9:0.1 hexane:iso-propanol, 0.25 mL/min); inseparable: 104.77 min (100 
%).  
 
6-Methyl-2-phenyl-chromene (58): 
 
The compound was prepared via the general procedure for chromene formation from para-
cresol (3 g, 27.8 mmol) and (3,3-diethoxyprop-1-enyl)benzene (2.87 g, 13.9 mmol), 
yielding the compound as a colourless oil (0.34 g, 11%) after purification via column 
chromatography (Eluent: 3:2, petroleum ether:toluene). νmax (film) / cm
-1
: 3086, 3062, 
3030, 2920, 2864, 1639, 1489, 1456, 1253, 1219, 1126, 1036, 875, 815, 702. 
1
H NMR 
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(300 MHz, CDCl3): δH 2.40 (3H, s, Ar-CH3), 5.91 (1H, dd, J = 10, 3 Hz, C3-H), 6.00-6.02 
(1H, m, C2-H), 6.62 (1H, dd, J = 10, 2 Hz, C4-H), 6.88 (1H, d, J = 8 Hz, C8-H), 6.96 (1H, 
d, J = 2 Hz, C5-H), 7.06 (1H, dd, J = 8, 2 Hz, C7-H), 7.45-7.62 (5H, m, Ph-H). 
13
C NMR 
(75 MHz, CDCl3): δC 20.6, 77.2, 115.9, 121.4, 124.3, 125.2, 127.2, 127.3, 128.5, 128.9, 
130.1, 130.5, 141.2, 151.3. HRMS m/z: 223.1116 [M + H]+; [C16H14O + H]+ requires 
223.1117. HPLC trace (90:10, 30 min, 1 mL/min); 4.77 min (48.10%), 4.99 min (51.90%). 
 
6-Nitro-2-isopropyl-chromene (59): 
 
 The compound was prepared using the general procedure for chromene formation from 4-
nitrophenol (0.80 g, 5.54 mmol) and 1,1-diethoxy-4-methylpent-2-ene   (0.475 g, 2.77 
mmol), yielding the compound as pale yellow viscous oil (0.2 g, 33%) after purification 
using column chromatography (Eluent: 3:2, petroleum ether:toluene). νmax (film) / cm
-1
: 
3073, 2965, 2874, 1613, 1579, 1335, 1241, 1089. 
1
H NMR (400 MHz, CDCl3): δH 1.00 
(6H, dd, J = 8, 7 Hz, (2x) 
i
Pr-CH3), 1.95-2.03 (1H, m, 
i
Pr-CH(CH3)2), 4.82-4.84 (1H, m, 
C2-H), 5.77 (1H, dd, J = 10, 3 Hz, C3-H), 6.43 (1H, dd, J = 10, 2 Hz, C4-H), 6.77 (1H, d, 
J = 9 Hz, C8-H), 7.81 (1H, d, J = 3 Hz, C5-H), 7.97 (1H, dd, J = 9, 3 Hz, C7-H). 
13
C NMR 
(75 MHz, CDCl3): δC 17.1, 17.6, 34.2, 81.6, 115.9, 121.5, 122.2, 123.1, 125.5, 126.1, 
141.5, 160.0. HRMS m/z: 237.1229 [M + NH4]+; [C12H13NO3 + NH4]+ requires 237.1234. 
HPLC trace (90:10, 30 min, 1 mL/min); 4.843 min (48.91%), 5.117 min (51.09%). 
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6-Cyano-2-isopropyl-chromene (60): 
 
The compound was prepared using the general procedure for chromene formation from 4-
cyanophenol (0.97 g, 8.1 mmol) and 1,1-diethoxy-4-methylpent-2-ene (0.7 g, 4.05 mmol), 
yielding the compound  as a colourless viscous oil (0.25 g, 31%) after purification using 
column chromatography (Eluent: 3:2, petroleum ether:toluene). νmax (film) /  cm
-1
: 3053, 
2965, 2931, 2874, 2225, 1603, 1489, 1379, 1252, 1130. 
1
H NMR (300 MHz, CDCl3): δH 
0.97 (6H, dd, J = 7, 5 Hz, (2x) 
i
Pr-CH3), 1.90-2.01 (1H, m, 
i
Pr-CH(CH3)2), 4.74-4.77 (1H, 
m, C2-H), 5.72 (1H, dd, J = 10, 3 Hz, C3-H), 6.35 (1H, dd, J = 10, 2 Hz, C4-H), 6.75 (1H, 
d, J = 8 Hz, C8-H), 7.16 (1H, d, J = 2 Hz, C5-H), 7.32 (1H, dd, J = 8, 2 Hz, C7-H). 
13
C 
NMR (75 MHz, CDCl3): δC 17.1, 17.5, 33.9, 81.0, 103.7, 116.5, 119.3, 122.3, 122.9, 125.9, 
130.2, 133.5, 158.0. HRMS m/z: 200.1062 [M + H]+; [C13H13NO + H]+ requires 200.1070. 
HPLC trace (90:10, 30 min, 1 mL/min); 5.023 min (49.90%), 5.417 min (50.10%). 
 
6-Chloro-2-isopropyl-chromene (61): 
 
The compound was prepared using the general procedure for chromene formation from 4-
chlorophenol (1.59 g, 12.4 mmol) and 1,1-Diethoxy-4-methylpent-2-ene (1.06 g, 6.2 
mmol), yielding the compound as a colourless oil (0.206 g, 16%) after purification using 
column chromatography (Eluent: 3:2, petroleum ether:toluene). νmax (film) / cm
-1
: 3050, 
2963, 2931, 2873, 1637, 1481, 1234, 1203, 1123, 1019, 997, 878, 814, 698. 
1
H NMR (300 
MHz, CDCl3): δH 1.00 (6H, dd, J = 7, 1 Hz, 2x 
i
Pr-CH3), 1.93-2.04 (1H, m, 
i
Pr-CH(CH3)2), 
4.61-4.65 (1H, m, C2-H), 5.73 (1H, dd, J = 10, 3 Hz, C3-H), 6.36 (1H, dd, J = 10, 2 Hz, 
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C4-H), 6.70 (1H, d, J = 9 Hz, C8-H), 6.92 (1H, d, J = 3 Hz, C5-H), 7.03 (1H, dd, J = 9, 3 
Hz, C7-H). 
13
C NMR (75 MHz, CDCl3): δC 17.5, 17.6, 33.4, 80.2, 116.9, 123.3, 123.6, 
125.3, 125.6, 126.0, 128.7, 152.7. HPLC trace (99.9:0.1, 120 min, 0.25 mL/min); 14.80 
min (49.74%), 15.87 min (50.26%). 
 
6-Methyl--2-isopropyl-chromene (62): 
 
The compound was prepared via the general procedure for chromene formation from para-
cresol (1.0 g, 9.2 mmol) and 1,1-diethoxy-4-methylpent-2-ene (0.79 g, 4.6 mmol), yielding 
the compound as a yellow oil (0.37 g, 43%) after purification via column chromatography 
(Eluent: 3:2, petroleum ether:toluene). νmax (film) / cm
-1
: 3018, 2961, 2929, 2872, 1636, 
1492, 1226, 1152, 999, 814. 
1
H NMR (400 MHz, CDCl3): δH 0.92 (6H, dd, J = 7, 6 Hz, 2x 
i
Pr-CH3), 1.87-1.95 (1H, m, 
i
Pr-CH(CH3)2), 2.16 (3H, s, Ar-CH3), 4.48-4.51 (1H, m, C2-
H), 5.61 (1H, dd, J = 10, 3 Hz, C3-H), 6.31 (1H, dd, J = 10, 2 Hz, C4-H), 6.60 (1H, d, J = 
8 Hz, C8-H), 6.68 (1H, d, J = 2 Hz, C5-H), 6.81 (1H, dd, J = 8, 2 Hz, C7-H). 
13
C NMR (75 
MHz, CDCl3): δC 17.6, 17.7, 20.4, 33.2, 79.9, 115.4, 121.8, 124.4, 124.6, 126.9, 129.5, 
129.9, 151.9. HPLC trace (99.9:0.1, 120 min, 0.25 mL/min); 33.46 min (50.27%), 35.47 
min (49.73%). 
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General Procedure for the Formation of Racemic Epoxides (A) 
 
 
The required chromene (1 equiv.) and meta-chloroperbenzoic acid (1 equiv.) were 
dissolved in dichloromethane (20 mL per 100 mg of chromene) at 0 °C, and allowed to stir 
until reaction completion. Saturated aqueous sodium hydrogen carbonate solution (5 mL 
per 100 mg of chromene) was added to quench the reaction. The organic layer was 
extracted against water and brine washes (10 mL per 100 mg of chromene), and combined 
with further dichloromethane extracts of the aqueous layer. The combined organic extracts 
were dried over magnesium sulfate, and excess solvent was removed under reduced 
pressure. The crude product was purified using column chromatography (ethyl acetate: 
petroleum ether: triethylamine).  
 
General Procedure for the Formation of Chiral Epoxides (B) 
 
 
Tetraphenylphosphonium monoperoxysulfate (4 equiv.) and iminium salt 41 (10 mol%) 
were dissolved in chloroform (20 mL per 100 mg of chromene) and cooled to −30 °C. The 
required chromene (1 equiv.) dissolved in chloroform (2 mL per 100 mg of chromene) was 
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then added slowly over 10 minutes to the reaction mixture. The reaction progress was 
monitored by 
1
H NMR spectroscopy of the crude reaction mixture. At 50% conversion, the 
reactions were quenched by the addition of diethyl ether (20 mL per 100 mg of chromene). 
The catalyst was removed by filtration through celite, washed with diethyl ether (10 mL 
per 100 mg of chromene), and solvents removed under reduced pressure. The crude 
product was purified using column chromatography (ethyl acetate: petroleum ether: 
triethylamine) to yield the chiral epoxide as a colourless solid or oil. 
 
6-Nitro-2-methyl-chromene epoxide (63): 
 
General procedure A: 6-Nitro-2-methyl-chromene 47 (0.205 g, 1.07 mmol) and meta-
chloroperbenzoic acid (0.184 g, 1.07 mmol) were dissolved in dichloromethane (40 mL) at 
0 °C, and left to react for 8 h. The racemic epoxide was isolated as a cream solid (0.20 g, 
90%; mp 86-88 °C) after purification using column chromatography (Eluent: 3:1:0.1, 
petroleum ether:ethyl acetate:triethylamine). νmax (film) / cm
-1
: 3075, 2984, 2935, 1620, 
1591, 1521, 1487, 1341, 1257, 1094, 878, 746. 
1
H NMR (300 MHz, CDCl3): δH (ratio of 
trans:cis, 1.8:1) 1.36 (3H, d, J = 7 Hz, CH3, trans), 1.61 (3H, d, J = 7 Hz, CH3, cis), 3.66 
(1H, dd, J = 4, 1 Hz, C3-H, trans), 3.73 (1H, d, J = 4 Hz, C3-H, cis), 3.95 (1H, d, J = 4 Hz, 
C4-H, trans), 4.00 (1H, d, J = 4 Hz, C4-H, cis), 4.43 (1H, q, J = 7 Hz, C2-H, cis), 4.87 
(1H, q, J = 7 Hz, C2-H, trans), 6.90 (2H, d, J = 9 Hz, C8-H, cis & trans), 8.14 (2H, dd, J = 
9, 3 Hz, C7-H, cis & trans), 8.28 (1H, d, J = 3 Hz, C5-H, trans), 8.31 (1H, d, J = 3 Hz, C5-
H, cis). 
13
C NMR (75 MHz, CDCl3): δC 16.6, 18.3, 48.1, 49.5, 58.6, 58.8, 69.7, 69.9, 117.9, 
118.6, 120.3, 120.6, 125.9, 126.0, 126.2, 126.4, 141.5, 141.6, 157.6, 159.4. HRMS m/z: 
206.0461 [M – H]-; [C10H9NO4 – H]
-
 requires 206.0459. HPLC trace (99.5:0.5 hexane:iso-
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propanol, 180 min, 0.5 mL/min); 60.31 min (21.22%), 74.09 min (21.79%), 95.06 min 
(28.69%), 100.87 min (28.29%). 
 
General procedure B: Tetraphenylphosphonium monoperoxysulfate (1.71 g, 3.8 mmol) 
and iminium salt 41 (0.068 g, 0.095 mmol) were dissolved in chloroform (40 mL) and 
cooled to −30 °C. 6-nitro-2-methyl-chromene 47 (0.182 g, 0.95 mmol) dissolved in 
chloroform (4 mL) was then added slowly over 10 minutes to the reaction mixture. The 
reaction was quenched at 48% conversion, and enantioenriched 6-nitro-2-methyl-chromene 
epoxide was isolated as a cream solid (0.065 g, 33%) after purification using column 
chromatography (Eluent: 3:1:0.1, petroleum ether: ethyl acetate: triethylamine). [α]D = 
−58.4, (c 0.005 g/mL CH2Cl2). HPLC trace (99.5:0.5, 180 min, 0.5 mL/min); 58.29 min 
(0.40%) cis, 70.71 min (26.78%) cis, 91.36 min (68.02%) trans, 97.75 min (4.79%) trans. 
 
6-Cyano-2-methyl-chromene epoxide (64): 
10 
 
General procedure A: 6-Cyano-2-methyl-chromene 48 (1.10 g, 6.42 mmol) and meta-
chloroperbenzoic acid (1.10 g, 6.42 mmol) were dissolved in dichloromethane (100 mL) at 
0 °C, and left to react for 6 h. The racemic epoxide was isolated as a cream solid (1.02 g, 
85%) after purification using column chromatography (Eluent: 3:1:0.1, petroleum 
ether:ethyl acetate:triethylamine). νmax (film) / cm
-1
: 2917, 2849, 2227, 1615, 1581, 1495, 
1253, 1229, 1159, 873. 
1
H NMR (300 MHz, CDCl3): δH (ratio of trans:cis = 1:1) 1.33 (3H, 
d, J = 7 Hz, CH3, trans), 1.58 (3H, d, J = 7 Hz, CH3, cis), 3.63 (1H, dd, J = 4, 1 Hz, C3-H, 
trans), 3.69 (1H, dd, J = 4, 1 Hz, C3-H, cis), 3.87 (1H, d, J = 4 Hz, C4-H, trans), 3.92 (1H, 
d, J = 4 Hz, C4-H, cis), 4.37 (1H, q, J = 6 Hz, C2-H, cis), 4.82 (1H, q, J = 6 Hz, C2-H, 
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trans), 6.88 (2H, d, J = 9 Hz, C8-H, cis & trans), 7.52 (2H, dd, J = 9, 2 Hz, C7-H, cis & 
trans), 7.64 (1H, d, J = 2 Hz, C5-H, trans), 7.66 (1H, d, J = 2 Hz, C5-H, cis). 
13
C NMR (75 
MHz, CDCl3): δC 16.5, 18.4, 48.0, 49.4, 58.8, 59.1, 69.3, 69.5, 104.4, 104.5, 118.4, 118.7, 
119.2, 121.1, 121.4, 133.9, 134.1, 134.3, 134.5, 155.7, 157.7. HRMS m/z: 187.0628 [M
+
]; 
C11H9NO2 requires 187.0633. HPLC trace (99.5:0.5, 180 min, 0.5 mL/min); 76.82 min 
(22.87%), 119.490 min (27.75%), 127.70 min (23.05%), 137.62 min (26.33%). 
 
General procedure B: Tetraphenylphosphonium monoperoxysulfate (0.9 g, 2 mmol) and 
iminium salt 41 (0.036 g, 0.05 mmol) were dissolved in chloroform (20 mL) and cooled to 
−30 °C. 6-cyano-2-methyl-chromene 48 (0.085 g, 0.50 mmol) dissolved in chloroform (2 
mL) was then added slowly over 10 minutes to the reaction mixture. The reaction was 
quenched at 52% conversion, and enantioenriched 6-cyano-2-methyl-chromene epoxide 
was isolated as a cream solid (0.031 g, 33 %, mp = 77-79 °C) after column 
chromatography (Eluent: 3:1:0.1, petroleum ether: ethyl acetate: triethylamine). [α]D = -74, 
(c 0.01 g/mL CHCl3). HPLC trace (99.5:0.5, 180 min, 0.5 mL/min); 74.88 min (0.50%) cis, 
116.04 min (5.14%) trans, 125.01 min (28.11%) cis, 132.81 min (66.26%) trans. 
 
6-Nitro-2-propyl-chromene epoxide (65): 
 
General procedure A: 6-Nitro-2-propyl-chromene 51 (0.310 g, 1.43 mmol) and meta-
chloroperbenzoic acid (0.245 g, 1.43 mmol) were dissolved in dichloromethane (50 mL) at 
0 °C, and left to react for 5 h. The racemic epoxide was isolated as a yellow oil (0.265 g, 
79%) after purification using column chromatography (Eluent; 10:1:0.1, petroleum ether: 
ethyl acetate: triethylamine). νmax (film) / cm
-1
: 2961, 2874, 1619, 1591, 1516, 1486, 1340, 
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1244, 1088. 
1
H NMR (400 MHz, CDCl3): δH (ratio of trans:cis = 2:1) 0.96 (3H, t, J = 7 Hz, 
propyl-CH3, trans), 1.04 (3H, t, J = 7 Hz, propyl-CH3, cis), 1.45-2.02 (8H, m, propyl-CH2-
CH2, cis & trans), 3.67 (1H, dd, J = 4, 1 Hz, C3-H, trans), 3.76 (1H, dd, J = 4, 1 Hz, C3-H, 
cis), 3.94 (1H, d, J = 4 Hz, C4-H, trans), 3.99 (1H, d, J = 4 Hz, C4-H, cis), 4.26-4.30 (1H, 
m, C2-H, cis), 4.70-4.73 (1H, m, C2-H, trans), 6.91 (1H, d, J = 9 Hz, C8-H, trans), 6.92 
(1H, d, J = 9 Hz, C8-H, cis), 8.14 (1H, dd, J = 9, 3 Hz, C7-H, cis), 8.15 (1H, dd, J = 9, 3 
Hz, C7-H, trans), 8.28 (1H, d, J = 3 Hz, C5-H, trans), 8.31 (1H, d, J = 3 Hz, C5-H, cis). 
13
C NMR (100 MHz, CDCl3): δC 14.0, 14.1, 18.4, 19.0, 33.3, 35.1, 48.6, 49.4, 58.4, 73.3, 
73.6, 118.1, 118.7, 120.7, 121.1, 126.1, 126.2, 126.3, 126.6, 141.6, 141.7, 157.9, 159.6. 
HRMS m/z: 236.0911 [M + H]+; [C12H13NO4 + H]+ requires 236.0918. HPLC trace 
(99.5:0.5, 180 min, 0.5 mL/min); 41.77 min (13.78%), 51.76 min (13.55%), 59.50 min 
(39.42%), 65.630 min (33.25%). 
 
General procedure B: Tetraphenylphosphonium monoperoxysulfate (2.31 g, 5.12 mmol) 
and iminium salt 41 (0.092 g, 0.128 mmol) were dissolved in chloroform (60 mL) and 
cooled to −30 °C. 6-nitro-2-propyl-chromene 51 (0.28 g, 1.28 mmol) dissolved in 
chloroform (6 mL) was then added slowly over 10 minutes to the reaction mixture. The 
reaction was quenched at 50% conversion, and enantioenriched 6-nitro-2-propyl-chromene 
epoxide was isolated as a yellow oil (0.12 g, 40%) after purification using column 
chromatography (Eluent: 10:1:0.1, petroleum ether: ethyl acetate: triethylamine). [α]D = 
−35, (c 0.01 g/mL CHCl3). HPLC trace (99.5:0.5, 180 min, 0.5 mL/min); 40.45 min 
(0.37%), 49.52 min (17.40%), 57.23 min (72.28%), 61.39 min (9.96%). 
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6-Cyano-2-propyl-chromene epoxide (66): 
 
General procedure A: 6-Cyano-2-propyl-chromene 52 (0.150 g, 0.75 mmol) and meta-
chloroperbenzoic acid (0.130 g, 0.75 mmol) were dissolved in dichloromethane (25 mL) at 
0 °C, and left to react for 5 h. The racemic epoxide was isolated as a colourless oil (0.13 g, 
81%) after purification using column chromatography (Eluent: 5:1:0.1, petroleum ether: 
ethyl acetate: triethylamine). νmax (film) / cm
-1
: 2963, 2925, 2224, 1745, 1610, 1579, 1494, 
1247, 1170. 
1
H NMR (400 MHz, CDCl3): δH (ratio of trans:cis = 3.5:1) 0.96 (3H, t, J = 7 
Hz, Propyl-CH3, trans), 1.03 (3H, t, J = 7 Hz, Propyl-CH3, cis), 1.45-1.85 (8H, m, Propyl-
CH2CH2, cis & trans), 3.65 (1H, dd, J = 4, 1 Hz, C3-H, trans), 3.74 (1H, d, J = 4 Hz, C3-
H, cis), 3.87 (1H, d, J = 4 Hz, C4-H, trans), 3.91 (1H, d, J = 4 Hz, C4-H, cis), 4.20-4.23 
(1H, m, C2-H, cis), 4.66-4.69 (1H, m, C2-H, trans), 6.89 (1H, d, J = 9 Hz, C8-H, trans), 
6.90 (1H, d, J = 9 Hz, C8-H, cis), 7.52-7.55 (2H, m, C7-H, cis & trans), 7.64 (1H, d, J = 2 
Hz, C5-H, trans), 7.67 (1H, d, J = 2 Hz, C5-H, cis). 
13
C NMR (75 MHz, CDCl3) δC: 13.6, 
13.8, 18.1, 18.6, 32.9, 34.9, 48.1, 49.0, 58.3, 72.7, 73.0, 104.5, 118.4, 118.7, 119.1, 121.7, 
133.9, 134.0, 134.3, 134.6, 156.0. HRMS m/z: 238.0840 [M+Na]
+
; [C13H13NO2+Na]
+
 
requires 238.0838. HPLC trace (99.5:0.5, 180 min, 0.5 mL/min); 27.14 min (10.86%), 
36.32 min (38.48%), 38.24 min (10.67%), 39.82 min (39.99%).  
 
General procedure B: Tetraphenylphosphonium monoperoxysulfate (2.15 g, 4.76 mmol) 
and iminium salt 41 (0.086 g, 0.12 mmol) were dissolved in chloroform (50 mL) and 
cooled to −30 °C. 6-cyano-2-propyl-chromene 52 (0.24 g, 1.19 mmol) dissolved in 
chloroform (5 mL) was then added slowly over 10 minutes to the reaction mixture. The 
reaction was quenched at 56% conversion, and enantioenriched 6-cyano-2-propyl-
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chromene epoxide was isolated as a colourless oil (0.100 g, 39%) after purification using 
flash column chromatography (Eluent: 5:1:0.1, petroleum ether: ethyl acetate: 
triethylamine), []D = −22, (0.004 g/mL, CH2Cl2). HPLC trace (99.5:0.5, 180 min, 0.5 
mL/min); 27.10 min (0.93%), 36.17 min (10.56%), 37.63 min (21.42%), 39.38 min 
(67.09%). 
 
6-Nitro-2-phenyl chromene epoxide (67): 
 
General procedure A: 6-Nitro-2-phenyl-chromene 55 (0.22 g, 0.87 mmol) and meta-
chloroperbenzoic acid (0.15 g, 0.87 mmol) were dissolved in dichloromethane (40 mL) at 0 
°C, and left to react for 8 h. The racemic epoxide was isolated as a colourless solid (0.22 g, 
94%; mp = 120-122 °C) after purification using column chromatography (Eluent: 4:1:0.1, 
petroleum ether: ethyl acetate: triethylamine). νmax (film) / cm
-1
: 3071, 2928, 1620, 1591, 
1515, 1485, 1339, 1236, 1041. 
1
H NMR (300 MHz, CDCl3): (only trans observed) δH 3.94 
(1H, dd, J = 4, 1 Hz, C3-H, trans), 4.13 (1H, d, J = 4 Hz, C4-H, trans), 5.73 (1H, s, C2-H, 
trans), 6.92 (1H, d, J = 9 Hz, C8-H, trans), 7.27-7.38 (5H, m, Ar-H), 8.17 (1H, dd, J = 9, 3 
Hz, C7-H, trans), 8.36 (1H, d, J = 3 Hz, C5-H, trans). 
13
C NMR (75 MHz, CDCl3) δC: 
48.8, 58.1, 75.7, 100.4, 118.6, 120.7, 126.2, 126.9, 127.2, 129.4, 129.6, 136.3, 158.1. 
HRMS m/z: 287.1025 [M + NH4]+; [C15H11NO4 + NH4]+ requires 287.1026. HPLC trace 
(90:10, 60 min, 1 mL/min); 26.63 min (48.44%), 43.18 min (51.56%). 
 
 
 
 
General procedure B: Tetraphenylphosphonium monoperoxysulfate (3.36 g, 7.44 mmol) 
and iminium salt 41 (0.132 g, 0.186 mmol) were dissolved in chloroform (100 mL) and 
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cooled to −30 °C. 6-nitro-2-phenyl-chromene 55 (0.47 g, 1.86 mmol) dissolved in 
chloroform (10 mL) was then added slowly over 10 minutes to the reaction mixture. The 
reaction was quenched at 26% conversion, and enantioenriched 6-nitro-2-phenyl-chromene 
epoxide was isolated as a colourless solid  (0.075 g, 15%) after purification using column 
chromatography (Eluent: 4:1:0.1, petroleum ether: ethyl acetate: triethylamine), []D = 
+51, (c 0.01 g/mL, CH2Cl2);  HPLC trace (90:10, 60 min, 1 mL/min); 23.97 min (88.13%), 
37.01 min (11.87%). 
 
6-Cyano-2-phenyl-chromene Epoxide (68): 
 
General procedure A: 6-Cyano-2-phenyl-chromene 56 (0.165 g, 0.71 mmol) and meta-
chloroperbenzoic acid (0.12 g, 0.71 mmol) were dissolved in dichloromethane (30 mL) at 0 
°C, and left to react for 8 h. The racemic epoxide was isolated as a cream solid (0.160 g, 
90%) after purification using column chromatography, (4:1:0.1, petroleum ether: ethyl 
acetate: triethylamine). νmax (film) / cm
-1
: 3057, 2903, 2223, 1610, 1577, 1491, 1242, 997. 
1
H NMR (500 MHz, CDCl3) δH (only trans observed) 3.94 (1H, dd, J = 4, 1 Hz, C3-H, 
trans), 4.08 (1H, d, J = 4 Hz, C4-H, trans), 5.73 (1H, s, C2-H, trans), 6.93 (1H, d, J = 9 
Hz, C8-H, trans), 7.28-7.39 (5H, m, Ar-H), 7.58 (1H, dd, J = 9, 2 Hz, C7-H, trans), 7.74 
(1H, d, J = 2 Hz, C5-H, trans). 
13
C NMR (125 MHz, CDCl3) δC: 48.5, 58.2, 75.2, 104.7, 
118.6, 118.9, 121.3, 127.0, 129.1, 129.3, 134.0, 134.8, 136.3, 156.1. HRMS m/z: 250.0859 
[M + H]
+
; [C16H11NO2+H]
+
 requires 250.0863. HPLC trace (90:10, 60 min, 1 mL/min); 
29.21 min (48.01%), 38.23 min (51.99%).  
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General procedure B: Tetraphenylphosphonium monoperoxysulfate (3.61 g, 8.0 mmol) 
and iminium salt 41 (0.144 g, 0.2 mmol) were dissolved in chloroform (100 mL) and 
cooled to −30 °C. 6-cyano-2-phenyl-chromene 56 (0.47 g, 2.0 mmol) dissolved in 
chloroform (10 mL) was then added slowly over 10 minutes to the reaction mixture. The 
reaction was quenched at 37% conversion, and enantioenriched 6-cyano-2-phenyl-
chromene epoxide was isolated as a cream solid (0.12 g, 24%; mp 136-138 °C) after 
purification using column chromatography (Eluent: 4:1:0.1, petroleum ether: ethyl acetate: 
triethylamine), []D = +72, (c 0.01 g/mL, CH2Cl2); HPLC trace (90:10, 60 min, 1 
mL/min); 26.23 min (88.99%), 34.17 min (11.01%). 
 
6-Nitro-2-isopropyl-chromene Epoxide (69): 
 
General procedure A: 6-Nitro-2-isopropyl-chromene 59 (0.26 g, 1.2 mmol) and meta-
chloroperbenzoic acid (0.2 g, 1.2 mmol) were dissolved in dichloromethane (50 mL) at 0 
°C, and left to react for 8 h. The racemic epoxide was isolated as a yellow oil (0.14 g, 50%) 
after purification using column chromatography (Eluent: 5:1:0.1, petroleum ether: ethyl 
acetate: triethylamine). νmax (film) / cm
-1
: 2965, 2923, 1620, 1591, 1520, 1486, 1341, 1256, 
1089. 
1
H NMR (400 MHz, CDCl3): δH (ratio of trans:cis, 4:1) 0.97 (6H, d, J = 9 Hz, 
i
Pr-
CH3, cis or trans), 1.09 (6H, d, J = 9 Hz, 
i
Pr-CH3, cis or trans), 1.99-2.09 (1H, m, 
CH(CH3)2, trans), 2.20-2.28 (1H, m, CH(CH3)2, cis), 3.73 (1H, dd, J = 6, 1 Hz, C3-H, 
trans), 3.85 (1H, d, J = 6 Hz, C3-H, cis), 3.94 (1H, d, J = 6 Hz, C4-H, cis), 3.96 (1H, d, J = 
6 Hz, C4-H, trans), 4.00 (1H, d, J = 8 Hz, C2-H, cis), 4.47 (1H, d, J = 8 Hz, C2-H, trans), 
6.91 (1H, d, J = 12 Hz, C8-H, trans), 6.94 (1H, d, J = 12 Hz, C8-H, cis), 8.15 (2H, dd, J = 
12, 4 Hz, C7-H, cis & trans), 8.28 (1H, d, J = 4 Hz, C5-H, trans), 8.31 (1H, d, J = 4 Hz, 
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C5-H, cis). 
13
C NMR (75 MHz, CDCl3): δC 18.2, 18.3, 18.4, 19.1, 31.5, 31.8, 48.5, 48.7, 
56.2, 56.9, 78.1, 78.8, 117.9, 118.2, 120.6, 121.0, 126.1, 126.2, 126.3, 126.7, 141.4, 159.0, 
160.2, 169.5. HRMS m/z: 236.0915 [M + H]+; [C12H13NO4 + H]+  requires 236.0918. 
HPLC trace (99.5:0.5, 180 min, 0.5 mL/min); 35.78 min (8.19% cis), 52.39 min (9.52% 
cis), 60.19 min (41.27% trans), 65.78 min (41.02% trans)  
 
General procedure B: Tetraphenylphosphonium monoperoxysulfate (1.17 g, 2.6 mmol) 
and iminium salt 41 (0.046 g, 0.065 mmol) were dissolved in chloroform (30 mL) and 
cooled to −30 °C. 6-nitro-2-isopropyl-chromene 59 (0.14 g, 0.65 mmol) dissolved in 
chloroform (3 mL) was then added slowly over 10 minutes to the reaction mixture. The 
reaction was quenched at 38% conversion, and enantioenriched 6-nitro-2-isopropyl-
chromene epoxide was isolated as a yellow oil (0.035 g, 25%) after purification using 
column chromatography (Eluent: 5:1:0.1, petroleum ether: ethyl acetate: triethylamine). 
[]D = −63, (c 0.004 g/mL CH2Cl2).  HPLC trace (99.5:0.5, 180 min, 0.5 mL/min); 35.74 
min (0.73% cis), 56.13 min (7.46% cis), 63.05 min (11.07% trans), 68.42 min (80.73% 
trans). 
 
6-Cyano-2-isopropyl-chromene epoxide (70): 
 
General procedure A: 6-Cyano-2-isopropyl-chromene 60 (0.29 g, 1.44 mmol) and meta-
chloroperbenzoic acid (0.25 g, 1.44 mmol) were dissolved in dichloromethane (60 mL) at 0 
°C, and left to react for 5 h. The racemic epoxide was isolated as a colourless oil (0.17 g, 
55%) after purification using column chromatography (Eluent: 5:1:0.1, petroleum ether: 
ethyl acetate: triethylamine). νmax (film) / cm
-1
: 2967, 2932, 2877, 2226, 1616, 1582, 1495, 
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1251, 1134, 1008, 876. 
1
H NMR (400 MHz, CDCl3): δH (ratio of trans:cis = 4:1) 0.97 (6H, 
d, J = 7 Hz, (2x)
i
Pr-CH3, cis or trans), 1.08 (6H, d, J = 7 Hz, (2x)
i
Pr-CH3, cis or trans), 
1.97-2.06 (1H, m, 
i
Pr-CH(CH3)2, trans), 2.20-2.27 (1H, m, 
i
Pr-CH(CH3)2, cis), 3.72 (1H, 
dd, J = 4, 1 Hz, C3-H, trans), 3.83 (1H, d, J = 4 Hz, C3-H, cis), 3.87 (1H, d, J = 4 Hz, C4-
H, cis), 3.89 (1H, d, J = 4 Hz, C4-H, trans), 3.95 (1H, d, J = 6 Hz, C2-H, cis), 4.42 (1H, d, 
J = 6 Hz, C2-H, trans), 6.89 (2H, d, J = 9 Hz, C8-H, cis & trans), 7.53 (2H, dd, J = 9, 2 
Hz, C7-H, cis & trans), 7.63 (1H, d, J = 2 Hz, trans), 7.67 (1H, d, J = 2 Hz, cis). 
13
C NMR 
(100 MHz, CDCl3): δC 18.7, 19.3, 31.5, 48.6, 56.6, 77.8, 78.5, 118.5, 118.9, 134.2, 134.8. 
HRMS m/z: 216.1021 [M + H]+; [C13H13NO2 + H]+ requires 216.1022. HPLC trace 
(99.5:0.5, 180 min, 0.5 mL/min); 42.44 min (10.10%), 64.01 min (39.00%), 80.14 min 
(9.96%), 84.10 min (40.94%). 
 
General procedure B: Tetraphenylphosphonium monoperoxysulfate (27.4 g, 60.8 mmol) 
and iminium salt 41 (1.09 g, 1.52 mmol) were dissolved in chloroform (300 mL) and 
cooled to −30 °C. 6-cyano-2-isopropyl-chromene 60 (3.0 g, 15.2 mmol) dissolved in 
chloroform (30 mL) was then added slowly over 10 minutes to the reaction mixture. The 
reaction was quenched at 36% conversion, and enantioenriched 6-cyano-2-isopropyl-
chromene epoxide was isolated as a colourless oil (0.75 g, 23%) after purification using 
column chromatography (Eluent: 5:1:0.1, petroleum ether: ethyl acetate: triethylamine). 
[]D = −52, (c 0.01 g/mL CH2Cl2); HPLC trace (99.5:0.5, 180 min, 0.5 mL/min); 43.17 
min (0.12%), 71.15 min (17.11%), 81.47 min (5.04%), 89.15 min (77.73%). 
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Formation of Alcohol (+)-80:
 11 
 
6-Cyano-2-phenyl-chromene epoxide 68 (1 g, 4.02 mmol) was dissolved in anhydrous 
methanol (50 mL) in a flame-dried round-bottomed flask. The solution was then purged 
with nitrogen, and a catalytic amount of palladium/carbon was added to the stirring 
solution, followed by the addition of hydrogen gas (1 atm). The reaction was allowed to 
stir at room temperature, with the reaction progress monitored by thin layer 
chromatography. Upon reaction completion, the reaction mixture was filtered through 
celite, and remaining organic solvents removed under reduced pressure. Alcohol 80 (1 g, 
99%) was isolated as a colourless oil after column chromatography (Eluent: 1:1, 
petrol:ethyl acetate). [α]D = + 28.0 (0.01 g/mL, CH2Cl2). νmax (film) / cm
-1
: 3424, 2224, 
1579, 1492, 1245. 
1
H NMR (400 MHz, CDCl3): 1.84 (1H, d, J = 4 Hz, OH), 2.92 (1H, dd, 
J = 16, 9 Hz, C4-H), 3.09 (1H, dd, J = 16, 5 Hz, C4-H), 4.08-4.22 (1H, m, C3-H), 4.91 
(1H, d, J = 8 Hz, C2-H), 6.99 (1H, d, J = 8 Hz, C8-H), 7.35-7.49 (7H, m, Ar-H & C5-H, 
C7-H).
 13
C NMR (100 MHz, CDCl3): 32.2, 67.4, 82.4, 104.4, 117.6, 119.1, 121.5, 126.9, 
129.0, 129.1, 132.0, 134.4, 137.1, 157.7; m/z found [M + Na]
+
 274.0842; 
[C16H13NO2+Na]
+
 requires 274.0838. 
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Formation of (10S)-camphorsulfonyl ester (+)-81:
 12 
 
To a flame-dried round bottom flask was added alcohol 80 (1.0 g, 3.98 mmol), (10S)-(+)-
camphorsulfonyl chloride (996 mg, 3.98 mmol) and dry toluene (50 mL). Triethylamine 
(1.1 mL, 7.96 mmol) was slowly added over 10 minutes and the reaction was left to stir 
under a nitrogen atmosphere for 24 h. Upon reaction completion, excess organic solvents 
were removed under reduced pressure. Purification via column chromatography (Eluent: 
6:1, petroleum ether:ethyl acetate) affords colourless crystalline 81. Slow recrystallization 
from dichloromethane/hexane afforded ester 81 (6-cyano-(2R)-phenyl-(3S)-
camphor(16S,19R)-sulfonylester chromene), as long colourless crystals (0.8 g, 43%, mp = 
153 – 155 °C); [α]D = + 44.0 (c 0.02 g/mL, CH2Cl2). νmax (film) / cm
-1
: 2963, 2226, 1743, 
1493, 1246, 906, 726. 
1
H NMR (400 MHz, CDCl3): 0.77 (3H, s, CH3), 0.98 (3H, s, CH3), 
1.35-1.41 (1H, m), 1.52-1.59 (1H, m), 1.88-2.01 (2H, m), 2.08 (1H, t, J = 4 Hz), 2.22-2.37 
(2H, m), 2.65 (1H, d, J = 15 Hz, AB system C15), 3.11 (2H, m), 3.35 (1H, d, J = 15 Hz, 
AB system C15), 5.22-5.25 (1H, m), 5.45 (1H, d, J = 5 Hz), 7.05 (1H, d, J = 9 Hz, C8-H), 
7.33-7.38 (6H, m, Ar-H & C5-H), 7.48 (1H, d, J = 9 Hz, C7-H). 
13
C NMR (100 MHz, 
CDCl3): 19.6, 19.7, 24.9, 26.8, 28.9, 42.4, 42.7, 47.9, 48.3, 57.9, 75.3, 78.9, 104.7, 117.6, 
118.9, 119.5, 126.0, 129.0, 129.1, 132.4, 134.2, 136.7, 157.0, 214.0; m/z found [M + 
NH4]
+
: 483.1945; [C26H27NO5S+NH4]
+
 requires 483.1948. 
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3.3.2 Iminium-salt Catalyst 41 Synthesis and Oxidant Formation 
 
2-(2-Bromoethyl)benzaldehyde (78): 
13 
 
Bromine (4.2 mL, 81.97 mmol) was added to an ice-cooled solution of isochroman 77 (10 
g, 74.52 mmol) in cyclohexane (70 mL) slowly down a reflux condenser over 5 minutes 
with stirring. After the vigorous reaction had calmed, the solution was refluxed until the 
reaction turned pale yellow and the liberation of hydrogen bromide gas had ceased. The 
solution was cooled to room temperature, and then solvents were removed in vacuo. The 
remaining oil was dissolved in hydrobromic acid (25 mL, 48% aq.) and heated under reflux 
for 10 minutes. The solution was then cooled and extracted with diethyl ether (3 x 100 
mL). The organic extracts were washed with water (2 x 30 mL), dilute sodium hydrogen 
carbonate (2 x 30 mL), and dried over MgSO4. Removal of the solvents under reduced 
pressure afforded crude 78 as a orange-brown oil. Purification of crude 78 by vacuum 
distillation (2 mbar, 50-54 °C) afforded 78 as a colourless liquid (7.015 g, 47%). νmax 
(film) / cm
-1
: 3021, 2969, 2743, 1703, 1599, 1291. δH (500 MHz, CDCl3) 3.36-3.64 (4H, 
m, Ph(CH2)2Br), 7.34 (1H, d, J = 8 Hz, CH arom., ortho to bromoethyl group), 7.49 (1H, t, 
J = 8 Hz, para to bromoethyl group), 7.56 (1H, t, J = 8 Hz, CH arom., para to formyl 
group), 7.83 (1H, d, J = 8 Hz, CH arom., ortho to formyl group), 10.15 (1H, s, CHO). δH 
(125 MHz, CDCl3) 32.8 (PhCH2), 36.3 (CH2Br), 127.7, 132.1, 133.7, 133.9, 134.5, 140.5 
(Ph), 192.9 (CHO). 
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N-((4S,5S)-2,2-Dimethyl-4-[4-(methylsulfanyl)-phenyl]-1,3-dioxan-5-yl]formamide 
(74): 
14 
 
Sodium methoxide in methanol (0.5 mL, 2.3 mmol) was added to a solution of (1S,2S)-(+)-
2-amino-1-(4-(methylthio)phenyl)-1,3-propandiol 72 (5 g, 23.4 mmol) in methanol (50 
mL), followed by the addition of methyl formate (1.4 mL, 25.7 mmol). The reaction was 
stirred at room temperature for 3.5 h, and the solvent removed under reduced pressure to 
yield N-(1S,2S)-1,3-dihydroxy-1-(4-(methylthio)phenyl)propan-2-yl)formamide as a 
yellow oil. The resulting formamide was dissolved in acetone (250 mL) followed by the 
addition of p-toluenesulfonic acid (0.5 g, 2.9 mmol) and 2,2-dimethoxypropane (30 mL). 
The reaction was stirred for 4 h at room temperature and monitored by TLC. The solvents 
were removed under reduced pressure and the residue was re-dissolved in ethyl acetate 
(250 mL) followed by washes with water (100 mL), Brine (100 mL) and saturated aqueous 
sodium hydrogen carbonate solution (2 x 100 mL). The combined organic layers were 
dried over magnesium sulfate, and the solvents removed under reduced pressure to give 74 
as a colourless oil (5.5 g, 84%); [α]D = + 0.9 (c 1.00, CHCl3) [Lit.
14
 [α]D = + 1.3 ° (c 1.27, 
CHCl3)]; vmax (film) / cm
-1
: 3310, 2991, 2251, 1668, 1496, 1382, 1165; 
1
H NMR (500 
MHz, CDCl3): 1.54 (3H, s, CH3, C7), 1.57 (3H, s, CH3, C8), 2.44 (3H, s, SCH3, C16), 3.83 
(1H, d, J = 12 Hz, NCHCHH-O, H6), 4.24 (1H, dd, J = 12 Hz,  NCHCHH-O, H6’), 4.24-
4.30 (1H, m, NCH, H5), 5.15 (1H, s, Ar-CH, H4), 6.68 (1H, d, J = 9 Hz, NH), 7.21-7.24 
(4H, m, 4 x CH arom., H10, H11, H12, H13), 7.91 (1H, s, NCHO, H18). 
13
C NMR (125 
MHz, CDCl3): 15.7 (SCH3, C16), 18.6 (CH3, C7), 29.7 (CH3, C8), 45.3, (CHNH, C5), 64.6 
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(CH2, C6), 71.4 (CH arom., C4), 99.7 (C quat., C2), 125.9 (2 x CH arom., C10, C11), 
126.3 (2 x CH arom., C12, C13), 135.1 (C quat. arom., C14), 137.7 (C quat. arom., C9), 
160.7 (CHO, C18). 
 
N-((4S,5S)-2,2-Dimethyl-4-[4-(methylsulfonyl)-phenyl]-1,3-dioxan-5-yl]formamide 
(75): 
14 
 
N-((4S,5S)-2,2-Dimethyl-4-[4-(methylsulfanyl)-phenyl]-1,3-dioxan-5-yl]formamide 74 
(4.0 g, 14.2 mmol) was dissolved in dichloromethane (100 mL) and cooled to 0 °C. A 
solution of m-CPBA (7.03 g, 31.0 mmol) in chloroform (20 mL) was added slowly to the 
reaction over 10 minutes. The mixture was stirred for 2 h, with the progress monitored by 
TLC. The organic layer was transferred to a separating funnel, and washed with saturated 
aqueous sodium hydrogen carbonate (2 x 50 mL), and dried over magnesium sulfate. The 
solvents were then removed under reduced pressure to yield 75 as a colourless oil. 
Recrystallization from chloroform/diethyl ether yielded 75 as colourless crystals (3.6 g, 
81%, mp = 145 – 146 °C, [Lit.14 mp 146 – 147 °C]); [α]D = −14.5 ° (c 1.11, CHCl3) [Lit. 
[α]D
20
 = −11.6 ° (c 1.21, CHCl3)]; vmax (film) / cm
-1
: 2995, 1674, 1515, 1383, 1301, 1239, 
1203, 1150, 1087. 
1
H NMR (500 MHz, CDCl3): 1.54 (3H, s, CH3, C7), 1.57 (3H, s, CH3, 
C8), 3.00 (3H, s, SCH3, C16), 3.82 (1H, dd, J = 12, 2 Hz, NCHCHHO, H6), 4.29 (1H, dd, 
J = 12, 2 Hz, NCHCHHO, H6’), 4.39 (1H, dd, J = 10, 2 Hz, NCH, H5), 5.25 (1H, s, Ar-
CH, H4), 6.48 (1H, d, J = 10 Hz, NH), 7.52 (2H, d, J = 8 Hz, 2 x CH arom., H10, H11), 
7.86 (2H, d, J = 9 Hz, 2 x CH arom., H12, H13), 7.91 (1H, s, NCHO, H18). 
13
C NMR (125 
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MHz, CDCl3): 18.9 (CH3, C7), 30.0 (CH3, C8), 44.8 (SCH3, C16), 45.5 (NCH, C5), 64.9 
(CH2, C6), 71.9 (CH arom., C4), 100.4 (C quat., C2), 127.0 (2 x CH, arom., C12, C13), 
127.6 (2 x CH arom., C11, C10), 140.0 (C quat., arom., C14), 144.9 (C quat., arom., C9), 
161.0 (NCHO, C18). 
 
(4S,5S)-2,2-Dimethyl-4-[4-(methylsulfonyl)-phenyl]-1,3-dioxan-5-amine (76): 
14 
 
N-((4S,5S)-2,2-Dimethyl-4-[4-(methylsulfonyl)-phenyl]-1,3-dioxan-5-yl]formamide 75 
(1.8 g, 5.8 mmol) was dissolved in aqueous hydrazine monohydrate (80 mL, 85%) and 
heated to reflux for 2.5 h. The reaction was cooled to room temperature, and extracted with 
ethyl acetate (3 x 50 mL). The organic layers were washed with water (100 mL), brine 
(100 mL), dried over magnesium sulfate and the solvents removed under reduced pressure 
to afford a colourless oil. Recrystallization of crude 76 from ethyl acetate/diethyl ether 
gave the product as colourless crystals (1.45 g, 88%, mp 120-121 °C [Lit.
14
 mp 120-122 
°C]); [α]D = + 65.3 (c 1.05, CHCl3), [Lit.
14
 [α]D =     +50 (c 1.00 CHCl3)]. vmax (film) / cm
-1
: 
3383, 2993, 1602, 1407, 1383, 1151, 1077, 913; 
1
H NMR (500 MHz, CDCl3): 1.55 (6H, s, 
2 x CH3, H7, H8), 2.85 (1H, m, CHNH2, H5), 3.06 (3H, s, SCH3, H16), 3.83 (1H, d, J = 
11Hz, NCCH2, H6), 4.32 (1H, dd, J = 12, 2 Hz, NCCH2, H6’), 5.20 (1H, m, ArCH, H4), 
7.57 (2H, d, J = 8 Hz, 2 x CH arom., H10, H11), 7.93 (2H, d, J = 8 Hz, 2 x CH arom., H12, 
H13); 
13
C NMR (125 MHz, CDCl3): 18.9 (CH3, C7), 29.9 (CH3, C8), 44.7 (SCH3, C16), 
49.5 (NCH, C5), 66.6 (CH2, C6), 73.6 (Ar-CH, C4), 99.6 (C quat., C2), 127.1 (2 x CH 
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arom., C12, C13), 127.5 (2 x CH arom., C10, C11), 139.6 (C quat., arom., C14), 146.5 (C 
quat., arom., C9). 
 
(+)-N-(4S,5S)-2,2-Dimethyl-4-[4-(methylsulfonyl)-phenyl]-1,3-dioxan-5-yl)-3,4-
dihydroisoquinolinium tetraphenylborate (41): 
14 
 
A solution of (4S,5S)-2,2-dimethyl-4-[4-(methylsulfonyl)-phenyl]-1,3-dioxan-5-amine 76 
(0.75 g, 3.0 mmol) in ethanol (7.5 mL) was added dropwise to an ice-cooled flask 
containing 2-(2-bromoethyl)benzaldehyde 78 (0.69 g, 3.3 mmol). The reaction was 
allowed to reach ambient temperature then stirred for 24h at room temperature. A solution 
of sodium tetraphenylborate (1.1 g, 3.3 mmol) in acetonitrile (1 mL) was added in one 
portion and the reaction was stirred for 5 minutes, followed by the removal of organic 
solvents under reduced pressure. Ethanol (10 mL) was added to the residue, followed by a 
few drops of water. The resulting solid was collected by filtration, washed with cold 
ethanol (10 mL) followed by diethyl ether (10 mL), affording a light yellow powder 41 
(1.4 g, 65%, mp 199 – 200 °C; [α]D = + 195 (c 1.06, Acetone) [Lit.
14
 [α]D = +126.7 (c 1.20 
acetone)]; vmax (film) / cm
-1
: 1635, 1600, 1574, 1480, 1384, 1315, 1264, 1203, 1151. 
1
H 
NMR (500 MHz, Acetone-d6): 1.69 (3H, s, CH3, H7 eq.), 1.73 (3H, s, CH3, H8 ax.), [2.61-
2.68 (1H, m), 2.86-2.93 (1H, m), Ar-CH2, isoq-4], 3.01 (3H, s, CH3, H16), [3.63-3.69 (1H, 
m), 4.11-4.17 (1H, m), CH2N, isoq-3], 4.50 (1H, d, J  = 14 Hz, NCHCH2, H6 eq.), 4.55-
4.56 (1H, m, NCHCH2, H5), 4.77 (1H, dd, J = 14, 3 Hz, H6 ax.), 6.06 (1H, d, J = 3 Hz, 
ArCH, H4), 6.79 (4H, t, J  = 7 Hz, 4 x CH arom., para in BPh4 gp.), 6.94 (8H, t, J = 7 Hz, 
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8 x CH arom., ortho in BPh4 gp.), 7.33-7.36 (8H, m, 8 x CH arom., meta in BPh4 gp.), 7.49 
(1H, t, J = 8 Hz, CH arom., isoq-8), 7.74-7.84 (3H, m, 3 x CH arom., isoq-6,7,9), 7.80 (2H, 
d, J = 8 Hz, 2 x CH arom., H10, H11), 7.96 (2H, d, J = 9 Hz, 2 x CH arom., H12, H13), 
9.28 (1H, s, NCH, isoq-1). 
13
C NMR (125 MHz, acetone-d6): 18.8 (CH3, C7), 25.3 (Ar-
CH2, isoq-4), 29.4 (CH3, C8), 44.2 (SCH3, C16), 52.3 (CH2N, isoq-3), 62.8 (CH2, C6), 
66.0 (NCH2, C5), 71.5 (Ar-CH, C4), 101.6 (C quat., C2), 122.3 (8 x CH arom., ortho in 
BPh4 gp.), 125.3 (C quat., arom., isoq-10), 126.0 (2 x CH arom., C12, C13), 127.5 (2 x CH 
arom., C10, C11), 128.8 (CH arom., isoq-6), 129.2 (CH arom., isoq-8), 129.3 (4 x CH 
arom., para in BPh4 gp.), 135.4 (CH arom., isoq-7), 137.0 (8 x CH arom., meta in BPh4 
gp.), 137.9 (CH arom., isoq-9), 139.6 (CH arom., C14), 142.3 (C quat., arom., isoq-5), 
143.1 (C quat., arom., C9), 165.0 (4 x C quat., arom., ipso in BPh4 gp.), 168.9 (NCH, isoq-
1). 
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Tetraphenylphosphonium monoperoxysulfate (71): 
15 
 
Oxone™ triple salt (2 KHSO5:KHSO4:K2SO4) (15.0 g, 48.8 mmol w.r.t. KHSO5) was 
dissolved in deionized water (300 mL), and the solution stirred at 10-15 °C (water bath). A 
solution of tetraphenylphosphonium chloride 79 (15.0 g, 40.0 mmol) in distilled 
dichloromethane (300 mL) was added over 5 minutes, and the mixture stirred for an 
additional 30 minutes. The organic layer was separated, and the solvent removed under 
reduced pressure at room temperature. Colourless 71 was transferred to a fritted glass 
funnel, and washed with distilled water (2 x 75 mL). The solid was dissolved in 
dichloromethane (180 mL), and the solution dried (MgSO4). Hexane was added until 
cloudiness developed, and the flask was placed in the freezer (- 20°C) for 2 h, producing a 
colourless precipitate of the salt about 85% pure in peroxide (15.4g, 70%). 
1
H NMR (400 
MHz, CDCl3): δH 7.64 (8H, m), 7.78 (8H, m), 7.89 (4H, m), 8.92 (1H, s). 
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3.3.3 Dihydroquinoline Epoxidation Section 
General Procedure for the formation of 3-chloro-3-methylbut-1-yne: 
16 
 
To a 2L three neck flask, equipped with stirrer flea, at 0 °C, was added calcium dichloride 
(23 g, 209 mmol), cuprous chloride (20 g, 204 mmol), copper powder (0.4 g, 6.67 mmol) 
and cold concentrated hydrochloric acid (250 mL). The solution was left to stir for 5 
minutes at 0 °C followed by purging the reaction with argon for 10 minutes. The 
corresponding tertiary alcohol (56 g, 667 mmol) was added dropwise over 30 minutes, and 
the reaction was left to stir for 1 hour at 0 – 5 °C. The upper organic layer was extracted 
directly from the reaction, and washed three times with cold concentrated hydrochloric 
acid (150 mL). The organic layer was further extracted with cold water (150 mL), saturated 
sodium hydrogen carbonate solution (150 mL) and dried on magnesium sulfate to afford 
the product as a colourless liquid (40 g, 58%). νmax (neat) / cm
-1
: 2984, 1448, 1368, 1226, 
1118, 786. 
1
H NMR (500 MHz, CDCl3): δH 1.82 (6H, s, (2x)-CH3), 2.59 (1H, s, CC-H). 
13
C NMR (75 MHz, CDCl3): 34.6, 56.9, 71.9, 86.5. The NMR data collected matches that 
found for commercially available 3-chloro-3-methylbut-1-yne. 
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General Procedure for the formation of Dihydroquinolines 
 
The required aniline and 3-chloro-3-methyl-but-1-yne (1 equiv.) were dissolved in toluene 
(15 mL/gram of aniline), to which cuprous chloride (1 equiv.) and fine copper powder (1 
equiv.) were added to the stirring solution. The reaction was submitted to reflux for 24 h. 
The reaction was allowed to cool, and water (10 mL/gram of aniline) added. The organic 
layer was extracted, and dichloromethane extracts from the aqueous phase were combined 
with the organic layer, and then dried over magnesium sulfate. Remaining solvents were 
removed under reduced pressure. Purification of the crude material using column 
chromatography (ethyl acetate:petroleum ether) afforded the dihydroquinolines as 
crystalline solids or oils.  
 
6-Cyano-2,2-dimethyl-1,2-dihydroquinoline (105):
 17 
 
6-Cyano-2,2-dimethyl-1,2-dihydroquinoline 105 was prepared via the general procedure 
for dihydroquinoline formation from 4-aminobenzonitrile (0.13 g, 1.0 mmol) and 3-chloro-
3-methyl-but-1-yne (0.11 g, 1.0 mmol), yielding compound 105 as a yellow solid (0.06 g, 
30%; mp 107-109 °C) after purification via column chromatography (Eluent: 2:1:0.1, 
(petroleum ether:ethyl acetate:triethylamine). νmax (film) / cm
-1
: 3346, 3038, 2981, 2960, 
2921, 2215, 1644, 1601, 1513, 1342, 1278, 1161. 
1
H NMR (300 MHz, CDCl3): δH 1.33 
(6H, s, 2x CH3), 4.27 (1H, bs, NH), 5.49 (1H, d, J = 10 Hz, C3-H), 6.17 (1H, d, J = 10 Hz, 
C4-H), 6.34 (1H, d, J = 8 Hz, C8-H), 7.06 (1H, d, J = 2 Hz, C5-H), 7.17 (1H, dd, J = 8, 2 
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Hz, C7-H).  
13
C NMR (75 MHz, CDCl3): δC 31.9 (2x CH3), 52.9, 98.0, 112.4, 119.3, 120.7, 
122.0, 130.3, 131.8, 133.0, 146.7. HRMS m/z 185.1072 [M + H]
+
; [C12H12N2+H]
+
 requires 
185.1073. 
 
6-Nitro-2,2-dimethyl-1,2-dihydroquinoline (106):
 18 
 
6-Nitro-2,2-dimethyl-1,2-dihydroquinoline 106 was prepared via the general procedure for 
dihydroquinoline formation from 4-nitroaniline (1.23 g, 8.88 mmol) and 3-chloro-3-
methyl-but-1-yne (0.9 g, 8.88 mmol), yielding compound 106 as a brown crystalline solid 
(0.58 g, 32%; mp 180-184 °C) after purification via column chromatography (Eluent: 
3:1:0.1, petroleum ether:ethyl acetate:triethylamine). νmax (film) / cm
-1
: 3330, 2969, 1648, 
1600, 1580, 1297, 1264, 1126, 1086. 
1
H NMR (300 MHz, CDCl3): δH 1.38 (6H, s, 2x 
CH3), 4.47 (1H, bs, NH), 5.54 (1H, dd, J = 10, 2 Hz, C3-H), 6.26 (1H, d, J = 10 Hz, C4-H), 
6.31 (1H, d, J = 9 Hz, C8-H), 7.77 (1H, d, J = 3 Hz, C5-H), 7.88 (1H, dd, J = 9, 3 Hz, C7-
H).  
13
C NMR (75 MHz, CDCl3): δC 25.6, 26.8, 28.0, 49.5, 107.1, 118.2, 118.9, 121.8, 
127.6. HRMS m/z 205.0966 [M + H]
+
; [C11H12N2O2 + H]
+
 requires 205.0972. 
 
6-Chloro-2,2-dimethyl-1,2-dihydroquinoline (107):
 19 
 
6-Chloro-2,2-dimethyl-1,2-dihydroquinoline 107 was prepared via the general procedure 
for dihydroquinoline formation from 4-chloroaniline (0.26 g, 2.0 mmol) and 3-chloro-3-
methyl-but-1-yne (0.21 g, 2.0 mmol), yielding compound 107 as a yellow solid (0.100 g, 
25%; mp 59-61 ˚C) after purification via column chromatography (Eluent: 6:1:0.1, 
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petroleum ether:ethyl acetate:triethylamine). νmax (film) / cm
-1
: 3388, 3037, 2964, 2925, 
1639, 1599, 1489, 1445, 1381, 1359, 1302, 1211, 1084. 
1
H NMR (300 MHz, CDCl3): δH 
1.30 (6H, s, (2x)-CH3), 3.66 (1H, bs, NH), 5.52 (1H, d, J = 10 Hz, C3-H), 6.20 (1H, d, J = 
10 Hz, C4-H), 6.34 (1H, d, J = 8 Hz, C8-H), 6.86 (1H, d, J = 2 Hz, C5-H), 6.91 (1H, dd, J 
= 8, 2 Hz, C7-H).  
13
C NMR (75 MHz, CDCl3): δC 30.9 (2x CH3), 52.2, 113.8, 121.4, 
121.6, 122.8, 126.1, 128.1, 132.3, 141.7. HRMS m/z 194.0728 [M + H]
+
; [C11H12NCl + 
H]
+
 requires 194.0731.  
 
2,2-Dimethyl-1,2-dihydroquinoline (108): 
20 
 
 
2,2-Dimethyl-1,2-dihydroquinoline 108 was prepared via the general procedure for 
dihydroquinoline formation from aniline (0.51 g, 5.5 mmol) and 3-chloro-3-methyl-but-1-
yne (0.56 g, 5.5 mmol), yielding compound 108 as a brown oil (0.123 g, 14 %) after 
purification via column chromatography (Eluent: 6:1:0.1, petroleum ether: ethyl 
acetate:triethylamine). νmax (film) / cm
-1
: 3377, 3030, 2963, 1637, 1605, 1464, 1318, 1135, 
1036, 974, 774, 744. 
1
H NMR (400 MHz, CDCl3): δH 1.33 (6H, s, 2x CH3), 3.59 (1H, bs, 
NH), 5.49 (1H, d, J = 10 Hz, C3-H), 6.30 (1H, d, J = 10 Hz, C4-H), 6.43 (1H, d, J = 8 Hz, 
C8-H), 6.62 (1H, t, J = 8 Hz, C7-H), 6.92 (1H, d, J = 8 Hz, C6-H), 7.00 (1H, t, J = 8 Hz, 
C5-H).  
13
C NMR (75 MHz, CDCl3): δC 31.1 (2x CH3), 52.1, 112.9, 117.3, 120.1, 123.8, 
126.7, 128.7, 131.0, 143.3. HRMS m/z 159.1043 [M]
+
; [C11H13N]
+
 requires 159.1043. 
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General Procedure for the synthesis of N-Trifluoroacetyl Dihydroquinolines 
 
Trifluoroacetic anhydride (2 equiv.) was added dropwise to a stirring solution of 
dihydroquinoline dissolved in dichloromethane (10 mL/100 mg of dihydroquinoline) and 
pyridine (1 equiv.) at 0 °C. The reaction was allowed to reach ambient temperature, and 
after further stirring for one hour, the reaction was quenched with water (5 mL/100 mg of 
dihydroquinoline). The organic phase was washed with copper sulfate solution, brine, and 
combined with dichloromethane extracts taken from the aqueous phase. The combined 
organic extracts were dried over magnesium sulfate, and remaining organic solvent 
removed under reduced pressure. The crude organic mixture was purified via column 
chromatography (ethyl acetate:petroleum ether). 
 
2,2-dimethyl-1-(trifluoroethanoyl)-1,2-dihydroquinoline-6-carbonitrile (115): 
 
Compound 115 was prepared via the general procedure for N-trifluoro-acetyl 
dihydroquinoline protection from 6-cyano-2,2-dimethyl-1,2-dihydroquinoline 105 (0.05 g, 
0.27 mmol), trifluoroacetic anhydride (0.11 g, 0.54 mmol) and pyridine (0.02 g, 0.27 
mmol), yielding compound 115 as a bright yellow crystalline solid (0.074 g, 97%; mp 97-
99 °C) after purification via column chromatography (Eluent: 6:1 petroleum ether:ethyl 
acetate). νmax (film) / cm
-1
: 2976, 2231, 1709, 1494, 1362, 1201, 1153. 
1
H NMR (300 MHz, 
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CDCl3): δH 1.57 (6H, s, 2x CH3), 5.88 (1H, d, J = 10 Hz, C3-H), 6.40 (1H, d, J = 10 Hz, 
C4-H), 6.89 (1H, d, J = 8 Hz, C8-H), 7.38 (1H, d, J = 2 Hz, C5-H), 7.46 (1H, dd, J = 8, 2 
Hz, C7-H). 
13
C NMR (75 MHz, CDCl3): δC 25.4 (2x CH3), 60.5 (C2), 110.0, 117.9 (q, JC-F 
= 265 Hz, CF3), 121.5, 122.3, 122.4, 127.5, 129.7, 131.7, 137.8, 139.4, 159.4 (q, JC-F = 33 
Hz, COCF3). HRMS m/z found 281.0894 [M + H]
+
; [C14H11F3N2O+H]
+
 requires 281.0896.  
 
1-(6-chloro-2,2-dimethylquinolin-1(2H)-yl)-2,2,2-trifluoroethanone (117): 
 
Compound 117 was prepared via the general procedure for N-trifluoro-acetyl 
dihydroquinoline protection from 6-chloro-2,2-dimethyl-1,2-dihydroquinoline 107 (0.052 
g, 0.27 mmol), trifluoroacetic anhydride (0.11 g, 0.54 mmol) and pyridine (0.02 g, 0.27 
mmol), yielding compound 117 as a yellow crystalline solid (0.052 g, 68%; mp 65-67 °C) 
after purification via column chromatography (Eluent: 6:1, petroleum ether:ethyl acetate). 
νmax (film) / cm
-1
: 2974, 2932, 1704, 1489, 1359, 1200, 1177, 892, 717. 
1
H NMR (400 
MHz, CDCl3): δH 1.54 (6H, s, 2x CH3), 5.81 (1H, d, J = 10 Hz, C3-H), 6.34 (1H, d, J = 10 
Hz, C4-H), 6.79 (1H, d, J = 8 Hz, C8-H), 7.09 (1H, d, J = 2 Hz, C5-H), 7.13 (1H, dd, J = 8, 
2 Hz, C7-H). 
13
C NMR (75 MHz, CDCl3): δC 25.3 (2x CH3), 60.2 (C2), 117.2 (q, JC-F = 
289 Hz, CF3), 122.1, 123.5, 123.6, 126.3, 127.5, 128.5, 132.2, 139.1, 158.6 (q, JC-F = 36 
Hz, COCF3). HRMS m/z found 290.0552 [M + H]
+
; [C13H11F3NClO+H]
+
 requires 
290.0554. 
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General procedure for the preparation of various nitrogen protected 
dihydroquinolines 
 
To a flame dried round bottom flask under an atmosphere of nitrogen was added 
dihydroquinoline (1 equiv.) and anhydrous THF (50 mL/gram of dihydroquinoline). The 
reaction mixture was cooled to -78 °C, to which n-BuLi (1.4 equiv.) was added slowly 
over 15 minutes, and left to stir for 2 h. This was followed by the slow addition of a 
solution of tert-butylcarboxyl anhydride/benzoyl chloride/benzyl chloroformate (1.5 
equiv.) in THF (10 mL/gram of dihydroquinoline) over 15 minutes. Reaction progress was 
monitored by TLC, then quenched with ammonium chloride solution (10 mL/gram of 
dihydroquinoline). Ethyl acetate (20 mL/gram of dihydroquinoline) was added, and the 
organic layers were separated. The combined organic layers were then washed with brine 
(10 mL/gram of dihydroquinoline), dried over sodium sulfate and concentrated under 
reduced pressure to afford the title compounds as viscous oils/solids. 
 
1-benzoyl-2,2-dimethyl-6-cyano-dihydroquinoline (120): 
 
Compound 120 was prepared via the general procedure for dihydroquinoline protection 
from 6-cyano-2,2-dimethyl-1,2-dihydroquinoline 105 (0.2 g, 1.1 mmol) and benzoyl 
chloride (0.23 g, 1.65 mmol), yielding compound 120 as a bright yellow luminescent oil 
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(0.127 g, 40%) after purification via column chromatography (Eluent: 6:1, petroleum 
ether:ethyl acetate). νmax (film) / cm
-1
: 2970, 2225, 1664, 1599, 1562, 1487, 1319, 1297, 
1242, 1147, 905. 
1
H NMR (400 MHz, CDCl3): δH 1.53 (6H, s, 2x CH3), 5.75 (1H, d, J  = 
10 Hz, C3-H), 6.24 (1H, d, J = 8 Hz, C8-H), 6.28 (1H, d, J = 10 Hz, C4-H), 6.87 (1H, dd, J 
= 8, 2 Hz, C7-H), 7.14 (1H, d, J = 2 Hz, C5-H), 7.18 (2H, t, J = 8 Hz, 2x Ph-CH meta), 
7.25-7.35 (1H, m, Ph-CH para), 7.45 (2H, d, J = 8 Hz, 2x Ph-CH ortho). 
13
C NMR (100 
MHz, CDCl3): δC 26.8 (2x CH3), 59.1 (C2), 106.1, 119.0, 121.5, 124.5, 126.3, 128.9 (2x 
PhCH), 129.7, 130.1 (2x PhCH), 130.9, 132.4, 136.2, 139.3, 142.5, 172.3. HRMS m/z 
289.1330 [M + H]
+
; [C19H16N2O+H]
+
 requires 289.1335. 
 
1-tert-butyoxycarbonyl-2,2-dimethyl-6-cyano-dihydroquinoline (121): 
 
Compound 121 was prepared via the general procedure for dihydroquinoline protection 
from 6-cyano-2,2-dimethyl-1,2-dihydroquinoline 105 (0.2 g, 1.1 mmol) and tert-
butoxycarboxyl anhydride (0.35 g, 1.65 mmol), yielding compound 121 as a bright yellow 
luminescent oil (0.1 g, 33%) after purification via column chromatography (Eluent: 6:1, 
petroleum ether:ethyl acetate). νmax (film) / cm
-1
: 2976, 2932, 2225, 1714, 1602, 1491, 
1369, 1304, 1224, 1145, 1065, 823. 
1
H NMR (400 MHz, CDCl3): δH 1.54 (9H, s, 3x CH3, 
t-Bu), 1.55 (6H, s, 2x CH3), 5.64 (1H, d, J = 10 Hz, C3-H), 6.23 (1H, d, J = 10 Hz, C4-H), 
7.19 (1H, d, J = 9 Hz, C8-H), 7.21 (1H, d, J = 2 Hz, C5-H), 7.33 (1H, dd, J = 9, 2 Hz, C7-
H). 
13
C NMR (100 MHz, CDCl3): δC 28.0 (2x CH3), 28.3 (3x CH3, t-Bu), 58.1, 82.7, 
104.9, 119.4, 121.4, 121.8, 125.6, 129.9, 131.3, 137.9, 141.9, 153.8. HRMS m/z 285.1600 
[M + H]
+
; [C17H20N2O2+H]
+
 requires 285.1598. 
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1-carboxybenzyl-2,2-dimethyl-6-cyano-dihydroquinoline (122): 
 
Compound 122 was prepared via the general procedure for dihydroquinoline protection 
from 6-cyano-2,2-dimethyl-1,2-dihydroquinoline 105 (0.2 g, 1.1 mmol) and benzyl 
chloroformate (0.35 g, 1.65 mmol), yielding compound 122 as a colourless powder (0.174 
g, 55%; mp 116-118 °C) after purification via column chromatography (Eluent: 6:1, 
petroleum ether:ethyl acetate). νmax (film) / cm
-1
: 2963, 2224, 1711, 1602, 1490, 1300, 
1216, 1059. 
1
H NMR (400 MHz, CDCl3): δH 1.55 (6H, s, 2x CH3), 5.26 (2H, s, Cbz-CH2), 
5.69 (1H, d, J = 10 Hz, C3-H), 6.26 (1H, d, J = 10 Hz, C4-H), 7.07 (1H, d, J = 9 Hz, C8-
H), 7.23 (1H, d, J = 2 Hz, C5-H), 7.27 (1H, dd, J = 9, 2 Hz, C7-H), 7.34-7.42 (5H, m, 5x 
PhCH). 
13
C NMR (100 MHz, CDCl3): δC 27.5 (2x CH3), 58.3, 68.2, 105.8, 114.0, 118.9, 
121.3, 122.5, 126.0, 128.7 (2x C), 128.7 (2x C), 129.6, 131.1, 135.1, 138.1, 140.9, 154.5. 
HRMS m/z found 318.1362 [M + H]
+
; [C20H18N2O2+H]
+
 requires 318.1368. 
 
1-tert-butyoxycarbonyl-2,2-dimethyl-6-chloro-dihydroquinoline (126): 
 
Compound 126 was prepared via the general procedure for dihydroquinoline protection 
from 6-chloro-2,2-dimethyl-1,2-dihydroquinoline 107 (0.2 g, 1.04 mmol) and tert-
butoxycarboxyl anhydride (0.34 g, 1.55 mmol), yielding compound 126 as a brown oil 
(0.12 g, 40%) after purification via column chromatography (Eluent: 10:1, petroleum 
ether:ethyl acetate). νmax (film) / cm
-1
: 2974, 1710, 1487, 1315, 1248, 1156. 
1
H NMR (400 
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MHz, CDCl3): δH 1.51 (9H, s, 3x CH3, t-Bu), 1.52 (6H, s, 2x CH3), 5.64 (1H, d, J = 10 Hz, 
C3-H), 6.21 (1H, d, J = 10 Hz, C4-H), 6.94 (1H, d, J = 2 Hz, C5-H), 7.03 (1H, dd, J = 9, 2 
Hz, C7-H), 7.11 (1H, d, J = 9 Hz, C8-H). 
13
C NMR (100 MHz, CDCl3): δC 27.6 (2x CH3), 
28.4 (3C, t-Bu), 57.4 (C2), 81.6, 122.2, 124.0, 125.6, 127.0, 127.3, 127.6, 136.1, 138.3, 
154.0. HRMS m/z 294.1259 [M + H]
+
; [C16H20ClNO2+H]
+
 requires 294.1255. 
 
1-carboxybenzyl-2,2-dimethyl-6-cyano-dihydroquinoline (127): 
 
 
Compound 127 was prepared via the general procedure for dihydroquinoline protection 
from 6-chloro-2,2-dimethyl-1,2-dihydroquinoline 107 (0.3 g, 0.92 mmol) and benzyl 
chloroformate (0.3 g, 1.38 mmol), yielding compound 127 as a yellow oil (0.072 g, 14%) 
after purification via column chromatography (Eluent: 10:1, petroleum ether:ethyl acetate). 
νmax (film) / cm
-1
: 2969, 1706, 1485, 1305, 1239, 1209, 1057. 
1
H NMR (400 MHz, CDCl3): 
δH 1.54 (6H, s, 2x CH3), 5.22 (2H, s, benzyl-CH2), 5.69 (1H, d, J = 10 Hz, C3-H), 6.24 
(1H, d, J = 10 Hz, C4-H), 6.96-7.00 (3H, m, C5-H, C7-H, C8-H), 7.33-7.39 (5H, m, Cbz-
PhCH). 
13
C NMR (125 MHz, CDCl3): δC 27.1 (2x CH3), 57.7, 67.6, 122.1, 124.6, 125.5, 
127.0, 127.7,  128.35, 128.38, 128.5 (2C), 128.6 (2C), 135.2, 135.6, 138.4, 154.6. HRMS 
m/z 328.1104 [M + H]
+
; [C19H18ClNO2+H]
+
 requires 328.1099. 
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General Procedure for the formation of Racemic Epoxides  
 
The required nitrogen protected dihydroquinoline (1 equiv.) was dissolved in 
dichloromethane (5 mL/0.02 g of dihydroquinoline) and cooled to 0 °C, to which meta-
chloroperbenzoic acid (2 equiv.) and sodium hydrogen carbonate (4 equiv.) were added as 
solids. The reaction was allowed to stir at 0 °C until reaction completion was observed by 
TLC. Saturated aqueous sodium hydrogen carbonate solution (2 mL/0.02 g of 
dihydroquinoline) was added to quench the reaction. The organic layer was extracted 
against water and brine washes, and combined with further dichloromethane extracts of the 
aqueous layer. The combined organic extracts were dried over magnesium sulfate, and 
excess solvent was removed under reduced pressure. The crude product was purified using 
flash column chromatography, utilising various ethyl acetate:petroleum ether:triethylamine 
eluents.  
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General Procedure for the Formation of Chiral Epoxides 
 
Aqueous conditions 
21
 
 
The required nitrogen protected dihydroquinoline (1 equiv.) and catalyst 82 (5 mol%) was 
dissolved in acetonitrile (1 mL/0.05 g of nitrogen protected dihydroquinoline) and water 
(0.1 mL/0.05 g of nitrogen protected dihydroquinoline) and the mixture cooled to 0 °C. A 
mixture of Oxone (2 equiv.) and sodium hydrogen carbonate (5 equiv.) was added as a 
solid in one portion to the mixture with vigorous stirring. The mixture was stirred at 0 °C 
until complete conversion of the alkene was observed by TLC. Diethyl ether (10 mL/0.05 g 
of nitrogen protected dihydroquinoline) was added, and the reaction mixture was filtered 
through a pad of mixed MgSO4 and sodium bisulfite. The solvent was removed in vacuo. 
Pure epoxides were obtained by column chromatography using ethyl acetate: petroleum 
ether: triethylamine as eluents. 
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General Procedure for the Formation of Chiral Epoxides 
 
Non-aqueous conditions 
22
 
 
Tetraphenylphosphonium monoperoxysulfate (2 equiv.) was dissolved in dichloromethane 
(2 mL/0.05 g TPPP) and the solution cooled to 0 °C. A solution of the iminium salt 41 (10 
mol%) in dichloromethane (0.5 mL/0.05 g TPPP) was cooled to 0 °C and added dropwise 
to the solution containing the TPPP over 20 minutes. The temperature of the reaction 
vessel was monitored to minimize the increase in temperature during the addition. A 
solution of the alkene in dichloromethane (0.5 mL/0.05 g TPPP) was added dropwise. The 
mixture was stirred at 0 °C with the reaction progress monitored by TLC. Diethyl ether 
(pre-cooled to the reaction temperature) (20 mL/0.05 g TPPP) was added to induce 
precipitation of the remaining oxidant, and the mixture ﬁltered through Celite. The solvents 
were removed in vacuo. If the reaction does not reach completion the epoxide can be 
separated from the alkene by column chromatography, eluting with ethyl acetate/light 
petroleum. 
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3,4-epoxy-2,2-dimethyl-1-(trifluoroethanoyl)-1,2-tetrahydroquinoline-6-carbonitrile 
(128): 
 
Non-chiral Epoxidation: Following the general procedure for the formation of racemic 
epoxides, compound 115 (0.06 g, 0.21 mmol), m-CPBA (0.07 g, 0.43 mmol) and NaHCO3 
(0.07 g, 0.86 mmol) were left to react at 0 °C for 24 hours. The crude reaction mixture was 
purified by flash column chromatography (eluents; petroleum ether: ethyl acetate: 
triethylamine, 6:1:0.1), affording 128 as a yellow-orange solid (0.038 g, 60%; mp 114-118 
°C). νmax (film) / cm
-1
: 2927, 2232, 1712, 1501, 1367, 1201, 1172, 1136, 832. 
1
H NMR 
(300 MHz, CDCl3): δH 1.28 (3H, s, CH3), 1.84 (3H, s, CH3), 3.50 (1H, d, J = 4 Hz, C3-H), 
3.94 (1H, d, J = 4 Hz, C4-H), 6.91 (1H, d, J = 8 Hz, C8-H), 7.63 (1H, dd, J = 2, 8 Hz, C7-
H), 7.77 (1H, d, J = 2 Hz, C5-H). 
13
C NMR (75 MHz, CDCl3): δC 21.6, 24.3, 50.6, 58.0, 
64.6, 110.3, 117.6, 125.6 (q, JC-F = 197 Hz, CF3), 127.2, 127.3, 133.3, 133.4, 138.4, 160.7 
(q, JC-F = 42 Hz, COCF3). HRMS m/z found 297.0841 [M + H]
+
; [C14H11F3N2O2+H]
+
 
requires 297.0845. HPLC trace (90:10 hexane:iso-propanol, flow rate: 1 mL/min); 14.75 
min (50.02 %), 16.80 min (49.98 %). 
 
Asymmetric Epoxidation  
Aqueous conditions: Following the general procedure for the formation of 
enantioenriched epoxides under aqueous conditions, compound 115 (0.05 g, 0.18 mmol) 
and catalyst 82 (0.006 g, 5 mol%) was dissolved in acetonitrile:water (10:1, 1 mL) and 
cooled to 0 °C. Oxone (0.22 g, 0.36 mmol) and sodium hydrogen carbonate (0.08 g, 0.9 
mmol) were added in one portion, and the reaction progress was monitored by TLC. The 
reaction mixture was purified by flash column chromatography (eluents; petroleum ether: 
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ethyl acetate: triethylamine, 6:1:0.1), affording 128 as a yellow-orange solid (0.041 g, 
76%). [α]D = −219.3 (c 0.017 g/mL, CH2Cl2); Chiral HPLC trace (90:10, 
hexane:isopropanol, flow rate: 1 mL/min); 14.80 min (31.32 %), 16.83 min (68.68 %). 
 
Non-Aqueous conditions: Tetraphenylphosphonium monoperoxysulfate (0.64 g, 1.42 
mmol) was dissolved in dichloromethane (8 mL) and the solution cooled to 0 °C. A 
solution of  iminium-salt 41 (0.05 g, 10 mol%) in dichloromethane (2 mL) was cooled to 0 
°C and added dropwise to the solution containing the TPPP over 20 minutes. The 
temperature of the reaction vessel was monitored to minimize the increase in temperature 
during the addition. A solution of compound 115 (0.2 g, 0.71 mmol) in dichloromethane (2 
mL) was added dropwise. The mixture was stirred at 0 °C for 120 hours, and quenched at 
this point to avoid any decomposition of the epoxide product being formed. The reaction 
mixture was purified by flash column chromatography (eluents; petroleum ether: ethyl 
acetate: triethylamine, 6:1:0.1), affording 128 as a yellow-orange solid (0.02 g, 10%). [α]D 
= −142.4 (c 0.01 g/mL, CH2Cl2); Chiral HPLC trace (90:10, hexane:isopropanol, flow rate: 
1 mL/min); 14.84 min (13.20%), 16.76 min (86.80%). 
 
 
 
 
 
 
 
 
(The discrepancy between the e.r. by HPLC and the relative magnitudes of the specific 
rotation measurements was noted in the viva) 
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3,4-epoxy-2,2-dimethyl-1-(trifluoroethanoyl)-6-chloro-1,2-tetrahydroquinoline (129): 
 
Non-chiral Epoxidation: Following the general procedure for the formation of racemic 
epoxides, compound 117 (0.1 g, 0.35 mmol), m-CPBA (0.12 g, 0.70 mmol) and NaHCO3 
(0.115 g, 1.38 mmol) were left to react at 0 °C for 24 hours. The crude reaction mixture 
was purified by flash column chromatography (eluent mixture, petroleum ether: ethyl 
acetate: triethylamine; 8:1:0.1), affording 129 as a yellow oil (0.055 g, 52%). 
1
H NMR 
(300 MHz, CDCl3): δH 1.22 (3H, s, CH3), 1.87 (3H, s, CH3), 3.44 (1H, d, J = 4 Hz, C3-H), 
3.86 (1H, d, J = 4 Hz, C4-H), 6.81 (1H, d, J = 8 Hz, C8-H), 7.30 (1H, dd, J = 2, 8 Hz, C7-
H), 7.45 (1H, d, J = 2 Hz, C5-H). 
13
C NMR (75 MHz, CDCl3): δC 20.6, 23.6, 51.0, 56.9, 
63.5, 116.1 (q, JC-F = 290 Hz, CF3), 124.6, 126.7, 128.1, 129.0, 131.4, 131.7, 158.7 (q, JC-F 
= 36 Hz, COCF3). HRMS m/z found 306.0506 [M + H]
+
; [C13H11ClF3NO2 + H]
+
 requires 
306.0503. Resolution of the enantiomers was achieved using 3 mg of europium(III) 
chelate/10 mg of epoxide (Appendix B). 
 
Asymmetric Epoxidation  
Aqueous conditions: Following the general procedure for the formation of 
enantioenriched epoxides under aqueous conditions, compound 117 (0.1 g, 0.34 mmol) and 
catalyst 82 (0.012 g, 5 mol%) was dissolved in acetonitrile:water (10:1, 2 mL) and cooled 
to 0 °C. Oxone (0.42 g, 0.68 mmol) and sodium hydrogen carbonate (0.15 g, 1.72 mmol) 
were added in one portion, and the reaction progress was monitored by TLC. The reaction 
mixture was purified by flash column chromatography (eluents; petroleum ether: ethyl 
acetate: triethylamine, 8:1:0.1), affording 129 as a yellow oil (0.091 g, 87%). [α]D = −77.6 
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(c 0.01 g/mL, CH2Cl2); Resolution of enantiomers was achieved using 3 mg of europium 
(III) chelate/10 mg of epoxide (Appendix B). 
 
Non-Aqueous conditions: Tetraphenylphosphonium monoperoxysulfate (0.62 g, 1.38 
mmol) was dissolved in dichloromethane (8 mL) and the solution cooled to 0 °C. A 
solution of  iminium-salt 41 (0.05 g, 10 mol%) in dichloromethane (2 mL) was cooled to 0 
°C and added dropwise to the solution containing the TPPP over 20 minutes. The 
temperature of the reaction vessel was monitored to minimize the increase in temperature 
during the addition. A solution of compound 117 (0.2 g, 0.69 mmol) in dichloromethane (2 
mL) was added dropwise. The mixture was stirred at 0 °C for 120 hours, and quenched at 
this point to avoid any decomposition of the epoxide product being formed. The reaction 
mixture was purified by flash column chromatography (eluents; petroleum ether: ethyl 
acetate: triethylamine, 8:1:0.1), affording 129 as a yellow oil (0.028 g, 13%). [α]D = −82 (c 
0.01 g/mL, CH2Cl2); Resolution of enantiomers was achieved using 3 mg of europium(III) 
chelate/10 mg of epoxide. 
 
3,4-epoxy-2,2-dimethyl-1-(benzoyl)-1,2-tetrahydroquinoline-6-carbonitrile (130): 
 
Non-chiral epoxidation: Following the general procedure for the formation of racemic 
epoxides, Compound 120 (0.06 g, 0.21 mmol), m-CPBA (0.07 g, 0.42 mmol) and NaHCO3 
(0.07 g, 0.86 mmol) were left to react at 0 °C for 24 hours. The crude reaction mixture was 
purified by flash column chromatography (eluent mixture, petroleum ether: ethyl acetate: 
triethylamine; 7:1:0.1), affording 130 as a colourless oil (0.034 g, 53%). νmax (film) / cm
-1
: 
3058, 2972, 2930, 2227, 1665, 1610, 1571, 1497, 1298, 1232, 827, 730. 
1
H NMR (300 
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MHz, CDCl3): δH 1.45 (3H, s, CH3), 1.84 (3H, s, CH3), 3.59 (1H, d, J = 4 Hz, C3-H), 3.97 
(1H, d, J = 4 Hz, C4-H), 6.41 (1H, d, J = 9 Hz, C8-H), 7.16 (1H, dd, J = 2, 9 Hz, C7-H), 
7.30 (2H, d, J = 8 Hz, Ar-H), 7.41 (1H, t, J = 8 Hz, Ar-H), 7.59-7.72 (3H, m, C5-H & 2x 
Ar-H). 
13
C NMR (75 MHz, CDCl3): δC 23.4, 24.9, 51.6, 55.8, 67.3, 106.1, 118.4, 124.4, 
125.5, 128.8, 130.3, 132.4, 132.5, 133.3, 136.5, 142.7, 173.3. HRMS m/z found 305.1288 
[M + H]
+
; [C19H16N2O2+H]
+
 requires 305.1285. Racemic HPLC trace (98:2, hexane:iso-
propanol, flow rate; 1 mL/min); 27.31 min (47.11 %), 30.40 min (52.89 %). 
 
Asymmetric Epoxidation  
Aqueous conditions: Following the general procedure for the formation of 
enantioenriched epoxides under aqueous conditions, compound 120 (0.05 g, 0.17 mmol) 
and catalyst 82 (0.006 g, 5 mol%) was dissolved in acetonitrile:water (10:1, 1 mL) and 
cooled to 0 °C. Oxone (0.21 g, 0.34 mmol) and sodium hydrogen carbonate (0.07 g, 0.87 
mmol) were added in one portion, and the reaction progress was monitored by TLC. The 
reaction mixture was purified by flash column chromatography (eluents; petroleum ether: 
ethyl acetate: triethylamine, 7:1:0.1), affording 130 as a colourless oil (0.035 g, 68%). [α]D 
= −197.6 (c 0.01 g/mL, CH2Cl2); Chiral HPLC trace (98:2, hexane:iso-propanol, flow rate; 
1 mL/min); 27.36 min (16.78 %), 30.10 min (83.22 %). 
 
3,4-epoxy-1-tert-butyoxycarbonyl-2,2-dimethyl-6-cyano-tetrahydroquinoline (131): 
 
Non-chiral Epoxidation: Following the general procedure for the formation of racemic 
epoxides, compound 121 (0.07 g, 0.25 mmol), m-CPBA (0.09 g, 0.50 mmol) and NaHCO3 
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(0.08 g, 1.0 mmol) were left to react at 0 °C for 24 hours. The crude reaction mixture was 
purified by flash column chromatography (eluents; petroleum ether: ethyl acetate: 
triethylamine, 10:1:0.1), affording epoxide 131 as a colourless oil (0.053 g, 71%). νmax 
(film) / cm
-1
: 2965, 2925, 2853, 2227, 1717, 1612, 1574, 1499, 1369, 1316, 1148. 
1
H NMR 
(300 MHz, CDCl3): δH 1.29 (3H, s, CH3), 1.49 (9H, s, t-Bu), 1.80 (3H, s, CH3), 3.47 (1H, 
d, J = 4 Hz, C3-H), 3.82 (1H, d, J = 4 Hz, C4-H), 7.14 (1H, d, J = 9 Hz, C8-H), 7.47 (1H, 
dd, J = 2, 9 Hz, C7-H), 7.60 (1H, d, J = 2 Hz, C5-H). 
13
C NMR (75 MHz, CDCl3): δC 22.7 
(CH3), 26.2 (CH3), 28.2 (3x CH3, t-Bu), 51.6, 55.3, 67.6, 82.7, 105.7, 118.8, 120.2, 124.1, 
124.3, 132.6, 133.4, 142.5. m/z found 301.1549 [M + H]+; C17H21O3N2 requires 301.1547. 
Racemic HPLC trace (99:1, hexane:iso-propanol, flow rate; 0.5 mL/min); 35.37 min (49.61 
%), 37.46 min (50.39 %). 
 
Asymmetric Epoxidation 
Aqueous conditions: Following the general procedure for the formation of 
enantioenriched epoxides under aqueous conditions, compound 121 (0.06 g, 0.21 mmol) 
and catalyst 82 (0.007 g, 5 mol%) was dissolved in acetonitrile:water (10:1, 1 mL) and 
cooled to 0 °C. Oxone (0.26 g, 0.42 mmol) and sodium hydrogen carbonate (0.09 g, 0.87 
mmol) were added in one portion, and the reaction progress was monitored by TLC. The 
reaction mixture was purified by flash column chromatography (eluents; petroleum ether: 
ethyl acetate: triethylamine, 10:1:0.1), affording 131 as a colourless oil (0.057 g, 90%). 
[α]D = −56.2 (c 0.02 g/mL, CH2Cl2); Chiral HPLC trace (99:1, hexane:iso-propanol, flow 
rate; 0.5 mL/min); 35.82 min (43.82 %), 37.88 min (56.18 %). 
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3,4-epoxy-1-carboxybenzyl-2,2-dimethyl-6-cyano-tetrahydroquinoline (132): 
 
Non-chiral Epoxidation: Following the general procedure for the formation of racemic 
epoxides, compound 122 (0.16 g, 0.50 mmol), m-CPBA (0.17 g, 1 mmol) and NaHCO3 
(0.17 g, 2.0 mmol) were left to react at 0 °C for 24 hours. The crude reaction mixture was 
purified by flash column chromatography (eluents; petroleum ether: ethyl acetate: 
triethylamine, 6:1:0.1), affording 132 as a colourless oil (0.13 g, 78%). νmax (film) / cm
-1
: 
2975, 2226, 1721, 1612, 1574, 1499, 1306, 1254, 1224, 1069. 
1
H NMR (300 MHz, 
CDCl3): δH 1.25 (3H, s, CH3), 1.84 (3H, s, CH3), 3.48 (1H, d, J = 4 Hz, C3-H), 3.83 (1H, d, 
J = 4 Hz, C4-H), 5.09 & 5.29 (2H, dd, J = 12, 79 Hz, CH2-benzyl), 6.95 (1H, d, J = 9 Hz, 
C8-H), 7.25-7.45 (6H, m, C7-H & 5x Ar-H), 7.61 (1H, d, J = 2 Hz, C5-H). 
13
C NMR (75 
MHz, CDCl3): δC 22.4 (CH3), 25.7 (CH3), 51.1, 55.6, 67.1, 68.1, 106.7, 118.4, 125.2, 
125.3, 128.6 (3C), 128.7 (2C), 132.5, 133.0, 135.1, 141.7, 155.2. HRMS m/z found 
335.1393 [M + H]
+
; [C20H18N2O3+H]
+
 requires 335.1390. Enantiomers could not be 
resolved via chiral HPLC nor using chiral shift reagent in the 
1
H NMR of 132. 
 
3,4-epoxy-1-tert-butyoxycarbonyl-2,2-dimethyl-6-chloro-tetrahydroquinoline (133): 
 
Non-chiral Epoxidation: Following the general procedure for the formation of racemic 
epoxides, compound 126 (0.1 g, 0.34 mmol), m-CPBA (0.12 g, 0.68 mmol) and NaHCO3 
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(0.11 g, 1.36 mmol) were left to react at 0 °C for 24 hours. The crude reaction mixture was 
purified by flash column chromatography (eluents; petroleum ether: ethyl acetate: 
triethylamine, 10:1:0.1), affording 133 as a yellow oil (0.055 g, 53%). νmax (film) / cm
-1
: 
2978, 1709, 1489, 1313, 1240, 1161, 1145. 
1
H NMR (300 MHz, CDCl3): δH 1.18 (3H, s, 
CH3), 1.45 (9H, s, t-Bu), 1.85 (3H, s, CH3), 3.42 (1H, d, J = 4 Hz, C3-H), 3.74 (1H, d, J = 
4 Hz, C4-H), 7.02 (1H, d, J = 9 Hz, C8-H), 7.18 (1H, dd, J = 3, 9 Hz, C7-H), 7.28 (1H, d, J 
= 3 Hz, C5-H). 
13
C NMR (75 MHz, CDCl3): δC 22.6 (CH3), 26.1 (CH3), 28.0 (3x CH3, t-
Bu), 51.2, 54.8, 67.4, 81.2, 126.1, 126.7, 128.4, 128.5, 128.7, 137.0, 154.7. HRMS m/z 
found 310.1208 [M + H]
+
; [C16H20ClNO3+H]
+
 requires 310.1204. Resolution of 
enantiomers was achieved using 3 mg of europium (III) chelate/10 mg of epoxide. 
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3.3.4 Iminium-salt Catalyst 82 Synthesis 
2,2’-bis(bromomethyl)biphenyl (140): 23 
 
 
2,2’-Biphenyldimethanol 139 (3 g, 14.0 mmol) was dissolved in neat hydrobromic acid (50 
mL) at room temperature, and then submitted to reflux for 2.5 h. Reaction progress was 
monitored by TLC, and upon reaction completion, the solution was cooled, toluene (100 
mL) added, and the organic layer was extracted. The organic extract was washed with 
saturated sodium hydrogen carbonate (100 mL), brine (100 mL), dried (MgSO4), and 
excess organic solvents removed under reduced pressure, affording 2,2’-
bis(bromomethyl)biphenyl 140 as a colourless solid (4.5 g, 95%; mp  92-94 °C). 
1
H NMR 
(300 MHz, CDCl3): δH 4.22 (2H, d, J = 10 Hz, 2x CHH-Br)), 4.37 (2H, d, J = 10 Hz, 2x 
CHH-Br), 7.30 (2H, dd, J = 8, 2 Hz, Ar-H), 7.40 (2H, ddd, J = 8, 8, 2 Hz, Ar-H), 7.44 (2H, 
dd, J = 8, 8, 2 Hz, Ar-H), 7.57 (2H, dd, J = 8, 2 Hz, Ar-H). 
13
C NMR (75 MHz, CDCl3): δC 
32.0, 128.3, 128.7, 130.2, 130.7, 135.9, 139.4. 
 
(4S,5S)-2,2-Dimethyl-4-phenyl-1,3-dioxan-5-amine (138): 
24 
 
Compound 138 was prepared according to the procedure reported by Thomas.
20
 (1S,2S)–
(+)–2-amino-1-phenyl-1,3-propanediol 135 (5.00 g, 29.9 mmol) was dissolved in MeOH 
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(50 mL), and methyl formate (2.77 mL, 44.85 mmol) and sodium methoxide (1.37 mL, 
25% in  methanol) were added. The mixture was stirred for 3.5 h and the solvent removed 
under reduced pressure. Diol 136 (5.80 g, 29.71 mmol) was then dissolved with acetone 
(250 mL), and 2,2-dimethoxypropane (31.39 mL, 297.10 mmol) and camphorsulfonic acid 
(0.68 g, 2.97 mmol) were added. The reaction was stirred for 4 h and progress was 
monitored by TLC. The solvents were removed under reduced pressure, and the residue 
was re-dissolved in ethyl acetate. The solution was washed with saturated sodium 
hydrogen carbonate solution, dried (MgSO4), and the solvents were removed under 
reduced pressure to afford formamide 137 as a colourless oil (6.61 g, 94%). N-((4S,5S)-
2,2-Dimethyl-4-phenyl-1,3-dioxan-5-yl)formamide 137 (6.58 g, 28.1 mmol), was 
dissolved in aqueous hydrazine hydrate (140 mL, 85%) and the solution heated under 
reflux for 3 h. The solution was allowed to reach ambient temperature and extracted with 
ethyl acetate (3 x 200 mL). The combined organic layers were washed with water (2 x 200 
mL) and brine (2 x 200 mL), dried (Na2SO4), and the solvents were removed under 
reduced pressure to afford aminodioxane 138 as a yellow oil (5.39 g, 87%). vmax (film)/cm
-
1
: 3365, 2990, 1663, 1498. 
1
H NMR (300 MHz, CDCl3): δ = 1.44 (6H, m, 2x CH3), 2.66 
(1H, dd, J = 4, 2 Hz, NCH, H5), 3.80 (1H, dd, J = 12, 2 Hz, NCHCHH-O, H6), 4.20 (1H, 
dd, J = 12, 2 Hz, NCHCHH-O, H6’), 5.01 (1H, s, PhCH, H4), 7.16-7.28 (5H, m, 5CH 
arom., Ph gp.). 
13
C NMR (75 MHz, CDCl3): δ = 18.5 (CH3, C7 or C8), 29.6 (CH3, C7 or 
C8), 49.6 (CH, NCH, C5), 66.0 (CH2, C6), 73.7 (Ar-CH, C4), 99.2 (C quat., C2), 125.7 (2 
CH arom., C10, C11), 127.5 (CH arom., C14), 128.5 (2 CH arom., C12, C13), 139.6 (C 
quat., arom., C9). 
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(−)-N-[(4S,5S)-2,2-Dimethyl-4-phenyl-1,3-dioxan-5-yl]-5H-dibenzo[c,e]azepinium 
Tetraphenylborate (82):
 
 
 
2,2’-Bis(bromomethyl)biphenyl 140 (4.24g, 12.5 mmol) and amine 138 (3.1 g, 13.8 mmol) 
were dissolved in MeCN (30 mL), to which K2CO3 (5.2g, 37.6 mmol) was added at room 
temperature. The reaction was submitted to reflux for 24 h, cooled, diluted with CH2Cl2 
(100 mL), extracted with water (2x 50 mL), brine (2x 50 mL), and dried over MgSO4. 
Excess solvents were removed under reduced pressure, affording amine 141 (4.87 g, 92%). 
Amine 141 (3 g, 7.79 mmol) was then dissolved in CH2Cl2 (15 mL), to which N-
bromosuccinimide (1.66 g, 9.35 mmol) was added, and left to stir for 5 minutes. Excess 
dichloromethane was removed under reduced pressure, and the remaining solid was re-
dissolved in ethanol (30 mL). Sodium tetraphenylborate (2.93 g, 8.50 mmol) was dissolved 
in a minimum amount of acetonitrile (4 mL), and added to the stirring solution at room 
temperature. After 5 minutes, the reaction was stopped and excess organic solvents 
removed under reduced pressure, affording 82 as a pale orange powder (3.72 g, 68%, mp 
187-188 °C). Further purification of 82 can be achieved by recrystallization from hot 
ethanol. [α]20D – 44.0° (c 1.01, CH3CN). vmax (film)/cm
-1
: 3055, 3038, 2999, 1633, 1579, 
1480, 1451, 1385.  
1
H NMR (400 MHz, DMSO-d6, 115 °C): δ = 1.71 (3H, s), 1.74 (3H, s), 
4.32 (1H, d, J = 22 Hz), 4.49 (1H, d, J = 22 Hz), 4.68–4.77 (1H, m), 4.72 (1H, dd, J = 22, 5 
Hz), 5.15 (1H, d, J = 22 Hz). 5.82 (1H, d, J = 4 Hz), 6.75 (4H, t, J = 12 Hz), 6.88 (8H, t, J 
= 12 Hz), 7.11-7.16 (5H, m), 7.20-7.25 (8H, m), 7.55-7.63 (3H, m), 7.64-7.69 (3H, m), 
7.92-7.94 (2H, m), 9.03 (1H, s). 
13
C NMR (100 MHz, DMSO-d6, 120 °C): δ = 18.1, 28.4, 
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42.7, 60.8, 66.1, 70.5, 99.9, 120.4, 124.1, 129.4, 132.6, 133.6, 135.0, 135.2, 140.5, 163.3, 
171.1. 
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4.0 Appendix A: X-ray Data 
The crystallographic data for the structures presented in the text are given in this section. 
Crystallographic analyses were carried out at the University of St. Andrews by Dr. A. M. 
Z. Slawin (Compound 81).  
 
Table 1. Crystal data and structure refinement for 81. 
Data Collection method             Rigaku Mercury70 diffractometer 
Empirical Formula C26H27NO5S 
Formula Weight 465.56 
Crystal Color, Habit colorless, prism 
Crystal Dimensions 0.050 X 0.050 X 0.050 mm 
Crystal System triclinic 
Lattice Type Primitive 
Lattice Parameters a =   8.081(2) Å 
 b =  10.686(4) Å 
 c =  14.044(5) Å 
  =  86.22(3) o 
  =  75.19(2) o 
  =  79.31(2) o 
 V = 1151.9(6) Å3 
Space Group P1 (#1) 
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Z value 2 
Dcalc 1.342 g/cm3 
F000 492.00 
(MoK) 1.787 cm-1 
B. Intensity Measurements  
Diffractometer Mercury70 
Radiation MoK ( = 0.71075 Å) 
Voltage, Current 50kV, 16mA 
Temperature -180.0oC 
Detector Aperture 70 x 70 mm 
Pixel Size 0.068 mm 
2max 50.7o 
No. of Reflections Measured Total: 7444 
 Unique: 5471 (Rint = 0.0607) 
 Friedel pairs: 1388 
Corrections Lorentz-polarization 
  Absorption 
  (trans. factors: 0.753 - 0.991) 
C. Structure Solution and Refinement  
Structure Solution Direct Methods 
Refinement Full-matrix least-squares on F2 
Function Minimized  w (Fo2 - Fc2)2  
Least Squares Weights w = 1/ [ 2(Fo2) + (0.1214 . P)2  
  + 0.0000 .  P ] 
  where P = (Max(Fo2,0) + 2Fc2)/3 
2max cutoff 50.7o 
Anomalous Dispersion All non-hydrogen atoms 
No. Observations (All reflections) 5471 
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No. Variables 595 
Reflection/Parameter Ratio 9.19 
Residuals: R1 (I>2.00(I)) 0.0683 
Residuals: R (All reflections) 0.1067 
Residuals: wR2 (All reflections) 0.1993 
Goodness of Fit Indicator 0.804 
Flack Parameter (Friedel pairs = 1388) -0.08(14) 
Max Shift/Error in Final Cycle 0.063 
Maximum peak in Final Diff. Map 0.45 e-/Å3 
Minimum peak in Final Diff. Map -0.30 e-/Å3 
 
Table 2. Atomic coordinates and equivalent isotopic displacement parameters (Å
2
) for 81 
atom    x    y    z  Beq 
S3     -0.0811(3)  0.4327(2)  0.7115(2)  3.53(5) 
S33     0.4920(3)  0.6206(2)  0.4160(2)  3.75(5) 
O1      0.0467(7)  0.8693(5)  0.6573(4)  3.31(11) 
O3     -0.1449(7)  0.5804(5)  0.7049(5)  4.18(12) 
O4     -0.2100(11)  0.3705(7)  0.6956(6)  7.8(3) 
O5      0.0916(10)  0.4010(6)  0.6538(5)  5.8(2) 
O17    -0.3959(8)  0.3209(7)  0.9146(5)  5.5(2) 
O31     0.4102(7)  0.1724(5)  0.4543(4)  3.05(10) 
O33     0.3961(7)  0.5119(5)  0.4775(4)  3.35(11) 
O34     0.6649(8)  0.5686(8)  0.3743(7)  7.9(3) 
O35     0.4528(12)  0.7209(6)  0.4830(6)  7.5(3) 
O47     0.0929(8)  0.7651(6)  0.2470(5)  5.4(2) 
N25    -0.1823(10)  1.1199(7)  0.2485(6)  4.7(2) 
N55     0.5853(9) -0.0759(7)  0.8767(6)  4.3(2) 
C2     -0.0285(11)  0.7657(8)  0.7100(6)  3.6(2) 
Appendix 
 
 
201 
 
C3     -0.0406(10)  0.6672(7)  0.6403(6)  2.6(2) 
C4     -0.1344(11)  0.7218(8)  0.5641(7)  4.0(2) 
C5     -0.1371(9)  0.9034(8)  0.4411(6)  3.2(2) 
C6     -0.1062(9)  1.0263(8)  0.4104(6)  2.8(2) 
C7     -0.0340(10)  1.0937(8)  0.4633(7)  3.5(2) 
C8      0.0140(11)  1.0418(8)  0.5472(7)  3.8(2) 
C9      0.0848(10)  0.7116(7)  0.7813(7)  3.1(2) 
C10     0.0160(12)  0.7154(8)  0.8801(7)  3.9(2) 
C11     0.1139(13)  0.6640(8)  0.9446(7)  4.1(2) 
C12     0.2832(13)  0.6046(8)  0.9098(7)  4.0(2) 
C13     0.3570(12)  0.5964(9)  0.8101(8)  4.5(2) 
C14     0.2561(12)  0.6516(8)  0.7444(7)  4.1(2) 
C15    -0.0729(10)  0.4148(7)  0.8354(6)  2.9(2) 
C16    -0.0761(9)  0.2815(7)  0.8782(6)  2.6(2) 
C17    -0.2617(11)  0.2545(8)  0.9252(6)  3.5(2) 
C18    -0.2446(10)  0.1423(8)  0.9930(7)  3.8(2) 
C19    -0.0481(10)  0.1145(8)  0.9856(7)  3.4(2) 
C20    -0.0010(10)  0.2482(7)  0.9701(6)  3.0(2) 
C21     0.0378(12)  0.0518(8)  0.8845(7)  4.1(2) 
C22     0.0126(11)  0.1634(7)  0.8118(7)  3.4(2) 
C23     0.1963(9)  0.2462(8)  0.9494(7)  3.8(2) 
C24    -0.0889(10)  0.3389(8)  1.0562(7)  3.9(2) 
C25    -0.1502(10)  1.0786(8)  0.3201(7)  3.7(2) 
C27    -0.0907(9)  0.8504(8)  0.5255(6)  3.1(2) 
C28    -0.0114(10)  0.9186(7)  0.5766(6)  2.8(2) 
C29     0.4464(10)  0.1268(7)  0.5398(6)  2.9(2) 
C30     0.5011(9)  0.2029(7)  0.5995(6)  2.5(2) 
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C32     0.3412(11)  0.3058(7)  0.4520(6)  3.2(2) 
C33     0.4752(9)  0.3775(7)  0.4716(6)  2.30(13) 
C34     0.5182(12)  0.3392(7)  0.5706(7)  3.7(2) 
C35     0.5372(9)  0.1504(8)  0.6880(6)  3.0(2) 
C36     0.5152(10)  0.0249(8)  0.7164(6)  3.0(2) 
C37     0.4617(10) -0.0504(7)  0.6540(6)  2.9(2) 
C38     0.4279(10)  0.0019(7)  0.5685(6)  3.2(2) 
C39     0.2944(11)  0.3450(7)  0.3573(6)  3.1(2) 
C40     0.4136(11)  0.3217(7)  0.2670(7)  3.3(2) 
C41     0.3690(11)  0.3646(8)  0.1782(7)  3.6(2) 
C42     0.2012(12)  0.4307(8)  0.1832(7)  3.9(2) 
C43     0.0821(12)  0.4525(8)  0.2723(7)  3.9(2) 
C44     0.1260(11)  0.4081(8)  0.3579(7)  3.8(2) 
C45     0.3722(11)  0.6570(7)  0.3273(6)  3.5(2) 
C46     0.3850(10)  0.7751(8)  0.2614(6)  3.2(2) 
C47     0.2307(11)  0.8043(9)  0.2136(8)  4.2(2) 
C48     0.2722(12)  0.8920(9)  0.1286(8)  5.1(2) 
C49     0.4563(11)  0.9120(9)  0.1331(7)  4.2(2) 
C50     0.5355(11)  0.7792(8)  0.1675(6)  3.4(2) 
C51     0.4254(13)  0.9953(9)  0.2219(7)  4.6(2) 
C52     0.3822(11)  0.9016(8)  0.3112(7)  3.6(2) 
C53     0.7121(11)  0.7778(10)  0.1867(8)  4.9(2) 
C54     0.5518(12)  0.6715(9)  0.0958(7)  4.6(2) 
C55     0.5560(10) -0.0307(8)  0.8054(7)  3.3(2) 
Beq = 8/3 
2(U11(aa*)
2 + U22(bb*)
2 + U33(cc*)
2 + 2U12(aa*bb*)cos  + 2U13(aa*cc*)cos  + 
2U23(bb*cc*)cos ) 
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Table 3. Bond Lengths [Å] for 81. 
atom atom distance atom atom distance 
S3 O3 1.570(6) S3 O4 1.404(10)  
S3 O5 1.416(7) S3 C15 1.755(9)  
S33 O33 1.599(6) S33 O34 1.393(7)  
S33 O35 1.411(7) S33 C45 1.747(10)  
O1 C2 1.432(10) O1 C28 1.373(10)  
O3 C3 1.477(9) O17 C17 1.219(11)  
O31 C29 1.347(10) O31 C32 1.432(9)  
O33 C33 1.458(8) O47 C47 1.231(11)  
N25 C25 1.142(13) N55 C55 1.144(12)  
C2 C3 1.516(13) C2 C9 1.540(13)  
C3 C4 1.494(13) C4 C27 1.514(12)  
C5 C6 1.401(11) C5 C27 1.388(12)  
C6 C7 1.364(13) C6 C25 1.452(13)  
C7 C8 1.384(13) C8 C28 1.389(11)  
C9 C10 1.357(12) C9 C14 1.395(11)  
C10 C11 1.375(14) C11 C12 1.374(13)  
C12 C13 1.377(13) C13 C14 1.413(15)  
C15 C16 1.511(10) C16 C17 1.549(11)  
C16 C20 1.556(12) C16 C22 1.567(10)  
C17 C18 1.489(12) C18 C19 1.538(12)  
C19 C20 1.533(12) C19 C21 1.549(12)  
C20 C23 1.542(11) C20 C24 1.538(11)  
C21 C22 1.537(12) C27 C28 1.391(13)  
C29 C30 1.405(12) C29 C38 1.392(11)  
C30 C34 1.507(11) C30 C35 1.406(11)  
C32 C33 1.524(13) C32 C39 1.487(12)  
C33 C34 1.530(13) C35 C36 1.404(12)  
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C36 C37 1.421(13) C36 C55 1.436(13)  
C37 C38 1.361(12) C39 C40 1.387(11)  
C39 C44 1.400(12) C40 C41 1.410(13)  
C41 C42 1.395(12) C42 C43 1.373(12)  
C43 C44 1.370(15) C45 C46 1.518(11)  
C46 C47 1.536(14) C46 C50 1.554(10)  
C46 C52 1.556(12) C47 C48 1.476(14)  
C48 C49 1.560(15) C49 C50 1.545(12)  
C49 C51 1.521(14) C50 C53 1.515(14)  
C50 C54 1.544(13) C51 C52 1.561(13)  
 
Table 4. Bond Angles [o] for 81. 
atom atom atom angle  atom atom atom angle 
O3 S3 O4 108.5(4)  O3 S3 O5 109.6(4) 
O3 S3 C15 100.6(4)  O4 S3 O5 119.4(5) 
O4 S3 C15 110.0(4)  O5 S3 C15 107.1(4) 
O33 S33 O34 109.1(4)  O33 S33 O35 103.8(4) 
O33 S33 C45 99.8(4)  O34 S33 O35 119.6(6) 
O34 S33 C45 111.9(5)  O35 S33 C45 110.4(5) 
C2 O1 C28 117.4(7)  S3 O3 C3 123.2(5) 
C29 O31 C32 115.5(6)  S33 O33 C33 122.5(4) 
O1 C2 C3 111.4(7)  O1 C2 C9 106.2(7) 
C3 C2 C9 113.0(7)  O3 C3 C2 103.9(6) 
O3 C3 C4 107.9(7)  C2 C3 C4 113.3(7) 
C3 C4 C27 112.1(8)  C6 C5 C27 119.0(9) 
C5 C6 C7 120.6(8)  C5 C6 C25 118.3(8) 
C7 C6 C25 121.1(8)  C6 C7 C8 121.1(8) 
C7 C8 C28 118.8(9)  C2 C9 C10 120.3(7) 
C2 C9 C14 120.0(8)  C10 C9 C14 119.5(9) 
C9 C10 C11 121.1(8)  C10 C11 C12 120.3(8) 
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C11 C12 C13 120.5(10)  C12 C13 C14 118.7(8) 
C9 C14 C13 119.9(8)  S3 C15 C16 115.2(6) 
C15 C16 C17 113.6(6)  C15 C16 C20 116.7(7) 
C15 C16 C22 120.2(6)  C17 C16 C20 97.6(6) 
C17 C16 C22 103.7(7)  C20 C16 C22 101.9(6) 
O17 C17 C16 125.3(8)  O17 C17 C18 127.2(8) 
C16 C17 C18 107.2(7)  C17 C18 C19 102.3(7) 
C18 C19 C20 102.2(6)  C18 C19 C21 105.8(8) 
C20 C19 C21 103.4(6)  C16 C20 C19 94.9(7) 
C16 C20 C23 114.1(6)  C16 C20 C24 113.4(6) 
C19 C20 C23 112.8(6)  C19 C20 C24 114.8(6) 
C23 C20 C24 106.9(8)  C19 C21 C22 102.5(6) 
C16 C22 C21 104.9(7)  N25 C25 C6 179.0(9) 
C4 C27 C5 119.9(8)  C4 C27 C28 120.4(8) 
C5 C27 C28 119.6(8)  O1 C28 C8 116.4(8) 
O1 C28 C27 122.7(7)  C8 C28 C27 120.9(8) 
O31 C29 C30 121.2(7)  O31 C29 C38 118.6(8) 
C30 C29 C38 120.2(8)  C29 C30 C34 120.9(8) 
C29 C30 C35 118.8(7)  C34 C30 C35 120.3(8) 
O31 C32 C33 107.6(7)  O31 C32 C39 111.3(7) 
C33 C32 C39 112.8(7)  O33 C33 C32 106.6(6) 
O33 C33 C34 106.8(6)  C32 C33 C34 112.3(7) 
C30 C34 C33 112.2(8)  C30 C35 C36 120.1(8) 
C35 C36 C37 119.9(8)  C35 C36 C55 120.5(9) 
C37 C36 C55 119.5(8)  C36 C37 C38 119.2(7) 
C29 C38 C37 121.8(9)  C32 C39 C40 122.0(8) 
C32 C39 C44 119.8(7)  C40 C39 C44 118.3(8) 
C39 C40 C41 121.1(8)  C40 C41 C42 118.3(7) 
C41 C42 C43 120.8(9)  C42 C43 C44 120.3(8) 
C39 C44 C43 121.1(8)  S33 C45 C46 121.7(7) 
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C45 C46 C47 110.1(8)  C45 C46 C50 122.0(6) 
C45 C46 C52 117.1(7)  C47 C46 C50 99.0(7) 
C47 C46 C52 104.5(7)  C50 C46 C52 101.4(7) 
O47 C47 C46 123.5(9)  O47 C47 C48               127.4(10) 
C46 C47 C48 108.9(8)  C47 C48 C49 100.9(8) 
C48 C49 C50 102.2(8)  C48 C49 C51 105.2(7) 
C50 C49 C51 103.9(8)  C46 C50 C49 94.2(6) 
C46 C50 C53 114.9(8)  C46 C50 C54 112.5(7) 
C49 C50 C53 112.1(8)  C49 C50 C54 114.0(8) 
C53 C50 C54 108.7(7)  C49 C51 C52 103.3(7) 
C46 C52 C51 103.3(7)  N55 C55 C36 178.6(9) 
 
Table 5. Anisotropic displacement parameters for 81. 
atom   U11   U22   U33   U12   U13   U23 
S3     0.063(2) 0.0399(13) 0.0358(13) -0.0196(11) -0.0169(11)        0.0115(9) 
S33    0.071(2) 0.0340(12) 0.050(2) -0.0234(11) -0.0309(12)       0.0127(10) 
O1     0.067(4) 0.027(3) 0.035(4) -0.013(3) -0.019(3)  0.012(3) 
O3     0.060(4) 0.043(4) 0.062(4) -0.020(3) -0.024(3)  0.021(3) 
O4     0.172(8) 0.086(6) 0.098(6) -0.092(6) -0.102(6)  0.039(5) 
O5     0.104(5) 0.047(4) 0.059(5) -0.017(4)  0.000(4)  0.008(3) 
O17    0.040(4) 0.092(5) 0.080(5) -0.015(4) -0.027(4)  0.034(4) 
O31    0.056(4) 0.026(3) 0.037(4) -0.009(3) -0.016(3)  0.002(3) 
O33    0.057(4) 0.033(3) 0.036(4) -0.012(3) -0.006(3)  0.002(3) 
O34    0.043(4) 0.114(6) 0.138(8) -0.019(4) -0.026(5)  0.077(6) 
O35    0.208(9) 0.042(4) 0.067(5) -0.035(5) -0.082(6)  0.012(4) 
O47    0.057(4) 0.071(5) 0.085(6) -0.015(4) -0.032(4)  0.007(4) 
N25    0.066(5) 0.058(5) 0.058(6) -0.020(4) -0.024(5)  0.028(5) 
N55    0.063(5) 0.055(5) 0.044(5)  -0.002(4) -0.021(4)  0.005(4) 
C2     0.055(5) 0.044(5) 0.043(6) -0.018(4) -0.021(5)  0.013(4) 
C3     0.041(4) 0.034(5) 0.031(5) -0.012(4) -0.021(4)  0.013(4) 
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C4     0.060(5) 0.053(6) 0.049(6) -0.019(5) -0.032(5)  0.019(5) 
C5     0.038(5) 0.034(5) 0.050(6) -0.011(4) -0.014(4)  0.015(4) 
C6     0.032(4) 0.041(5) 0.029(5)  -0.003(4) -0.007(4)  0.009(4) 
C7     0.040(5) 0.033(5) 0.051(6)  -0.002(4)  -0.004(4)  0.019(4) 
C8     0.058(5) 0.029(5) 0.052(7)  -0.003(4) -0.009(5)  0.001(4) 
C9     0.048(5) 0.028(5) 0.043(6) -0.007(4) -0.016(5)  0.010(4) 
C10    0.072(6) 0.026(5) 0.049(7) -0.011(4) -0.013(5)             -0.005(4) 
C11    0.097(8) 0.039(5) 0.027(5) -0.018(5) -0.021(5)  0.006(4) 
C12    0.076(7) 0.043(6) 0.042(6) -0.016(5) -0.033(5)  0.007(5) 
C13    0.064(6) 0.046(6) 0.067(8) -0.009(5) -0.025(6)             -0.005(5) 
C14    0.079(7) 0.053(6) 0.029(5) -0.037(5) -0.010(5)  0.006(4) 
C15    0.040(4) 0.028(4) 0.047(5) -0.008(4) -0.020(4)  0.009(4) 
C16    0.039(4) 0.029(4) 0.035(5) -0.009(4) -0.013(4)  0.010(4) 
C17    0.059(6) 0.051(6) 0.030(5) -0.024(5) -0.016(4)  0.008(4) 
C18    0.053(5) 0.057(6) 0.042(6) -0.026(5) -0.015(5)  0.016(5) 
C19    0.056(5) 0.034(5) 0.039(6) -0.013(4) -0.012(4)  0.009(4) 
C20    0.046(5) 0.032(5) 0.038(5) -0.007(4) -0.016(4)  0.011(4) 
C21    0.076(6) 0.026(5) 0.053(7) -0.004(5) -0.018(5)  0.005(4) 
C22    0.059(5) 0.025(5) 0.046(6) -0.008(4) -0.015(5)  0.001(4) 
C23    0.037(5) 0.055(6) 0.053(6) -0.010(4) -0.012(4)  0.003(5) 
C24    0.052(5) 0.050(6) 0.052(6) -0.021(4) -0.011(5)             -0.012(5) 
C25    0.040(5) 0.045(6) 0.053(7) -0.010(4) -0.013(5)  0.023(5) 
C27    0.034(4) 0.043(5) 0.037(6) -0.005(4) -0.007(4)  0.016(4) 
C28    0.045(5) 0.034(5) 0.030(5) -0.011(4) -0.012(4)  0.010(4) 
C29    0.043(5) 0.033(5) 0.030(5)  -0.001(4) -0.006(4)  0.003(4) 
C30    0.036(4) 0.029(5) 0.028(5) -0.003(4) -0.006(4)             -0.003(4) 
C32    0.060(5) 0.034(5) 0.032(5) -0.009(4) -0.017(4)  0.005(4) 
C33    0.036(4) 0.017(4) 0.033(5) -0.008(3)  -0.003(4)  0.004(3) 
C34    0.073(6) 0.023(5) 0.052(6) -0.015(4) -0.029(5)  0.014(4) 
C35    0.038(4) 0.045(6) 0.032(5)  -0.002(4) -0.013(4)  0.005(4) 
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C36    0.035(4) 0.041(5) 0.035(5) -0.007(4) -0.004(4)  0.005(4) 
C37    0.051(5) 0.028(5) 0.035(5) -0.013(4) -0.013(4)  0.003(4) 
C38    0.051(5) 0.033(5) 0.038(6) -0.009(4) -0.014(4)  0.004(4) 
C39    0.066(6) 0.027(5) 0.032(5) -0.025(4) -0.016(4)  0.004(4) 
C40    0.053(5) 0.030(5) 0.044(6) -0.010(4) -0.017(5)  0.005(4) 
C41    0.062(6) 0.040(5) 0.042(6) -0.021(5) -0.019(5)  0.001(4) 
C42    0.072(6) 0.050(6) 0.034(6) -0.022(5) -0.022(5)  0.014(4) 
C43    0.060(6) 0.042(5) 0.061(7) -0.023(5) -0.031(6)  0.005(5) 
C44    0.054(6) 0.039(5) 0.056(7) -0.020(5) -0.013(5)  0.003(5) 
C45    0.073(6) 0.029(5) 0.040(5) -0.022(4) -0.026(5)  0.010(4) 
C46    0.050(5) 0.042(5) 0.028(5) -0.005(4) -0.010(4)  0.002(4) 
C47    0.045(5) 0.050(6) 0.071(7) -0.013(5) -0.027(5)  0.005(5) 
C48    0.082(7) 0.060(6) 0.063(7) -0.018(5) -0.038(6)  0.017(5) 
C49    0.070(6) 0.059(6) 0.037(6) -0.019(5) -0.026(5)  0.015(5) 
C50    0.060(5) 0.036(5) 0.031(5) -0.005(4) -0.008(4)  0.002(4) 
C51    0.085(7) 0.042(6) 0.060(7) -0.020(5) -0.038(6)  0.004(5) 
C52    0.056(5) 0.042(5) 0.044(6) -0.011(4) -0.016(5)             -0.006(4) 
C53    0.048(5) 0.075(7) 0.067(7) -0.026(5) -0.008(5)             -0.007(6) 
C54    0.066(6) 0.065(6) 0.039(6) -0.029(5)  0.008(5)              -0.013(5) 
C55    0.046(5) 0.050(6) 0.035(6) -0.011(4) -0.016(4)  0.005(5) 
The general temperature factor expression: exp(-22(a*2U11h
2 + b*2U22k
2 + c*2U33l
2 + 2a*b*U12hk + 
2a*c*U13hl + 2b*c*U23kl)) 
 
Table 6. Hydrogen coordinates for 81. 
Atom    x    y    z  Biso 
H2     -0.1484  0.8001  0.7494  4.28 
H3      0.0778  0.6202  0.6085  3.14 
H4A    -0.1032  0.6624  0.5086  4.77 
H4B    -0.2612  0.7308  0.5929  4.77 
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H5     -0.1889  0.8571  0.4047  3.81 
H7     -0.0164  1.1776  0.4422  4.22 
H8      0.0633  1.0895  0.5841  4.52 
H10    -0.1018  0.7542  0.9050  4.63 
H11     0.0644  0.6695  1.0136  4.97 
H12     0.3497  0.5689  0.9549  4.75 
H13     0.4735  0.5544  0.7859  5.45 
H14     0.3050  0.6478  0.6753  4.86 
H15A    0.0344  0.4418  0.8418  3.48 
H15B   -0.1729  0.4729  0.8752  3.48 
H18A   -0.2833  0.0691  0.9707  4.61 
H18B   -0.3121  0.1630  1.0611  4.61 
H19    -0.0144  0.0654  1.0429  4.04 
H21A   -0.0213 -0.0178  0.8744  4.92 
H21B    0.1626  0.0176  0.8780  4.92 
H22A    0.1259  0.1773  0.7688  4.08 
H22B   -0.0626  0.1469  0.7700  4.08 
H23A    0.2364  0.2157  1.0084  4.55 
H23B    0.2205  0.3325  0.9320  4.55 
H23C    0.2573  0.1893  0.8947  4.55 
H24A   -0.0534  0.3037  1.1156  4.72 
H24B   -0.2154  0.3486  1.0680  4.72 
H24C   -0.0537  0.4223  1.0398  4.72 
H32     0.2334  0.3235  0.5066  3.90 
H33     0.5834  0.3642  0.4169  2.76 
H34A    0.6387  0.3506  0.5666  4.41 
H34B    0.4391  0.3960  0.6222  4.41 
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H35     0.5766  0.1999  0.7287  3.65 
H37     0.4497 -0.1362  0.6717  3.50 
H38     0.3906 -0.0482  0.5272  3.80 
H40     0.5271  0.2760  0.2650  3.91 
H41     0.4511  0.3489  0.1166  4.31 
H42     0.1688  0.4611  0.1242  4.69 
H43    -0.0313  0.4985  0.2746  4.73 
H44     0.0407  0.4203  0.4187  4.58 
H45A    0.4028  0.5830  0.2834  4.16 
H45B    0.2482  0.6620  0.3623  4.16 
H48A    0.1881  0.9731  0.1369  6.12 
H48B    0.2754  0.8528  0.0661  6.12 
H49     0.5270  0.9448  0.0704  5.00 
H51A    0.5305  1.0305  0.2216  5.48 
H51B    0.3270  1.0664  0.2233  5.48 
H52A    0.2664  0.9321  0.3550  4.34 
H52B    0.4708  0.8908  0.3498  4.34 
H53A    0.7441  0.7001  0.2239  5.88 
H53B    0.7072  0.8525  0.2249  5.88 
H53C    0.7990  0.7799  0.1238  5.88 
H54A    0.4425  0.6783  0.0761  5.48 
H54B    0.5766  0.5888  0.1286  5.48 
H54C    0.6466  0.6791  0.0374  5.48 
 
Table 7. Bond lengths involving hydrogens (Å) for 81. 
Atom  atom distance atom atom distance 
C2 H2 1.000 C3 H3 1.000  
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C4 H4A 0.990 C4 H4B 0.990  
C5 H5 0.950 C7 H7 0.950  
C8 H8 0.950 C10 H10 0.950  
C11 H11 0.950 C12 H12 0.950  
C13 H13 0.950 C14 H14 0.950  
C15 H15A 0.990 C15 H15B 0.990  
C18 H18A 0.990 C18 H18B 0.990  
C19 H19 1.000 C21 H21A 0.990  
C21 H21B 0.990 C22 H22A 0.990  
C22 H22B 0.990 C23 H23A 0.980  
C23 H23B 0.980 C23 H23C 0.980  
C24 H24A 0.980 C24 H24B 0.980  
C24 H24C 0.980 C32 H32 1.000  
C33 H33 1.000 C34 H34A 0.990  
C34 H34B 0.990 C35 H35 0.950  
C37 H37 0.950 C38 H38 0.950  
C40 H40 0.950 C41 H41 0.950  
C42 H42 0.950 C43 H43 0.950  
C44 H44 0.950 C45 H45A 0.990  
C45 H45B 0.990 C48 H48A 0.990  
C48 H48B 0.990 C49 H49 1.000  
C51 H51A 0.990 C51 H51B 0.990  
C52 H52A 0.990 C52 H52B 0.990  
C53 H53A 0.980 C53 H53B 0.980  
C53 H53C 0.980 C54 H54A 0.980  
C54 H54B 0.980 C54 H54C 0.980 
Table 8. Torsion Angles (o) for 81. 
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 (Those having bond angles > 160 or < 20 degrees are excluded.) 
atom1 atom2 atom3 atom4    angle  atom1 atom2 atom3 atom4    angle 
O4 S3 O3 C3 -127.3(6)   O5 S3 O3 C3 4.8(7)  
O3 S3 C15 C16 159.9(5)   C15 S3 O3 C3      117.3(6)  
O4 S3 C15 C16 45.6(6)   O5 S3 C15 C16     85.6(6)  
O34 S33 O33 C33 -10.8(7)   O35 S33 O33 C33   -139.4(6)  
O33 S33 C45 C46 167.0(5)   C45 S33 O33 C33    106.6(5)  
O34 S33 C45 C46 -77.7(7)   O35 S33 C45 C46 58.2(7)  
C2 O1 C28 C8 158.4(5)   C2 O1 C28 C27      -21.9(8)  
C28 O1 C2 C3 44.8(8)   C28 O1 C2 C9       168.3(5)  
S3 O3 C3 C2 -124.7(6)   S3 O3 C3 C4       114.7(6)  
C29 O31 C32 C33 59.7(7)   C29 O31 C32 C39    -176.1(6)  
C32 O31 C29 C30 -31.9(9)   C32 O31 C29 C38     147.8(6)  
S33 O33 C33 C32 -129.5(5)   S33 O33 C33 C34     110.2(5)  
O1 C2 C3 O3 -171.2(6)   O1 C2 C3 C4       -54.3(8)  
O1 C2 C9 C10 117.1(7)   O1 C2 C9 C14     -66.7(8)  
C3 C2 C9 C10 -120.4(7)   C3 C2 C9 C14 55.8(9)  
C9 C2 C3 O3 69.2(7)   C9 C2 C3 C4      -173.9(6)  
O3 C3 C4 C27 153.7(5)   C2 C3 C4 C27 39.2(8)  
C3 C4 C27 C5 166.9(6)   C3 C4 C27 C28      -16.0(9)  
C6 C5 C27 C4 175.7(5)   C6 C5 C27 C28 -1.4(9)  
C27 C5 C6 C7 -0.9(9)   C27 C5 C6 C25     178.0(6)  
C5 C6 C7 C8 1.4(10)   C25 C6 C7 C8      -177.5(6)  
C6 C7 C8 C28 0.5(10)   C7 C8 C28 O1       176.7(6)  
C7 C8 C28 C27 -2.9(10)   C2 C9 C10 C11     178.0(7)  
C2 C9 C14 C13 -176.8(7)   C10 C9 C14 C13      -0.6(13)  
C14 C9 C10 C11 1.8(13)   C9 C10 C11 C12      -1.6(14)  
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C10 C11 C12 C13 0.3(14)   C11 C12 C13 C14 0.8(14)  
C12 C13 C14 C9 -0.6(14)   S3 C15 C16 C17      -89.9(6)  
S3 C15 C16 C20 157.7(4)   S3 C15 C16 C22 33.6(9)  
C15 C16 C17 O17 13.5(12)   C15 C16 C17 C18    -160.5(6)  
C15 C16 C20 C19 175.9(5)   C15 C16 C20 C23      -66.4(7)  
C15 C16 C20 C24 56.2(8)   C15 C16 C22 C21     161.5(7)  
C17 C16 C20 C19 54.6(6)   C17 C16 C20 C23     172.3(6)  
C17 C16 C20 C24 -65.1(7)   C20 C16 C17 O17     137.1(8)  
C20 C16 C17 C18 -36.9(7)   C17 C16 C22 C21      -70.3(7)  
C22 C16 C17 O17 -118.6(9)   C22 C16 C17 C18 67.4(8)  
C20 C16 C22 C21 30.6(7)   C22 C16 C20 C19      -51.1(6)  
C22 C16 C20 C23 66.5(7)   C22 C16 C20 C24    -170.8(6)  
O17 C17 C18 C19 -170.9(9)   C16 C17 C18 C19 3.0(8)  
C17 C18 C19 C20 33.1(8)   C17 C18 C19 C21      -74.8(7)  
C18 C19 C20 C16 -55.3(6)   C18 C19 C20 C23    -174.0(6)  
C18 C19 C20 C24 63.2(8)   C18 C19 C21 C22 70.4(8)  
C20 C19 C21 C22 -36.7(8)   C21 C19 C20 C16 54.4(7)  
C21 C19 C20 C23 -64.3(8)   C21 C19 C20 C24     173.0(6)  
C19 C21 C22 C16 3.1(9)   C4 C27 C28 O1 6.7(10)  
C4 C27 C28 C8 -173.7(6)   C5 C27 C28 O1     -176.2(6)  
C5 C27 C28 C8 3.4(10)   O31 C29 C30 C34 1.1(9)  
O31 C29 C30 C35 -180.0(5)   O31 C29 C38 C37    -179.8(5)  
C30 C29 C38 C37 -0.1(10)   C38 C29 C30 C34    -178.7(6)  
C38 C29 C30 C35 0.3(9)   C29 C30 C34 C33 -1.7(9)  
C29 C30 C35 C36 -1.2(9)   C34 C30 C35 C36     177.7(6)  
C35 C30 C34 C33 179.4(6)   O31 C32 C33 O33   -175.1(5)  
O31 C32 C33 C34 -58.5(7)   O31 C32 C39 C40    -55.1(10)  
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O31 C32 C39 C44 125.3(7)   C33 C32 C39 C40 66.1(9)  
C33 C32 C39 C44 -113.5(7)   C39 C32 C33 O33 61.6(7)  
C39 C32 C33 C34 178.3(5)   O33 C33 C34 C30     146.9(6)  
C32 C33 C34 C30 30.3(8)   C30 C35 C36 C37 2.0(9)  
C30 C35 C36 C55 178.4(6)   C35 C36 C37 C38      -1.8(10)  
C55 C36 C37 C38 -178.2(6)   C36 C37 C38 C29 0.9(10)  
C32 C39 C40 C41 -177.1(7)   C32 C39 C44 C43     175.8(7)  
C40 C39 C44 C43 -3.8(12)   C44 C39 C40 C41 2.5(12)  
C39 C40 C41 C42 -0.4(12)   C40 C41 C42 C43      -0.5(13)  
C41 C42 C43 C44 -0.7(14)   C42 C43 C44 C39 2.9(14)  
S33 C45 C46 C47 -163.4(5)   S33 C45 C46 C50 81.4(9)  
S33 C45 C46 C52 -44.2(8)   C45 C46 C47 O47     21.4(11)  
C45 C46 C47 C48 -162.7(6)   C45 C46 C50 C49     173.3(8)  
C45 C46 C50 C53 -69.9(10)   C45 C46 C50 C54     55.2(11)  
C45 C46 C52 C51 171.8(6)   C47 C46 C50 C49 52.6(7)  
C47 C46 C50 C53 169.4(6)   C47 C46 C50 C54     -65.5(7)  
C50 C46 C47 O47 150.5(8)   C50 C46 C47 C48     -33.6(8)  
C47 C46 C52 C51 -66.1(7)   C52 C46 C47 O47   -105.2(9)  
C52 C46 C47 C48 70.7(7)   C50 C46 C52 C51 36.4(7)  
C52 C46 C50 C49 -54.2(7)   C52 C46 C50 C53 62.6(8)  
C52 C46 C50 C54 -172.3(6)   O47 C47 C48 C49     174.6(9)  
C46 C47 C48 C49 -1.0(9)   C47 C48 C49 C50 36.0(8)  
C47 C48 C49 C51 -72.3(8)   C48 C49 C50 C46      -55.6(7)  
C48 C49 C50 C53 -174.7(6)   C48 C49 C50 C54 61.3(8)  
C48 C49 C51 C52 74.6(8)   C50 C49 C51 C52      -32.4(8)  
C51 C49 C50 C46 53.7(8)   C51 C49 C50 C53      -65.4(8)  
C51 C49 C50 C54 170.6(7)   C49 C51 C52 C46 -2.7(9)  
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4.1 Appendix B: Determining enantiomeric excesses by HPLC or by Chiral Shift 
Experiments of 
1
H NMR spectra 
Determination of enantiomeric excess of 56, 60, 68, 70 by HPLC. 
HPLC conditions: Column Eurocel 01 280 x 4.6 mm, 5 μm particle size. 
Flow: 0.5 mL / min 
Hexane:Isopropanol: 99.5:0.5  
Area % Report for racemic 56 
Data File: C:\EZChrom Elite\Enterprise\Projects\Dave\PhCNchromene3.dat 
 
 
Area % Report for enantioenriched 56 
Data File: C:\EZChrom 
Elite\Enterprise\Projects\Dave\paper2011\dd288alkenerecSM2bis.dat  
 
UV Results     
Retention Time Area Area % Height Height % 
40.663 62108870 42.69 1051182 48.05 
43.417 83370682 57.31 1136548 51.95 
     
Totals     
 145479552 100.00 2187730 100.00 
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UV Results     
Retention Time Area Area % Height Height % 
41.337 514307753 47.94 6969959 50.28 
43.470 558463298 52.06 6891331 49.72 
Totals     
 1072771051 100.00 13861290 100.00 
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HPLC conditions: Column Eurocel 01 280 x 4.6 mm, 5 μm particle size. 
Flow: 1 mL / min 
Hexane:Isopropanol: 90:10 
Area % Report for racemic 60 
Data File: C:\EZChrom Elite\Enterprise\Projects\Dave\1st year phd\dd084SM2.dat 
 
 
UV Results     
Retention Time Area Area % Height Height % 
5.023 12826528 49.90 1555434 54.11 
5.417 12876177 50.10 1319204 45.89 
     
Totals     
 25702705 100.00 2874638 100.00 
 
 
Area % Report for enantioenriched 60  
Data File: C:\EZChrom Elite\Enterprise\Projects\Dave\1st year phd\dd110SMR.dat  
 
UV Results     
Retention Time Area Area % Height Height % 
5.117 7847582 24.93 979532 27.86 
5.543 23633357 75.07 2535759 72.14 
Totals     
 31480939 100.00 3515291 100.00 
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HPLC conditions: Column Eurocel 01 280 x 4.6 mm, 5 μm particle size. 
Flow: 1 mL / min 
Hexane:Isopropanol: 90:10 
Area % Report for racemic 68  
Data File: C:\EZChrom Elite\Enterprise\Projects\Dave\paper2011\287racepox.dat  
 
UV Results     
Retention Time Area Area % Height Height % 
29.213 479698387 48.01 7228572 54.34 
38.227 519477371 51.99 6072709 45.66 
     
Totals     
 999175758 100.00 13301281 100.00 
 
Area % Report for enantioenriched 68  
Data File: C:\EZChrom Elite\Enterprise\Projects\Dave\paper2011\dd288epox.dat   
 
UV Results     
Retention Time Area Area % Height Height % 
26.227 227664852 88.99 4739603 90.55 
34.170 28179676 11.01 494739 9.45 
     
Totals     
 255844528 100.00 5234342 100.00 
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HPLC conditions: Column Eurocel 01 280 x 4.6 mm, 5 μm particle size. 
Flow: 0.5 mL / min 
Hexane:Isopropanol: 99.5:0.5 
Area % Report for racemic 70  
Data File: C:\EZChrom Elite\Enterprise\Projects\Dave\1st year phd\dd094.2.dat 
 
  
Area % Report for enantioenriched 70 
Data File: C:\EZChrom Elite\Enterprise\Projects\Dave\1st year phd\dd110epoxide2.dat  
 
 
 
UV Results     
Retention Time Area Area % Height Height % 
43.173 67588 0.12 1184 0.29 
71.150 9270749 17.11 75500 18.73 
81.470 2730918 5.04 23856 5.92 
89.147 42121596 77.73 302562 75.06 
Totals     
 54190851 100.00 403102 100.00 
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UV Results     
Retention Time Area Area % Height Height % 
42.440 190699438 10.10 2671724 18.95 
64.013 735938851 39.00 5454226 38.69 
80.140 187967029 9.96 1504738 10.68 
84.103 772625826 40.94 4465081 31.68 
Totals     
 1887231144 100.00 14095769 100.00 
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Determination of enantiomeric excess of epoxide 129 using chiral europium shift 
reagent (europium (III) tris[3-(hepta-fluropropylhydroxymethylene)-(+)-camphorate]  
 
Racemic epoxide 129 resolved using 3 mg [(+)-Eu(hfc)3] per 10 mg of compound 129 
 
Enantioenriched epoxide 129; (aqueous conditions, catalyst 83, ee = 22%) 
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Enantioenriched epoxide 129; (non-aqueous conditions, catalyst 41, ee = 62%) 
 
 
